{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **3. Pondération statistique** (TF-IDF / OKapiBM25)  \n",
    "\n",
    "https://stackoverflow.com/questions/46580932/calculate-tf-idf-using-sklearn-for-n-grams-in-python  \n",
    "http://scikit-learn.sourceforge.net/stable/modules/generated/sklearn.feature_extraction.text.TfidfVectorizer.html#sklearn-feature-extraction-text-tfidfvectorizer  \n",
    "https://scikit-learn.org/stable/modules/feature_extraction.html#text-feature-extraction\n",
    "\n",
    "https://pypi.org/project/rank-bm25/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "path = '../04-filtrage/output/'\n",
    "acteur = 'inesss'\n",
    "tag = ''\n",
    "\n",
    "if tag:\n",
    "    csv_file = acteur + '_' + tag + '_significant-collocations.csv'\n",
    "\n",
    "else:\n",
    "    csv_file = acteur + '_significant-collocations.csv'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Lire le vocabulaire** (termes retenus au prétraitement)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Collocation</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>réponses rapides</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>1319</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>cours d'évaluation</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>1288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>réponses rapides disponibles</td>\n",
       "      <td>NOM ADJ ADJ</td>\n",
       "      <td>1179</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>usage optimal</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>1138</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>bicarbonate de sodium</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>980</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6665</th>\n",
       "      <td>année de vie</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6666</th>\n",
       "      <td>entrée en vigueur</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6667</th>\n",
       "      <td>fumarate de nom</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6668</th>\n",
       "      <td>utilisation et résultats cliniques en contexte...</td>\n",
       "      <td>NOM KON NOM ADJ PRP NOM ADJ</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6669</th>\n",
       "      <td>usage optimal guides</td>\n",
       "      <td>NOM ADJ NOM</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6670 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Collocation  \\\n",
       "0                                      réponses rapides   \n",
       "1                                    cours d'évaluation   \n",
       "2                          réponses rapides disponibles   \n",
       "3                                         usage optimal   \n",
       "4                                 bicarbonate de sodium   \n",
       "...                                                 ...   \n",
       "6665                                       année de vie   \n",
       "6666                                  entrée en vigueur   \n",
       "6667                                    fumarate de nom   \n",
       "6668  utilisation et résultats cliniques en contexte...   \n",
       "6669                               usage optimal guides   \n",
       "\n",
       "             Structure syntaxique  Fréquence  \n",
       "0                         NOM ADJ       1319  \n",
       "1                     NOM PRP NOM       1288  \n",
       "2                     NOM ADJ ADJ       1179  \n",
       "3                         NOM ADJ       1138  \n",
       "4                     NOM PRP NOM        980  \n",
       "...                           ...        ...  \n",
       "6665                  NOM PRP NOM          6  \n",
       "6666                  NOM PRP NOM          6  \n",
       "6667                  NOM PRP NOM          6  \n",
       "6668  NOM KON NOM ADJ PRP NOM ADJ          6  \n",
       "6669                  NOM ADJ NOM          6  \n",
       "\n",
       "[6670 rows x 3 columns]"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from pandas import *\n",
    "\n",
    "with open(path+csv_file, encoding='utf-8') as f:\n",
    "    csv = read_csv(f)[[\"Collocation\", \"Structure syntaxique\", \"Fréquence\"]] # \"LLR\", \"p-value\"]]\n",
    "\n",
    "csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "vocabulaire = [t.lower() for t in list(csv['Collocation'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "On a un vocabulaire de 6670 formes.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['réponses rapides',\n",
       " \"cours d'évaluation\",\n",
       " 'réponses rapides disponibles',\n",
       " 'usage optimal',\n",
       " 'bicarbonate de sodium',\n",
       " 'jamp lurasidone',\n",
       " \"attente d'évaluation\",\n",
       " 'listes des médicaments',\n",
       " 'version française',\n",
       " 'services sociaux',\n",
       " \"demande en cours d'évaluation\",\n",
       " 'demande en cours',\n",
       " \"guide d'usage\",\n",
       " \"guide d'usage optimal\",\n",
       " 'demande en attente',\n",
       " 'inesss express',\n",
       " 'pré ac en attente',\n",
       " 'dénomination commune',\n",
       " 'nom du fabricant',\n",
       " \"recommandation de l'inesss\",\n",
       " 'besoins hospitaliers',\n",
       " 'décision du ministre',\n",
       " 'sulfonate calcique de jamp',\n",
       " 'citrate liquid',\n",
       " 'calcium polystyrene',\n",
       " 'sodium pour injection',\n",
       " 'calcium polystyrene sulfonate',\n",
       " 'bicarbonate de sodium pour injection',\n",
       " 'injection de glycopyrrolate',\n",
       " 'apo eletriptan',\n",
       " 'sulfonate calcique',\n",
       " 'dépôt pour évaluation',\n",
       " \"attente d'un dépôt\",\n",
       " \"attente d'un dépôt pour évaluation\",\n",
       " 'adultes atteints',\n",
       " 'citrate liquid angita calcium',\n",
       " 'apo eletriptan apotex',\n",
       " 'fumarate de apo eletriptan apotex',\n",
       " 'jamp glycopyrrolate',\n",
       " 'injection de glycopyrrolate jamp glycopyrrolate',\n",
       " 'jamp lurasidone jamp',\n",
       " 'jamp glycopyrrolate jamp',\n",
       " 'citrate liquid angita',\n",
       " 'angita quétiapine fumarate de apo eletriptan',\n",
       " 'jamp lurasidone jamp lurasidone',\n",
       " 'fumarate de apo',\n",
       " \"bromhydrate d'bicarbonate\",\n",
       " 'évaluations récemment',\n",
       " 'apotex élétriptan bromhydrate',\n",
       " 'jamp lurasidone chlorhydrate',\n",
       " 'sodium darunavir jamp',\n",
       " 'apo eletriptan apotex élétriptan bromhydrate',\n",
       " \"bromhydrate d'bicarbonate de sodium\",\n",
       " 'jamp darunavir dextrose',\n",
       " 'bicarbonate de sodium darunavir jamp',\n",
       " 'jamp lurasidone jamp lurasidone chlorhydrate',\n",
       " 'evaluation publiée',\n",
       " 'halycil accelera propylthiouracile',\n",
       " 'halycil accelera',\n",
       " 'angita quétiapine fumarate',\n",
       " 'fumarate de apo eletriptan',\n",
       " \"apotex élétriptan bromhydrate d'bicarbonate\",\n",
       " 'évaluations récemment publiées',\n",
       " 'sulfonate calcique de jamp lurasidone',\n",
       " 'apo eletriptan apotex élétriptan',\n",
       " 'sulfonate calcique de jamp lurasidone jamp',\n",
       " 'injection de glycopyrrolate jamp',\n",
       " 'angita quétiapine',\n",
       " 'apotex élétriptan',\n",
       " \"bromhydrate d'bicarbonate de sodium pour injection\",\n",
       " 'fumarate de apo eletriptan apotex élétriptan',\n",
       " \"pré ac en attente d'évaluation\",\n",
       " \"médicament d'exception\",\n",
       " \"évolution de l'épidémie\",\n",
       " 'épidémie de covid',\n",
       " \"suivi de l'évolution\",\n",
       " \"évolution de l'épidémie de covid\",\n",
       " \"suivi de l'évolution de l'épidémie de covid\",\n",
       " \"suivi de l'évolution de l'épidémie\",\n",
       " 'traitement des patients',\n",
       " \"risques d'hospitalisation\",\n",
       " 'projections des besoins',\n",
       " 'projections des besoins hospitaliers',\n",
       " 'hospitalisation et projections',\n",
       " 'hospitalisation et projections des besoins hospitaliers',\n",
       " 'hospitalisation et projections des besoins',\n",
       " \"risques d'hospitalisation et projections\",\n",
       " 'patients adultes',\n",
       " \"demande en attente d'évaluation\",\n",
       " 'protocole médical',\n",
       " 'réponse rapide',\n",
       " 'patients adultes atteints',\n",
       " \"demande en attente d'un dépôt pour évaluation\",\n",
       " \"demande en attente d'un dépôt\",\n",
       " 'pré ac en cours',\n",
       " \"pré ac en cours d'évaluation\",\n",
       " 'indication reconnue',\n",
       " 'traitement du cancer',\n",
       " 'traitement des patients adultes',\n",
       " 'projet aligné',\n",
       " 'projet aligné inesss acmts',\n",
       " 'projet aligné inesss',\n",
       " 'brain injury',\n",
       " 'cancer du poumon',\n",
       " 'produit biosimilaire',\n",
       " 'traitement des patients adultes atteints',\n",
       " 'inscription avec conditions',\n",
       " 'patients atteints',\n",
       " 'protocole médical national',\n",
       " 'méthode de réponse',\n",
       " 'méthode de réponse rapide',\n",
       " 'traumatic brain',\n",
       " \"médicaments d'exception\",\n",
       " 'traumatic brain injury',\n",
       " \"extrait de l'avis au ministre\",\n",
       " 'biologie médicale',\n",
       " 'listes de médicaments',\n",
       " 'nom commercial',\n",
       " 'système du sang',\n",
       " 'soins intensifs',\n",
       " 'cancer du poumon non à petites cellules',\n",
       " \"demande d'inscription\",\n",
       " 'soins palliatifs',\n",
       " 'liste des médicaments',\n",
       " 'professionnelle scientifique',\n",
       " 'description du médicament',\n",
       " 'kio autres recommandations',\n",
       " 'dépôt électronique',\n",
       " 'évaluation des médicaments',\n",
       " \"guides d'usage optimal\",\n",
       " \"guides d'usage\",\n",
       " 'post covid',\n",
       " 'aide à la décision',\n",
       " \"modes d'intervention\",\n",
       " 'publication associée',\n",
       " 'diabète de type',\n",
       " 'produits de connaissance',\n",
       " 'santé mentale',\n",
       " 'chlamydia et gonorrhoeae',\n",
       " \"coup d'oeil\",\n",
       " 'études cliniques',\n",
       " 'liste de médicaments',\n",
       " 'pembrolizumab merck',\n",
       " 'contexte de la covid',\n",
       " 'ordonnances collectives',\n",
       " 'outil clinique',\n",
       " 'affections post covid',\n",
       " 'contexte de pandémie',\n",
       " 'affections post',\n",
       " 'traitement pharmacologique',\n",
       " \"communiqué suivi de l'évolution\",\n",
       " 'communiqué suivi',\n",
       " \"communiqué suivi de l'évolution de l'épidémie\",\n",
       " \"outil d'aide\",\n",
       " \"réévaluation en cours d'évaluation\",\n",
       " 'réévaluation en cours',\n",
       " 'traitement adjuvant',\n",
       " \"modes d'intervention en santé\",\n",
       " 'formule nutritive',\n",
       " 'intervention en santé',\n",
       " 'régime général',\n",
       " \"fins d'inscription\",\n",
       " 'application inesss guides',\n",
       " 'application inesss',\n",
       " \"outil d'aide à la décision\",\n",
       " 'réponse rapide covid',\n",
       " 'transfert de connaissances',\n",
       " 'traitement des adultes',\n",
       " 'maladie de lyme',\n",
       " \"adultes atteints d'un cancer\",\n",
       " 'google play',\n",
       " 'nom commercial à venir',\n",
       " 'états des connaissances',\n",
       " 'coordination scientifique',\n",
       " 'mise en oeuvre',\n",
       " 'usage optimal sont disponibles',\n",
       " \"guides d'usage optimal sont disponibles\",\n",
       " 'études cliniques en cours',\n",
       " 'ventilation assistée',\n",
       " 'ventilation assistée échangeur',\n",
       " 'prophylaxie et traitement',\n",
       " 'élaboration et mise en oeuvre',\n",
       " 'mise en oeuvre de la méthode',\n",
       " 'oeuvre de la méthode de réponse',\n",
       " 'mise en oeuvre de la méthode de réponse',\n",
       " 'soins intensifs ventilation',\n",
       " 'méthode de réponse rapide dans le contexte',\n",
       " 'élaboration et mise',\n",
       " 'mise en oeuvre de la méthode de réponse rapide',\n",
       " 'réponse rapide dans le contexte de la covid',\n",
       " 'traitements en contexte',\n",
       " 'oeuvre de la méthode',\n",
       " 'oeuvre de la méthode de réponse rapide',\n",
       " 'inspq visitez',\n",
       " 'soins intensifs ventilation assistée',\n",
       " 'échangeur de chaleur',\n",
       " 'ordonnance collective',\n",
       " 'regard sur la pandémie',\n",
       " 'réponse rapide dans le contexte',\n",
       " 'élaboration et mise en oeuvre de la méthode',\n",
       " 'réponses rapides disponibles études cliniques',\n",
       " 'contributions des uetmis',\n",
       " 'contributions des uetmis soins intensifs',\n",
       " \"sites d'intérêt visitez\",\n",
       " 'rapports disponibles présentations cliniques',\n",
       " 'réponses rapides disponibles regard',\n",
       " 'présentations cliniques',\n",
       " 'réponses rapides un coup',\n",
       " 'projections des besoins hospitaliers traitements',\n",
       " 'réponses rapides disponibles services',\n",
       " 'rapports disponibles',\n",
       " 'réponses rapides disponibles méthode de réponse rapide',\n",
       " 'intérêt visitez',\n",
       " 'réponses rapides disponibles cancérologie',\n",
       " 'réponses rapides disponibles études',\n",
       " 'réponses rapides disponibles affections',\n",
       " 'alternatives de traitements en contexte',\n",
       " 'projections des besoins hospitaliers traitements spécifiques',\n",
       " 'procédures diagnostiques',\n",
       " 'réponses rapides disponibles affections post',\n",
       " 'traitements en contexte de pandémie',\n",
       " \"sites d'intérêt\",\n",
       " 'réponses rapides disponibles études cliniques en cours',\n",
       " 'réponses rapides disponibles investigation',\n",
       " 'méthode de réponse rapide covid',\n",
       " 'alternatives de traitements',\n",
       " 'besoins hospitaliers traitements spécifiques',\n",
       " 'réponses rapides disponibles rétablissement',\n",
       " 'réponses rapides disponibles méthode de réponse',\n",
       " 'contributions des uetmis soins',\n",
       " 'rétablissement et reprise',\n",
       " 'réponses rapides disponibles services sociaux',\n",
       " 'traitements spécifiques à la covid',\n",
       " 'besoins hospitaliers traitements',\n",
       " 'rapports disponibles présentations',\n",
       " 'réponses rapides disponibles méthode',\n",
       " 'traitements spécifiques',\n",
       " 'alternatives de traitements en contexte de pandémie',\n",
       " 'réponses rapides disponibles autres traitements',\n",
       " \"demandes d'inscription\",\n",
       " 'ordonnance associée',\n",
       " 'produit du système',\n",
       " 'produit du système du sang',\n",
       " 'conseil a recommandé',\n",
       " 'médicaments biosimilaires',\n",
       " \"traitement de l'hidradénite\",\n",
       " \"patients adultes atteints d'un cancer\",\n",
       " 'traitement pharmacologique des itss',\n",
       " \"traitement des patients adultes atteints d'un cancer\",\n",
       " 'hidradénite suppurée',\n",
       " \"traitement de l'hidradénite suppurée\",\n",
       " 'mode continu',\n",
       " 'hypertension artérielle',\n",
       " 'médicaments du régime',\n",
       " 'médicaments du régime général',\n",
       " 'hidradénite suppurée réévaluation en cours',\n",
       " 'hidradénite suppurée réévaluation',\n",
       " \"traitement de l'hidradénite suppurée réévaluation\",\n",
       " 'réévaluation en attente',\n",
       " 'pratiques cliniques',\n",
       " \"dépôt électronique d'une demande d'inscription\",\n",
       " \"dépôt électronique d'une demande\",\n",
       " 'sras cov',\n",
       " \"demande d'inscription fiche\",\n",
       " 'inscription fiche',\n",
       " 'ordonnance individuelle',\n",
       " 'traitement du cancer du poumon',\n",
       " 'ministère de la santé',\n",
       " 'médicaments multisources',\n",
       " \"traitement d'entretien\",\n",
       " \"processus d'évaluation\",\n",
       " 'santé publique',\n",
       " \"recommandation de l'inesss ajout\",\n",
       " 'biologie médicale et génomique',\n",
       " 'protocoles médicaux',\n",
       " 'coût de traitement',\n",
       " 'ministère de la santé et des services sociaux',\n",
       " 'ministère de la santé et des services',\n",
       " 'institut national',\n",
       " 'soutien au guide',\n",
       " 'portrait et projections',\n",
       " 'projections des hospitalisations',\n",
       " 'portrait et projections des hospitalisations',\n",
       " 'patients âgés',\n",
       " 'protocoles médicaux nationaux',\n",
       " 'traitement des adultes atteints',\n",
       " 'médicaments évalués',\n",
       " 'pembrolizumab merck traitement',\n",
       " \"soutien au guide d'usage optimal\",\n",
       " \"soutien au guide d'usage\",\n",
       " 'professionnel scientifique',\n",
       " 'cardiologie et maladies',\n",
       " 'étude pour la liste',\n",
       " 'rencontre présoumission',\n",
       " 'ministre sur les génériques',\n",
       " 'cardiologie et maladies neurovasculaires',\n",
       " 'maladies neurovasculaires',\n",
       " \"réévaluation en attente d'évaluation\",\n",
       " 'pratiques cliniques préventives',\n",
       " 'cliniques préventives',\n",
       " 'besoins hospitaliers au québec',\n",
       " 'écoulement urétral',\n",
       " 'dépistage et pratiques cliniques préventives',\n",
       " 'dépistage et pratiques cliniques',\n",
       " 'dépistage et pratiques',\n",
       " \"institut national d'excellence\",\n",
       " 'excellence en santé',\n",
       " 'produits du système',\n",
       " \"institut national d'excellence en santé\",\n",
       " 'effets indésirables',\n",
       " 'ministre de la santé',\n",
       " 'produits du système du sang',\n",
       " 'ministre de la santé et des services',\n",
       " 'ministre de la santé et des services sociaux',\n",
       " 'liste de médicaments du régime',\n",
       " 'monothérapie pour le traitement',\n",
       " 'liste de médicaments du régime général',\n",
       " 'données probantes',\n",
       " 'médicaments aux fins',\n",
       " \"évaluation des médicaments aux fins d'inscription\",\n",
       " 'qualité de vie',\n",
       " 'évaluation des médicaments aux fins',\n",
       " \"médicaments aux fins d'inscription\",\n",
       " \"institut national d'excellence en santé et en services\",\n",
       " 'excellence en santé et en services sociaux',\n",
       " 'préavis obligatoire',\n",
       " \"spectre de l'autisme\",\n",
       " 'système de santé',\n",
       " 'excellence en santé et en services',\n",
       " 'rencontre postsoumission',\n",
       " 'maladie pulmonaire',\n",
       " 'trouble du spectre',\n",
       " 'indications reconnues',\n",
       " 'maladie pulmonaire obstructive',\n",
       " 'risque cardiovasculaire',\n",
       " 'cancer de la prostate',\n",
       " 'traitement des patients atteints',\n",
       " 'prise de décision',\n",
       " 'colite ulcéreuse',\n",
       " \"ordonnance individuelle d'ajustement\",\n",
       " \"trouble du spectre de l'autisme\",\n",
       " 'experts consultés',\n",
       " 'maladie pulmonaire obstructive chronique',\n",
       " 'rhinosinusite aiguë',\n",
       " 'troubles neurocognitifs',\n",
       " 'évaluations en mode continu',\n",
       " 'dépistage du cancer',\n",
       " \"risque d'hospitalisation\",\n",
       " 'évaluations en mode',\n",
       " 'médicaments génériques',\n",
       " 'bgp pharma',\n",
       " 'ordonnances associées',\n",
       " 'évaluation scientifique',\n",
       " \"attente d'un avis de conformité\",\n",
       " 'traitement de la colite',\n",
       " 'traitement de la colite ulcéreuse',\n",
       " 'décisions du ministre',\n",
       " \"adultes atteints d'un lymphome\",\n",
       " 'cellules métastatique',\n",
       " 'produits de santé',\n",
       " 'traumatisme craniocérébral',\n",
       " 'indicateurs de qualité',\n",
       " 'évaluation demande',\n",
       " 'asthme sévère',\n",
       " 'adalimumab amgen',\n",
       " \"traitement de l'uvéite\",\n",
       " \"adultes atteints d'un cancer du poumon\",\n",
       " 'présoumission avec les fabricants',\n",
       " 'polyangéite microscopique',\n",
       " 'sandoz produit',\n",
       " 'traitement des plaies',\n",
       " 'gène ret',\n",
       " 'sandoz produit biosimilaire',\n",
       " \"cancer de l'endomètre\",\n",
       " 'granulomatose avec polyangéite',\n",
       " 'postsoumission avec les fabricants',\n",
       " 'point de vue',\n",
       " 'pneumonie acquise',\n",
       " 'évaluation aux fins',\n",
       " 'aspects économique',\n",
       " 'médicaments présentés',\n",
       " 'maladies chroniques',\n",
       " 'références publiées',\n",
       " 'cord injury',\n",
       " 'évolution du risque',\n",
       " 'trauma care',\n",
       " \"guide d'usage optimal rhinosinusite aiguë\",\n",
       " 'hospitalisation pour les personnes infectées',\n",
       " 'documentation scientifique',\n",
       " 'produits de santé naturels',\n",
       " \"évolution du risque d'hospitalisation\",\n",
       " 'santé naturels',\n",
       " 'médicaments multisources génériques',\n",
       " \"risque d'hospitalisation pour les personnes infectées\",\n",
       " 'mild traumatic',\n",
       " 'usage optimal rhinosinusite',\n",
       " 'usage optimal rhinosinusite aiguë',\n",
       " \"guide d'usage optimal rhinosinusite\",\n",
       " 'hospitalisation pour les personnes infectées par le sras',\n",
       " 'pneumonie acquise en communauté',\n",
       " 'fabricants rencontre',\n",
       " 'préavis obligatoire demandé',\n",
       " 'usage optimal pneumonie',\n",
       " 'préavis obligatoire demandé aux fabricants',\n",
       " \"guide d'usage optimal pneumonie\",\n",
       " 'mild traumatic brain',\n",
       " 'usage optimal pneumonie acquise',\n",
       " 'ajout aux listes',\n",
       " 'évaluation amgevita adalimumab',\n",
       " \"modification d'une indication\",\n",
       " 'trouble lié',\n",
       " 'évaluation amgevita adalimumab amgen',\n",
       " 'évaluation amgevita',\n",
       " 'ajout aux listes de médicaments',\n",
       " 'conseil scientifique',\n",
       " \"évaluation aux fins d'inscription\",\n",
       " \"modification d'une indication reconnue\",\n",
       " 'services sociaux msss',\n",
       " \"trouble lié à l'usage\",\n",
       " 'indication reconnue aux listes',\n",
       " \"recommandation de l'inesss ajout aux listes\",\n",
       " \"modalités d'évaluation\",\n",
       " 'professionnels de la santé',\n",
       " \"traitement de l'asthme\",\n",
       " 'approche syndromique',\n",
       " \"médicaments multisources génériques à l'étude\",\n",
       " 'mild traumatic brain injury',\n",
       " \"note d'autres références\",\n",
       " \"médicaments multisources génériques à l'étude pour la liste\",\n",
       " \"demande d'exemption\",\n",
       " \"recommandations de l'inesss\",\n",
       " 'indication reconnue aux listes des médicaments',\n",
       " 'principaux experts consultés',\n",
       " 'liste des principaux experts consultés',\n",
       " 'inhibiteurs de la pompe',\n",
       " 'liste des principaux',\n",
       " 'liste des principaux experts',\n",
       " 'principaux experts',\n",
       " 'pratique clinique',\n",
       " 'pompe à protons',\n",
       " 'investigation de traitement et de suivi',\n",
       " 'fibrillation auriculaire',\n",
       " 'traitement du diabète',\n",
       " 'investigation de traitement',\n",
       " 'inhibiteurs de la pompe à protons',\n",
       " 'dermatite atopique',\n",
       " 'jeunes et familles',\n",
       " \"modalités d'évaluation des médicaments\",\n",
       " 'insuffisance cardiaque',\n",
       " 'services sociaux inesss',\n",
       " 'niveaux de soins',\n",
       " 'mucosite oropharyngée',\n",
       " 'dépistage néonatal',\n",
       " 'experts consultés autres recommandations',\n",
       " 'réactif quantitatif',\n",
       " \"recommandations de l'inesss transmises\",\n",
       " 'bêta lactamines',\n",
       " 'système de mesure',\n",
       " 'critères économique',\n",
       " 'inesss transmises',\n",
       " \"modalités d'évaluation des médicaments aux fins\",\n",
       " 'services en traumatologie',\n",
       " 'analyses de biologie médicale',\n",
       " \"modalités d'évaluation des médicaments aux fins d'inscription\",\n",
       " \"publication des recommandations de l'inesss\",\n",
       " 'analyses de biologie',\n",
       " 'publication des recommandations',\n",
       " 'régime public',\n",
       " 'candidose buccale',\n",
       " 'sédation palliative',\n",
       " 'pertes vaginales',\n",
       " 'traitement de la sclérose',\n",
       " 'ministre sur certains médicaments',\n",
       " 'continuum de services',\n",
       " 'fabricants demande',\n",
       " 'déficience intellectuelle',\n",
       " 'évaluation des technologies',\n",
       " 'ensemble des critères',\n",
       " 'élimination fécale',\n",
       " 'pertes vaginales inhabituelles',\n",
       " 'fibrose kystique',\n",
       " \"virus de l'immunodéficience\",\n",
       " 'références utilisées',\n",
       " 'critères prévus',\n",
       " 'dépôt électronique temporaire',\n",
       " 'immunodéficience humaine',\n",
       " 'dépôt électronique temporaire pour les demandes',\n",
       " 'continuum de services en traumatologie',\n",
       " 'ensemble des critères prévus',\n",
       " \"virus de l'immunodéficience humaine\",\n",
       " 'évaluation des médicaments biosimilaires',\n",
       " \"coup d'œil\",\n",
       " 'sédation palliative continue',\n",
       " \"maladie d'alzheimer\",\n",
       " 'hépatite c maladie',\n",
       " 'severe traumatic',\n",
       " 'rétention urinaire',\n",
       " 'médicaments biosimilaires médicaments',\n",
       " \"fabricants demande d'inscription\",\n",
       " 'fiches rencontre',\n",
       " 'infections urinaires',\n",
       " 'bronchite aiguë',\n",
       " \"candidose buccale chez l'adulte\",\n",
       " 'lignes directrices',\n",
       " \"trouble lié à l'usage d'alcool\",\n",
       " \"demandes d'inscription autres fiches\",\n",
       " 'fiches rencontre postsoumission',\n",
       " 'inscription autres fiches',\n",
       " 'hépatite c maladie pulmonaire obstructive',\n",
       " 'severe traumatic brain',\n",
       " 'traitement au fer',\n",
       " 'hépatite c maladie pulmonaire',\n",
       " 'soins palliatifs nausées',\n",
       " \"usage d'alcool\",\n",
       " 'fabricants rencontre présoumission',\n",
       " \"évaluation d'une demande d'exemption de la méthode\",\n",
       " 'ppb rendez',\n",
       " \"santé naturels virus de l'immunodéficience\",\n",
       " \"médicaments en attente d'un avis de conformité\",\n",
       " \"médicaments biosimilaires évaluation d'une demande\",\n",
       " \"recommandation de l'inesss décision\",\n",
       " 'maladie pulmonaire obstructive chronique médicaments biosimilaires',\n",
       " 'médicaments génériques produits de santé',\n",
       " 'médicaments en attente',\n",
       " \"demande d'exemption de la méthode\",\n",
       " 'aide médicale',\n",
       " 'états unis',\n",
       " 'médicaments génériques produits',\n",
       " 'présentation power point',\n",
       " 'évaluation des médicaments biosimilaires évaluation',\n",
       " \"modalités et processus d'évaluation\",\n",
       " 'déficience physique',\n",
       " 'données clinico',\n",
       " 'modalités et processus',\n",
       " \"santé naturels virus de l'immunodéficience humaine\",\n",
       " 'santé naturels virus',\n",
       " \"évaluation d'une demande\",\n",
       " 'fer intraveineux',\n",
       " 'aide médicale à mourir',\n",
       " \"traitement d'appoint\",\n",
       " 'maladies cardiovasculaires',\n",
       " 'nouveautés dans le réseau',\n",
       " 'maladie pulmonaire obstructive chronique médicaments',\n",
       " 'médicaments génériques produits de santé naturels',\n",
       " 'traitement de la fibrose',\n",
       " 'médicaments biosimilaires évaluation',\n",
       " 'exemption de la méthode',\n",
       " \"médicaments biosimilaires médicaments d'exception\",\n",
       " \"évaluation d'une demande d'exemption\",\n",
       " \"recommandation de l'inesss décision du ministre\",\n",
       " 'feuille de suivi',\n",
       " 'maladie de lyme ppe',\n",
       " \"traitement au fer intraveineux chez l'adulte\",\n",
       " 'soins palliatifs fièvre',\n",
       " 'dermatite atopique modérée',\n",
       " 'lyme ppe',\n",
       " 'allergies aux bêta lactamines',\n",
       " 'clinico administratives',\n",
       " 'sol inj',\n",
       " 'rétention urinaire aigüe',\n",
       " 'innovations technologiques',\n",
       " 'severe traumatic brain injury',\n",
       " 'données clinico administratives',\n",
       " 'traitement au fer intraveineux',\n",
       " 'soins palliatifs détresse',\n",
       " 'allergies aux bêta',\n",
       " 'contexte réel',\n",
       " \"fer intraveineux chez l'adulte\",\n",
       " 'usage optimal des immunoglobulines',\n",
       " 'inscription de médicaments',\n",
       " \"recommandation de l'inesss médicaments\",\n",
       " 'sclérose latérale amyotrophique',\n",
       " 'pratiques relatives',\n",
       " 'sclérose latérale',\n",
       " 'msss covid',\n",
       " 'collaborateurs institutionnels',\n",
       " \"constats de l'inesss\",\n",
       " 'plan de travail',\n",
       " 'pertinence et indications',\n",
       " 'trouble déficitaire',\n",
       " 'trouble dépressif',\n",
       " 'trouble dépressif caractérisé',\n",
       " 'trouble dépressif caractérisé majeur',\n",
       " 'traitement de la dermatite',\n",
       " 'association avec une chimiothérapie',\n",
       " \"trouble déficitaire de l'attention\",\n",
       " 'soins critiques',\n",
       " 'traitement de la dermatite atopique modérée',\n",
       " 'traitement prophylactique',\n",
       " 'trauma patients',\n",
       " 'excellence clinique',\n",
       " 'traitement de la dermatite atopique',\n",
       " \"régie de l'assurance\",\n",
       " \"refus d'inscription\",\n",
       " 'services de santé',\n",
       " 'professionnels impliqués',\n",
       " 'sclérose en plaques',\n",
       " 'colloques à venir',\n",
       " \"demandes d'inscription de médicaments\",\n",
       " 'documentation scientifique disponible',\n",
       " 'maladie du québec',\n",
       " 'thrombose veineuse',\n",
       " 'projets en cours',\n",
       " \"traitement des personnes avec un trouble déficitaire de l'attention\",\n",
       " 'nom commercial dénomination',\n",
       " 'procédures de biologie',\n",
       " 'standardisation des pratiques',\n",
       " 'cancer du sein triple négatif',\n",
       " \"patients adultes atteints d'un lymphome\",\n",
       " 'monothérapie pour le traitement des patients',\n",
       " 'score combiné positif',\n",
       " 'traitement des personnes avec un trouble',\n",
       " 'ténofovir disoproxil fumarate',\n",
       " 'nom commercial dénomination commune',\n",
       " 'traitement des personnes avec un trouble déficitaire',\n",
       " 'cancer du sein triple',\n",
       " 'demande nouvelle',\n",
       " 'score combiné',\n",
       " 'standardisation des pratiques relatives',\n",
       " 'procédures de biologie médicale',\n",
       " 'guide de pratique',\n",
       " 'statut de la demande',\n",
       " 'ténofovir disoproxil',\n",
       " \"traitement des patients adultes atteints d'un lymphome\",\n",
       " 'conseil reconnaît',\n",
       " 'score combiné positif scp',\n",
       " \"traitement d'entretien du déficit grave\",\n",
       " 'ajinomoto formule',\n",
       " 'fibrose kystique chez les patients',\n",
       " \"traitement de l'asthme sévère\",\n",
       " 'entretien du déficit',\n",
       " 'mutation del du gène cftr',\n",
       " \"évaluation scientifique par l'inesss\",\n",
       " 'dupilumab sanofiaven',\n",
       " 'alerte inesss',\n",
       " 'déficit grave',\n",
       " 'tumeurs expriment',\n",
       " \"traitement de l'uvéite non infectieuse\",\n",
       " 'mutation del',\n",
       " 'néphropathie chronique',\n",
       " 'médicaments présentés dans le tableau',\n",
       " 'fusion du gène',\n",
       " 'bgp pharma produit',\n",
       " 'fibrose kystique chez les patients âgés',\n",
       " \"traitement d'entretien du déficit\",\n",
       " 'faricimab roche',\n",
       " 'organon produit',\n",
       " 'traitement de la sclérose latérale amyotrophique',\n",
       " 'entretien du déficit grave en antitrypsine',\n",
       " 'traitement de la fibrose kystique',\n",
       " 'problèmes techniques',\n",
       " 'selpercatinib lilly',\n",
       " 'pratiques relatives aux allergies aux bêta',\n",
       " 'traitement de la sclérose latérale',\n",
       " 'tézacaftor ivacaftor et ivacaftor vertex',\n",
       " 'standardisation des pratiques relatives aux allergies',\n",
       " 'pfizer produit',\n",
       " 'infections respiratoires',\n",
       " 'monothérapie pour le traitement des patients adultes',\n",
       " 'selpercatinib lilly pour le traitement',\n",
       " 'pratiques relatives aux allergies',\n",
       " 'standardisation des pratiques relatives aux allergies aux bêta lactamines',\n",
       " 'ordonnances associées aide',\n",
       " 'atrophie vulvovaginale',\n",
       " 'gène cftr',\n",
       " \"soutien à l'implantation\",\n",
       " \"patients adultes atteints d'un cancer de l'endomètre\",\n",
       " 'documents institutionnels emplois',\n",
       " 'commentaire sur un médicament',\n",
       " 'asthme sévère de type',\n",
       " 'pfizer produit biosimilaire',\n",
       " \"traitement de l'insomnie\",\n",
       " 'adalimumab amgen produit',\n",
       " 'conseil scientifique comités',\n",
       " 'milieu de vie',\n",
       " 'fusion du gène ret',\n",
       " 'documents institutionnels',\n",
       " 'chlorhydrate de elvium',\n",
       " 'adalimumab amgen produit biosimilaire',\n",
       " 'organon produit biosimilaire',\n",
       " \"communauté chez l'adulte\",\n",
       " 'cariprazine abbvie traitement',\n",
       " 'uvéite non infectieuse',\n",
       " 'pharma pour le traitement',\n",
       " \"patients adultes atteints d'un cancer du poumon\",\n",
       " 'cellules localement',\n",
       " 'tenofovir ténofovir disoproxil',\n",
       " 'merck en association',\n",
       " 'phénotype éosinophilique',\n",
       " 'traitement de la fibrose kystique chez les patients',\n",
       " 'cellules localement avancé',\n",
       " 'tézacaftor ivacaftor et ivacaftor',\n",
       " 'faricimab roche traitement',\n",
       " 'tézacaftor ivacaftor',\n",
       " 'entretien du déficit grave',\n",
       " 'agent de suppléance',\n",
       " 'mutation del du gène',\n",
       " 'cariprazine abbvie',\n",
       " 'déficit grave en antitrypsine',\n",
       " 'forme co teneur',\n",
       " 'chloral hydrate',\n",
       " 'traitement de la fibrose kystique chez les patients âgés',\n",
       " 'ajinomoto formule nutritive',\n",
       " 'pratiques relatives aux allergies aux bêta lactamines',\n",
       " 'corticothérapie orale',\n",
       " \"traitement de l'asthme sévère de type\",\n",
       " 'inesss express stage',\n",
       " \"traitement des patients adultes atteints d'un cancer du poumon\",\n",
       " 'signataires plan',\n",
       " 'hypertension artérielle hypolipémiants',\n",
       " 'lyme ppe mucosite oropharyngée naloxone',\n",
       " 'gonorrhoeae davc',\n",
       " 'ajustement professionnels',\n",
       " 'hypertension artérielle hypolipémiants infections',\n",
       " \"usage d'alcool troubles\",\n",
       " 'pertes vaginales inhabituelles premarin',\n",
       " 'infections urinaires inhibiteurs de la pompe',\n",
       " 'dénomination commune nom',\n",
       " 'protocole médical problèmes techniques',\n",
       " \"rhinosinusite aiguë chez l'adulte\",\n",
       " \"trouble lié à l'usage d'alcool troubles\",\n",
       " 'alcool troubles neurocognitifs document complémentaire',\n",
       " 'écoulement urétral élimination',\n",
       " 'écoulement urétral élimination fécale',\n",
       " 'ajustement professionnels impliqués protocole',\n",
       " 'élimination fécale hydroxychloroquine et chloroquine',\n",
       " 'lyme ppe mucosite',\n",
       " 'lyme ppe mucosite oropharyngée',\n",
       " 'algorithme décisionnel',\n",
       " 'alcool troubles',\n",
       " \"fer intraveineux chez l'adulte trouble dépressif\",\n",
       " 'rétention urinaire aigüe sédation',\n",
       " 'incertitude existante',\n",
       " \"ordonnance individuelle d'ajustement professionnels impliqués\",\n",
       " 'protocole médical problèmes',\n",
       " \"candidose buccale chez l'adulte chlamydia\",\n",
       " 'gonorrhoeae davc eampoc',\n",
       " 'maladie de lyme ppe mucosite oropharyngée',\n",
       " 'demande nouvelle forme',\n",
       " 'signataires plan de travail',\n",
       " \"ordonnance individuelle d'ajustement professionnels\",\n",
       " 'soins palliatifs détresse soins',\n",
       " 'soins palliatifs détresse soins palliatifs',\n",
       " \"usage d'alcool troubles neurocognitifs\",\n",
       " \"pneumonie acquise en communauté chez l'adulte\",\n",
       " 'mucosite oropharyngée naloxone pertes vaginales',\n",
       " 'ajustement professionnels impliqués',\n",
       " 'sédation palliative continue soins',\n",
       " \"fer intraveineux chez l'adulte trouble\",\n",
       " 'rétention urinaire aigüe sédation palliative',\n",
       " 'mucosite oropharyngée naloxone',\n",
       " 'démarche utilisée',\n",
       " \"trouble lié à l'usage d'alcool troubles neurocognitifs\",\n",
       " 'hypertension artérielle hypolipémiants infections urinaires',\n",
       " 'mucosite oropharyngée naloxone pertes',\n",
       " 'alcool troubles neurocognitifs',\n",
       " 'capsule vidéo',\n",
       " 'maladie de lyme ppe mucosite',\n",
       " 'chlamydia et gonorrhoeae davc',\n",
       " 'infections urinaires inhibiteurs',\n",
       " 'sédation palliative continue soins palliatifs',\n",
       " 'évaluation foquest',\n",
       " 'usage optimal bronchite aiguë',\n",
       " 'réseau de la santé',\n",
       " 'usage optimal bronchite',\n",
       " 'évaluation foquest méthylphénidate',\n",
       " \"guide d'usage optimal bronchite\",\n",
       " 'évaluation nucala',\n",
       " 'évaluation vabysmo',\n",
       " 'évaluation vabysmo faricimab',\n",
       " 'pansement absorbant',\n",
       " 'évaluation foquest méthylphénidate chlorhydrate de elvium',\n",
       " 'colite ulcéreuse pré',\n",
       " 'traitement de la colite ulcéreuse pré',\n",
       " \"guide d'usage optimal bronchite aiguë\",\n",
       " 'données médico',\n",
       " 'évaluation foquest méthylphénidate chlorhydrate',\n",
       " 'dénomination commune nom du fabricant',\n",
       " 'cancer du col',\n",
       " 'services sociaux généraux',\n",
       " 'évaluation opdivo',\n",
       " \"publication de l'avis au ministre\",\n",
       " 'nom commercial dénomination commune nom',\n",
       " 'collège des médecins',\n",
       " \"cancer du col de l'utérus\",\n",
       " 'survie globale',\n",
       " 'évaluation hulio',\n",
       " \"cours d'évaluation amgevita adalimumab\",\n",
       " 'indications de transmission',\n",
       " 'patients atteints de cancer',\n",
       " 'médico administratives',\n",
       " \"cours d'évaluation hulio\",\n",
       " 'soutien au guo',\n",
       " 'médecins du québec',\n",
       " 'évaluation hulio adalimumab',\n",
       " 'dispositifs médicaux',\n",
       " \"cours d'évaluation amgevita\",\n",
       " 'évaluation biatain',\n",
       " 'données médico administratives',\n",
       " \"emplois l'inesss\",\n",
       " 'innovations technologiques et dispositifs',\n",
       " 'indications de transmission des prélèvements',\n",
       " 'transmission des prélèvements',\n",
       " \"col de l'utérus\",\n",
       " 'innovations technologiques et dispositifs médicaux',\n",
       " 'chlorhydrate de jamp',\n",
       " \"cours d'évaluation hulio adalimumab\",\n",
       " \"attente d'évaluation foquest méthylphénidate\",\n",
       " 'évaluation vraylar cariprazine',\n",
       " 'usage des anticoagulants',\n",
       " 'emergency department',\n",
       " 'évaluation vraylar cariprazine abbvie traitement',\n",
       " \"attente d'évaluation foquest\",\n",
       " 'publication des décisions',\n",
       " 'évaluation vraylar cariprazine abbvie',\n",
       " 'pertinence et indications de transmission des prélèvements',\n",
       " 'pertinence du dépistage',\n",
       " 'pertinence et indications de transmission',\n",
       " 'ministre des médicaments',\n",
       " 'évaluation vraylar',\n",
       " 'collège des médecins du québec',\n",
       " 'recommandations quant à la pertinence',\n",
       " 'évaluation trikafta',\n",
       " \"attente d'évaluation foquest méthylphénidate chlorhydrate\",\n",
       " 'usage optimal herpès',\n",
       " 'séquençage de nouvelle génération',\n",
       " 'psoriasis en plaques',\n",
       " 'documentation scientifique disponible au moment',\n",
       " 'séquençage de nouvelle',\n",
       " \"régime général d'assurance\",\n",
       " 'mesure de la glycémie',\n",
       " \"cours d'évaluation vraylar cariprazine\",\n",
       " 'travaux menant',\n",
       " 'stade avancé',\n",
       " \"cours d'évaluation vraylar cariprazine abbvie\",\n",
       " \"recommandation de l'inesss modification\",\n",
       " 'allergies aux pénicillines',\n",
       " 'liste du rgam',\n",
       " \"cours d'évaluation vraylar\",\n",
       " \"modèle d'ordonnance\",\n",
       " 'coups et projets',\n",
       " \"laboratoire d'anatomopathologie\",\n",
       " 'interventions de réadaptation',\n",
       " \"traitement de l'insuffisance\",\n",
       " 'nouveautés bons',\n",
       " 'évaluation ultomiris',\n",
       " 'nouveautés bons coups',\n",
       " 'plaisir de les partager',\n",
       " 'mesure des procédures',\n",
       " 'mesure des procédures de biologie médicale',\n",
       " 'évaluation ultomiris ravulizumab',\n",
       " \"unité d'évaluation\",\n",
       " 'mesure des procédures de biologie',\n",
       " 'ajustement de la warfarine',\n",
       " 'coups et projets en cours',\n",
       " 'répertoire québécois',\n",
       " 'clostridium difficile',\n",
       " 'fumarate de angita',\n",
       " 'résultats cliniques',\n",
       " 'glucose dans le sang',\n",
       " 'forme rémittente',\n",
       " 'fabricants de médicaments',\n",
       " 'année complète',\n",
       " 'sars cov',\n",
       " \"publication de l'avis au ministre des médicaments\",\n",
       " 'conseil juge',\n",
       " \"cours d'évaluation trikafta\",\n",
       " \"recommandation de l'inesss inscription\",\n",
       " \"demande en cours d'évaluation vabysmo faricimab\",\n",
       " 'répertoire québécois et système',\n",
       " 'médicaments du rgam',\n",
       " 'système de mesure des procédures',\n",
       " 'système de mesure des procédures de biologie',\n",
       " 'amyotrophie spinale',\n",
       " \"demande en cours d'évaluation vraylar\",\n",
       " \"cours d'évaluation vabysmo faricimab\",\n",
       " 'outil de transfert',\n",
       " \"demande en cours d'évaluation vraylar cariprazine\",\n",
       " 'trouble développemental',\n",
       " 'réseau de trauma',\n",
       " \"attente d'évaluation biatain\",\n",
       " 'cohort study',\n",
       " 'système de mesure des procédures de biologie médicale',\n",
       " \"cours d'évaluation vabysmo\",\n",
       " \"demande en cours d'évaluation vabysmo\",\n",
       " 'essais cliniques',\n",
       " 'protection de la jeunesse',\n",
       " 'lymphome diffus à grandes',\n",
       " 'développemental du langage',\n",
       " 'pression négative',\n",
       " 'cancer du sein métastatique',\n",
       " 'liste des médicaments du rgam',\n",
       " 'lymphome diffus',\n",
       " 'mode continu inesss',\n",
       " 'ans présentant',\n",
       " 'inesss met',\n",
       " 'brentuximab védotine',\n",
       " 'outil de transfert de connaissances',\n",
       " 'trouble développemental du langage',\n",
       " 'lymphome diffus à grandes cellules',\n",
       " 'thérapie par pression négative',\n",
       " 'mousse hydrophile',\n",
       " 'ministre sur opdivo',\n",
       " 'mode continu inesss express',\n",
       " 'stade iii',\n",
       " 'thérapie par pression',\n",
       " 'leucémie myéloïde',\n",
       " 'groupe recevant',\n",
       " \"recommandations de l'inesss transmises au ministre\",\n",
       " 'procréation assistée',\n",
       " 'évaluation en mode continu',\n",
       " 'inesss transmises au ministre',\n",
       " 'enfants âgés',\n",
       " 'soins de longue durée',\n",
       " 'indication reconnue à la liste',\n",
       " 'cancer du sein invasif précoce',\n",
       " 'gestion du risque',\n",
       " 'soins de longue',\n",
       " 'hypertension artérielle pulmonaire',\n",
       " \"demande en attente d'évaluation biatain\",\n",
       " 'cancer du sein invasif',\n",
       " 'évaluation en mode',\n",
       " 'collaborateurs institutionnels directions',\n",
       " 'infarctus aigu du myocarde',\n",
       " 'fins de remboursement',\n",
       " 'sang du québec',\n",
       " 'infarctus aigu',\n",
       " 'pansement antimicrobien',\n",
       " 'réseau de la santé et des services',\n",
       " \"algorithmes d'investigation de traitement\",\n",
       " \"algorithmes d'investigation de traitement et de suivi\",\n",
       " 'critical care',\n",
       " 'traitement standard',\n",
       " 'réseau de la santé et des services sociaux',\n",
       " \"algorithmes d'investigation\",\n",
       " 'analyse des données',\n",
       " 'inesss inesss',\n",
       " 'imagerie médicale',\n",
       " 'liste des produits',\n",
       " 'prise en charge des patients',\n",
       " 'adénocarcinome rénal',\n",
       " 'stade précoce',\n",
       " 'tumeurs solides',\n",
       " 'interféron bêta',\n",
       " 'amélioration continue',\n",
       " 'résonance magnétique',\n",
       " 'pertinence du dépistage néonatal',\n",
       " 'liste des produits du système',\n",
       " 'transfert des connaissances',\n",
       " 'évaluation des tests',\n",
       " 'risque de complications',\n",
       " 'efficacité des interventions',\n",
       " 'ans présentant un trouble',\n",
       " 'médicament réfère',\n",
       " \"outil d'aide à la décision en cas\",\n",
       " 'voies respiratoires',\n",
       " 'traitement du diabète de type',\n",
       " 'surveillance du glucose',\n",
       " \"demande d'évaluation\",\n",
       " 'décision en cas',\n",
       " 'soulagement des symptômes',\n",
       " \"chiens d'assistance\",\n",
       " \"transplantation d'organes\",\n",
       " 'aide à la décision en cas',\n",
       " 'intervalle de confiance',\n",
       " 'registre des traumatismes',\n",
       " 'guide de pratique clinique',\n",
       " 'niveau de preuve',\n",
       " 'dénomination commune sujet réactif',\n",
       " 'système du sang du québec',\n",
       " 'outil clinique dialogue',\n",
       " 'dénomination commune sujet réactif quantitatif',\n",
       " 'liste des médicaments du régime',\n",
       " 'herpès simplex',\n",
       " 'condylomes externes',\n",
       " 'services de réadaptation',\n",
       " 'réactif quantitatif du glucose',\n",
       " \"portrait de l'usage\",\n",
       " 'fin de vie',\n",
       " 'gestion et analyse',\n",
       " 'troubles mentaux',\n",
       " 'réactif quantitatif du glucose dans le sang',\n",
       " 'traitement topique',\n",
       " 'liste des produits du système du sang',\n",
       " 'produits du système du sang du québec',\n",
       " 'liste des médicaments du régime général',\n",
       " 'jim boulanger',\n",
       " 'conseil considère',\n",
       " 'herpès génital',\n",
       " 'irm mammaire',\n",
       " 'hormone de croissance',\n",
       " \"prophylaxie de l'influenza\",\n",
       " 'inesss recommande',\n",
       " 'traitement pharmacologique des itss approche syndromique',\n",
       " 'leucémie myéloïde chronique',\n",
       " \"traitement de l'insuffisance cardiaque\",\n",
       " 'traitement pharmacologique des itss approche',\n",
       " \"médicaments à l'étude\",\n",
       " 'trauma center',\n",
       " 'revue systématique',\n",
       " ...]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print('On a un vocabulaire de {} formes.'.format(len(vocabulaire)))\n",
    "vocabulaire"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Lire le corpus**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, shutil, re\n",
    "from pathlib import Path\n",
    "from os import path\n",
    "from pandas import *\n",
    "\n",
    "base_path = '../03-corpus/2-data/1-fr/'\n",
    "if tag:\n",
    "    base_path = path.join(base_path, acteur, acteur + '_' + tag + '.csv')\n",
    "\n",
    "else:\n",
    "    base_path = path.join(base_path, acteur +  '.csv')\n",
    "        \n",
    "with open(base_path, \"r\", encoding = \"UTF-8\") as f:\n",
    "    data = read_csv(base_path, sep=',')\n",
    "    text = data['text'].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "On a donc un corpus de 1226 documents.\n"
     ]
    }
   ],
   "source": [
    "text = text[:round(len(text))]\n",
    "\n",
    "nb_docs = len(text)\n",
    "\n",
    "print(\"On a donc un corpus de {} documents.\".format(nb_docs))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Nettoyage**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "corpus = [str(t).strip('\\n').lower().replace('’', '\\'') for t in text]\n",
    "    \n",
    "punct = '[!#$%&\\(\\)•►*+,-\\/:;<=>?@[\\]^_{|}~©«»—“”–—]'\n",
    "spaces = '\\s+'\n",
    "postals = '([a-zA-Z]+\\d+|\\d+[a-zA-Z]+)+'\n",
    "phones = '\\d{3}\\s\\d{3}-\\d{4}' #très simple (trop)\n",
    "\n",
    "corpus = [re.sub(punct, ' ', t).replace(\"' \", \"'\" ).replace(\"'\", \"'\") for t in corpus]\n",
    "corpus = [re.sub(spaces, ' ', t) for t in corpus]\n",
    "corpus = [str(t).strip('\\n').lower().replace('’', '\\'') for t in corpus]\n",
    "corpus = [re.sub(spaces, ' ', t) for t in corpus]\n",
    "corpus = [re.sub(phones, ' ', t) for t in corpus]\n",
    "corpus = [re.sub(postals, ' ', t) for t in corpus]\n",
    "corpus = [re.sub(punct, ' ', t) for t in corpus]\n",
    "corpus = [t.replace(\"  \", \" \" ) for t in corpus]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### **Appliquer le prétraitement**\n",
    "Si les termes passées comme vocabulaire sont lemmatisés, changer le paramètre lem pour True au moment d'appliquer la fonction nlp(corpus)  \n",
    "Le TfIdfVectorizer de sklearn va extraire lui-mêmes les ngrammes, faire le filtrage des mots fonctionnels et calculer le tf-idf pour nos termes d'intérêt ;  \n",
    "Or, si les termes qu'on lui donne comme vocabulaire ont été lemmatisés, on veut donc aussi lui passer un corpus lemmatisé."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "from nltk.tokenize import RegexpTokenizer\n",
    "from french_lefff_lemmatizer.french_lefff_lemmatizer import FrenchLefffLemmatizer\n",
    "\n",
    "def nlp(corpus, lem=False): \n",
    "    if not lem:\n",
    "        # Tokenisation\n",
    "        tokenizer = RegexpTokenizer(r\"\\w\\'|\\w+\")\n",
    "\n",
    "        tokens = [tokenizer.tokenize(doc) for  doc in corpus]\n",
    "        len_corpus = len(nltk.flatten(tokens))\n",
    "        print(\"Avec le RegExpTokenizer, notre corpus contient {} tokens.\".format(len_corpus))\n",
    "\n",
    "        return tokens\n",
    "\n",
    "    else:\n",
    "        # POS tagging\n",
    "        input = [\" \".join(nltk.flatten(doc)).replace(\"' \", \"'\") for doc in tokens]\n",
    "        import treetaggerwrapper\n",
    "        tagger = treetaggerwrapper.TreeTagger(TAGLANG='fr')\n",
    "\n",
    "        path = '../04-filtrage/mapping_treeTagger_lefff.csv'\n",
    "\n",
    "        with open(path) as f:\n",
    "            csv = read_csv(f)\n",
    "\n",
    "        treeTag = [term for term in csv['TreeTagger'].tolist()] \n",
    "        lefff = [term for term in csv['Lefff'].tolist()]\n",
    "\n",
    "        mapping = {term : lefff[treeTag.index(term)] for term in treeTag}\n",
    "\n",
    "        tagged= [tagger.tag_text(doc) for doc in input]\n",
    "\n",
    "        tuples_doc = []\n",
    "        for doc in tagged:\n",
    "            tuples = []\n",
    "            for t in doc:\n",
    "                token = t.split('\\t')[0]\n",
    "                pos = mapping[t.split('\\t')[1]]\n",
    "\n",
    "                tuples.append([token, pos])\n",
    "            tuples_doc.append(tuples)\n",
    "\n",
    "        #Lemmatisation\n",
    "        lemmatizer = FrenchLefffLemmatizer()\n",
    "        docs_lemmas = []\n",
    "\n",
    "        for doc in tuples_doc:\n",
    "            doc_lemma = []\n",
    "            for t in doc:\n",
    "                term_lemmatized = \"\"\n",
    "                if(lemmatizer.lemmatize(t[0], t[1]) == []):\n",
    "                    term_lemmatized = lemmatizer.lemmatize(t[0])\n",
    "                else:\n",
    "                    term_lemmatized = lemmatizer.lemmatize(t[0], t[1])[0][0] # [0][0] pour avoir le lemme seul et non (lemme, pos)\n",
    "            \n",
    "                if len(term_lemmatized) >1 :\n",
    "                    doc_lemma.append(term_lemmatized)\n",
    "            docs_lemmas.append(doc_lemma)\n",
    "\n",
    "        docs_lemmas = [\" \".join(doc) for doc in docs_lemmas]\n",
    "\n",
    "        return docs_lemmas"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "# corpus = nlp(corpus)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "file_path = '../04-filtrage/mwe_stopwords.txt'\n",
    "\n",
    "with open (file_path, 'r', encoding='utf-8') as f:\n",
    "    mwe_sw = [t.lower().strip('\\n') for t in f.readlines()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "# max_df : ignore words that appear in 85% of documents, \n",
    "# min df:  ignore words that appear in less than 1% of documents \n",
    "# vocabulary = vocabulaire\n",
    "\n",
    "# Sans utiliser le vocabulaire\n",
    "# tfidf = TfidfVectorizer(min_df=0.1, stop_words=None, ngram_range=(2,4), max_df=0.85, use_idf=True)\n",
    "\n",
    "# def identity_tokenizer(text):\n",
    "#     return text\n",
    "# tokenizer=identity_tokenizer\n",
    "\n",
    "# vocabulary = vocabulaire\n",
    "tfidf = TfidfVectorizer(vocabulary = set(vocabulaire),ngram_range=(1,12), use_idf=True, lowercase=False)\n",
    "tfs = tfidf.fit_transform(corpus)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "features_names = tfidf.get_feature_names_out()\n",
    "corpus_index = [corpus.index(n) for n in corpus]\n",
    "\n",
    "import pandas as pd\n",
    "df = pd.DataFrame(tfs.T.todense(), index=features_names, columns=corpus_index).transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>aberration génomique</th>\n",
       "      <th>aberration génomique tumorale</th>\n",
       "      <th>aberration génomique tumorale egfr</th>\n",
       "      <th>absence de données</th>\n",
       "      <th>absence de détérioration</th>\n",
       "      <th>abus physique</th>\n",
       "      <th>acceptabilité professionnelle</th>\n",
       "      <th>acceptabilité professionnelle et sociale</th>\n",
       "      <th>acceptabilité professionnelle et sociale des productions</th>\n",
       "      <th>accident vasculaire</th>\n",
       "      <th>...</th>\n",
       "      <th>évolution du risque</th>\n",
       "      <th>évolution du risque d'hospitalisation</th>\n",
       "      <th>évolution fonctionnelle</th>\n",
       "      <th>évolution la médecine</th>\n",
       "      <th>évolution rapide</th>\n",
       "      <th>îlots de langerhans</th>\n",
       "      <th>îlots de langerhans chez les personnes atteintes</th>\n",
       "      <th>œdème maculaire</th>\n",
       "      <th>œdème maculaire diabétique</th>\n",
       "      <th>œdème maculaire diabétique pré</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1221</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1223</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>857</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>860</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1226 rows × 6670 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      aberration génomique  aberration génomique tumorale  \\\n",
       "0                      0.0                            0.0   \n",
       "0                      0.0                            0.0   \n",
       "0                      0.0                            0.0   \n",
       "3                      0.0                            0.0   \n",
       "4                      0.0                            0.0   \n",
       "...                    ...                            ...   \n",
       "1221                   0.0                            0.0   \n",
       "686                    0.0                            0.0   \n",
       "1223                   0.0                            0.0   \n",
       "857                    0.0                            0.0   \n",
       "860                    0.0                            0.0   \n",
       "\n",
       "      aberration génomique tumorale egfr  absence de données  \\\n",
       "0                                    0.0                 0.0   \n",
       "0                                    0.0                 0.0   \n",
       "0                                    0.0                 0.0   \n",
       "3                                    0.0                 0.0   \n",
       "4                                    0.0                 0.0   \n",
       "...                                  ...                 ...   \n",
       "1221                                 0.0                 0.0   \n",
       "686                                  0.0                 0.0   \n",
       "1223                                 0.0                 0.0   \n",
       "857                                  0.0                 0.0   \n",
       "860                                  0.0                 0.0   \n",
       "\n",
       "      absence de détérioration  abus physique  acceptabilité professionnelle  \\\n",
       "0                          0.0            0.0                            0.0   \n",
       "0                          0.0            0.0                            0.0   \n",
       "0                          0.0            0.0                            0.0   \n",
       "3                          0.0            0.0                            0.0   \n",
       "4                          0.0            0.0                            0.0   \n",
       "...                        ...            ...                            ...   \n",
       "1221                       0.0            0.0                            0.0   \n",
       "686                        0.0            0.0                            0.0   \n",
       "1223                       0.0            0.0                            0.0   \n",
       "857                        0.0            0.0                            0.0   \n",
       "860                        0.0            0.0                            0.0   \n",
       "\n",
       "      acceptabilité professionnelle et sociale  \\\n",
       "0                                          0.0   \n",
       "0                                          0.0   \n",
       "0                                          0.0   \n",
       "3                                          0.0   \n",
       "4                                          0.0   \n",
       "...                                        ...   \n",
       "1221                                       0.0   \n",
       "686                                        0.0   \n",
       "1223                                       0.0   \n",
       "857                                        0.0   \n",
       "860                                        0.0   \n",
       "\n",
       "      acceptabilité professionnelle et sociale des productions  \\\n",
       "0                                                   0.0          \n",
       "0                                                   0.0          \n",
       "0                                                   0.0          \n",
       "3                                                   0.0          \n",
       "4                                                   0.0          \n",
       "...                                                 ...          \n",
       "1221                                                0.0          \n",
       "686                                                 0.0          \n",
       "1223                                                0.0          \n",
       "857                                                 0.0          \n",
       "860                                                 0.0          \n",
       "\n",
       "      accident vasculaire  ...  évolution du risque  \\\n",
       "0                     0.0  ...                  0.0   \n",
       "0                     0.0  ...                  0.0   \n",
       "0                     0.0  ...                  0.0   \n",
       "3                     0.0  ...                  0.0   \n",
       "4                     0.0  ...                  0.0   \n",
       "...                   ...  ...                  ...   \n",
       "1221                  0.0  ...                  0.0   \n",
       "686                   0.0  ...                  0.0   \n",
       "1223                  0.0  ...                  0.0   \n",
       "857                   0.0  ...                  0.0   \n",
       "860                   0.0  ...                  0.0   \n",
       "\n",
       "      évolution du risque d'hospitalisation  évolution fonctionnelle  \\\n",
       "0                                       0.0                      0.0   \n",
       "0                                       0.0                      0.0   \n",
       "0                                       0.0                      0.0   \n",
       "3                                       0.0                      0.0   \n",
       "4                                       0.0                      0.0   \n",
       "...                                     ...                      ...   \n",
       "1221                                    0.0                      0.0   \n",
       "686                                     0.0                      0.0   \n",
       "1223                                    0.0                      0.0   \n",
       "857                                     0.0                      0.0   \n",
       "860                                     0.0                      0.0   \n",
       "\n",
       "      évolution la médecine  évolution rapide  îlots de langerhans  \\\n",
       "0                       0.0               0.0                  0.0   \n",
       "0                       0.0               0.0                  0.0   \n",
       "0                       0.0               0.0                  0.0   \n",
       "3                       0.0               0.0                  0.0   \n",
       "4                       0.0               0.0                  0.0   \n",
       "...                     ...               ...                  ...   \n",
       "1221                    0.0               0.0                  0.0   \n",
       "686                     0.0               0.0                  0.0   \n",
       "1223                    0.0               0.0                  0.0   \n",
       "857                     0.0               0.0                  0.0   \n",
       "860                     0.0               0.0                  0.0   \n",
       "\n",
       "      îlots de langerhans chez les personnes atteintes  œdème maculaire  \\\n",
       "0                                                  0.0              0.0   \n",
       "0                                                  0.0              0.0   \n",
       "0                                                  0.0              0.0   \n",
       "3                                                  0.0              0.0   \n",
       "4                                                  0.0              0.0   \n",
       "...                                                ...              ...   \n",
       "1221                                               0.0              0.0   \n",
       "686                                                0.0              0.0   \n",
       "1223                                               0.0              0.0   \n",
       "857                                                0.0              0.0   \n",
       "860                                                0.0              0.0   \n",
       "\n",
       "      œdème maculaire diabétique  œdème maculaire diabétique pré  \n",
       "0                            0.0                             0.0  \n",
       "0                            0.0                             0.0  \n",
       "0                            0.0                             0.0  \n",
       "3                            0.0                             0.0  \n",
       "4                            0.0                             0.0  \n",
       "...                          ...                             ...  \n",
       "1221                         0.0                             0.0  \n",
       "686                          0.0                             0.0  \n",
       "1223                         0.0                             0.0  \n",
       "857                          0.0                             0.0  \n",
       "860                          0.0                             0.0  \n",
       "\n",
       "[1226 rows x 6670 columns]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "# from pathlib import Path\n",
    "\n",
    "# base_path = '../05-transformation/' + acteur + '/'\n",
    "# Path(base_path).mkdir(parents=True, exist_ok=True)\n",
    "\n",
    "# if sous_corpus:\n",
    "#     path = base_path + tag + '/'\n",
    "#     titre = tag\n",
    "\n",
    "# else:\n",
    "#     titre = acteur\n",
    "\n",
    "# df.to_csv(base_path + titre + '_matrice-TFIDF.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "terms_weighted = []\n",
    "rows, cols = tfs.nonzero()\n",
    "for row, col in zip(rows,cols):\n",
    "    terms_weighted.append([features_names[col], tfs[row,col]])\n",
    "\n",
    "terms_weighted = DataFrame(terms_weighted, columns=['Collocation', 'TF-IDF'])\n",
    "terms_weighted.sort_values([\"TF-IDF\"], \n",
    "                    axis=0,\n",
    "                    ascending=[False], \n",
    "                    inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Collocation</th>\n",
       "      <th>TF-IDF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5776</th>\n",
       "      <td>usage optimal</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6639</th>\n",
       "      <td>développement durable</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8278</th>\n",
       "      <td>ministre sur les génériques</td>\n",
       "      <td>0.987677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78348</th>\n",
       "      <td>formules nutritives</td>\n",
       "      <td>0.928014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7989</th>\n",
       "      <td>professionnelle scientifique</td>\n",
       "      <td>0.923344</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19105</th>\n",
       "      <td>patients atteints</td>\n",
       "      <td>0.001125</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18947</th>\n",
       "      <td>réponse rapide covid</td>\n",
       "      <td>0.001088</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19534</th>\n",
       "      <td>affections post covid</td>\n",
       "      <td>0.001083</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19535</th>\n",
       "      <td>affections post</td>\n",
       "      <td>0.001083</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19076</th>\n",
       "      <td>post covid</td>\n",
       "      <td>0.001081</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>93194 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                        Collocation    TF-IDF\n",
       "5776                  usage optimal  1.000000\n",
       "6639          développement durable  1.000000\n",
       "8278    ministre sur les génériques  0.987677\n",
       "78348           formules nutritives  0.928014\n",
       "7989   professionnelle scientifique  0.923344\n",
       "...                             ...       ...\n",
       "19105             patients atteints  0.001125\n",
       "18947          réponse rapide covid  0.001088\n",
       "19534         affections post covid  0.001083\n",
       "19535               affections post  0.001083\n",
       "19076                    post covid  0.001081\n",
       "\n",
       "[93194 rows x 2 columns]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_weighted = terms_weighted.drop_duplicates(keep='first')\n",
    "\n",
    "terms_weighted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "terms_weighted = pd.merge(csv, terms_weighted, on='Collocation').drop_duplicates(\n",
    "  subset = ['Collocation', 'Fréquence'],\n",
    "  keep = 'first').reset_index(drop = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Collocation</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence</th>\n",
       "      <th>TF-IDF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>réponses rapides</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>1319</td>\n",
       "      <td>0.649766</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>réponses rapides disponibles</td>\n",
       "      <td>NOM ADJ ADJ</td>\n",
       "      <td>1179</td>\n",
       "      <td>0.550419</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>usage optimal</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>1138</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>bicarbonate de sodium</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>980</td>\n",
       "      <td>0.263692</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>jamp lurasidone</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>963</td>\n",
       "      <td>0.263692</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5251</th>\n",
       "      <td>année de vie</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "      <td>0.266166</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5252</th>\n",
       "      <td>entrée en vigueur</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "      <td>0.065645</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5253</th>\n",
       "      <td>fumarate de nom</td>\n",
       "      <td>NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "      <td>0.298408</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5254</th>\n",
       "      <td>utilisation et résultats cliniques en contexte...</td>\n",
       "      <td>NOM KON NOM ADJ PRP NOM ADJ</td>\n",
       "      <td>6</td>\n",
       "      <td>0.192468</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5255</th>\n",
       "      <td>usage optimal guides</td>\n",
       "      <td>NOM ADJ NOM</td>\n",
       "      <td>6</td>\n",
       "      <td>0.151508</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5256 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Collocation  \\\n",
       "0                                      réponses rapides   \n",
       "1                          réponses rapides disponibles   \n",
       "2                                         usage optimal   \n",
       "3                                 bicarbonate de sodium   \n",
       "4                                       jamp lurasidone   \n",
       "...                                                 ...   \n",
       "5251                                       année de vie   \n",
       "5252                                  entrée en vigueur   \n",
       "5253                                    fumarate de nom   \n",
       "5254  utilisation et résultats cliniques en contexte...   \n",
       "5255                               usage optimal guides   \n",
       "\n",
       "             Structure syntaxique  Fréquence    TF-IDF  \n",
       "0                         NOM ADJ       1319  0.649766  \n",
       "1                     NOM ADJ ADJ       1179  0.550419  \n",
       "2                         NOM ADJ       1138  1.000000  \n",
       "3                     NOM PRP NOM        980  0.263692  \n",
       "4                         NOM ADJ        963  0.263692  \n",
       "...                           ...        ...       ...  \n",
       "5251                  NOM PRP NOM          6  0.266166  \n",
       "5252                  NOM PRP NOM          6  0.065645  \n",
       "5253                  NOM PRP NOM          6  0.298408  \n",
       "5254  NOM KON NOM ADJ PRP NOM ADJ          6  0.192468  \n",
       "5255                  NOM ADJ NOM          6  0.151508  \n",
       "\n",
       "[5256 rows x 4 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_weighted"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Test : clustering (documents)**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "def cluster_text(corpus):\n",
    "    # vocabulary = vocabulaire\n",
    "    vectorizer = TfidfVectorizer(vocabulary = set(vocabulaire), tokenizer=identity_tokenizer, ngram_range=(2,5), use_idf=True, lowercase=False, stop_words= mwe_sw)\n",
    "    X = vectorizer.fit_transform(corpus)\n",
    "\n",
    "    import matplotlib.pyplot as plt\n",
    "    from sklearn.cluster import KMeans\n",
    "    Sum_of_squared_distances = []\n",
    "    K = range(2,10)\n",
    "    for k in K:\n",
    "       km = KMeans(n_clusters=k, max_iter=200, n_init=10)\n",
    "       km = km.fit(X)\n",
    "       Sum_of_squared_distances.append(km.inertia_)\n",
    "    plt.plot(K, Sum_of_squared_distances, 'bx-')\n",
    "    plt.xlabel('k')\n",
    "    plt.ylabel('Sum_of_squared_distances')\n",
    "    plt.title('Elbow Method For Optimal k')\n",
    "    plt.show()\n",
    "\n",
    "    print('How many clusters do you want to use?')\n",
    "    true_k = int(input())\n",
    "    model = KMeans(n_clusters=true_k, init='k-means++', max_iter=200, n_init=10)\n",
    "    model.fit(X)\n",
    "\n",
    "    labels=model.labels_\n",
    "    clusters=pd.DataFrame(list(zip(text,labels)),columns=['title','cluster'])\n",
    "    #print(clusters.sort_values(by=['cluster']))\n",
    "\n",
    "    for i in range(true_k):\n",
    "        print(clusters[clusters['cluster'] == i])\n",
    "        clusters.to_csv('../06-clustering/' + acteur + '_clusters.csv')\n",
    "        \n",
    "    return"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "#cluster_text(corpus)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **OKapi BM25**\n",
    "https://hal.archives-ouvertes.fr/hal-00760158 "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "from rank_bm25 import BM25Okapi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Avec le RegExpTokenizer, notre corpus contient 641308 tokens.\n"
     ]
    }
   ],
   "source": [
    "corpus = nlp(corpus)\n",
    "bm25 = BM25Okapi(corpus)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "#tokenizer = RegexpTokenizer(r\"\\w\\'|\\w+\")\n",
    "tokenized_queries = [t.split() for t in set(vocabulaire)]\n",
    "\n",
    "features_names = [t for t in set(vocabulaire)]\n",
    "corpus_index = [corpus.index(n) for n in corpus]\n",
    "\n",
    "tab = [bm25.get_scores(query) for query in tokenized_queries]\n",
    "df = pd.DataFrame(tab, index=features_names, columns=corpus_index).transpose()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['diagnostic', 'confirmé'],\n",
       " ['trauma', 'patients'],\n",
       " ['régime', 'public'],\n",
       " ['solution', \"d'intelligence\", 'artificielle'],\n",
       " ['cancer', 'infectées', 'par', 'le', 'sras', 'cov'],\n",
       " ['dispositifs', \"d'accès\", 'vasculaire'],\n",
       " ['conseil', 'en', 'traumatologie'],\n",
       " ['rétention', 'urinaire'],\n",
       " ['herpès', 'génital'],\n",
       " ['cardiologie', 'et', 'maladies', 'neurovasculaires'],\n",
       " ['publication', 'de', \"l'état\", 'des', 'pratiques'],\n",
       " ['évaluation', 'foquest', 'méthylphénidate', 'chlorhydrate'],\n",
       " ['formule', 'nutritive'],\n",
       " ['traitement', 'de', \"l'oedème\"],\n",
       " ['blessures', 'médullaires'],\n",
       " ['validation', 'analytique', 'de', 'tests'],\n",
       " ['instituts', 'de', 'recherche', 'en', 'santé'],\n",
       " ['réactif', 'quantitatif', 'du', 'temps'],\n",
       " ['cardio', 'ou', 'neuro', 'vasculaires'],\n",
       " ['nom', 'du', 'fabricant', 'novartis'],\n",
       " ['présence', 'de', 'douleurs'],\n",
       " ['rinçage', 'pour', 'les', 'dispositifs', \"d'accès\"],\n",
       " ['prise', 'en', 'charge', 'de', \"l'infarctus\"],\n",
       " ['comité', \"d'experts\"],\n",
       " ['réanimation', 'cardiorespiratoire', 'naloxone'],\n",
       " ['milieu', 'ambulatoire'],\n",
       " ['investigation', 'diagnostique', 'du', 'cancer'],\n",
       " ['nom', 'du', 'fabricant', 'roche', 'forme'],\n",
       " ['patients', 'usagers', 'proches'],\n",
       " ['lyme', 'aux', 'stades', 'localisé'],\n",
       " ['itss', 'mycoplasma'],\n",
       " ['santé', 'de', 'la', 'population'],\n",
       " ['forme', 'grave', 'de', 'la', 'granulomatose'],\n",
       " ['publication', 'de', \"l'avis\", 'au', 'ministre'],\n",
       " ['système', 'nerveux'],\n",
       " ['association', 'avec', 'le', 'bortézomib', 'et', 'la', 'dexaméthasone'],\n",
       " ['génito', 'urinaire'],\n",
       " ['demande', 'ultérieure'],\n",
       " ['outil', 'clinique', 'céphalée'],\n",
       " ['cas', 'échéant'],\n",
       " ['jeunes', 'et', 'familles'],\n",
       " ['antipsychotiques', 'atypiques'],\n",
       " ['projet', 'aligné', 'inesss', 'acmts'],\n",
       " ['étude', 'de', 'cohorte'],\n",
       " ['transplantation', 'cardiaque', 'et', 'pulmonaire', 'au', 'québec'],\n",
       " ['modifications', 'des', 'indications'],\n",
       " ['usage', \"d'alcool\", 'troubles'],\n",
       " ['selpercatinib', 'lilly', 'pour', 'le', 'traitement'],\n",
       " ['bunod', 'bausch', 'réduction', 'de', 'la', 'pression'],\n",
       " ['prise', 'de', 'décision', 'partagée', 'formations'],\n",
       " ['troubles', 'graves', 'du', 'comportement', 'meilleures'],\n",
       " ['québec', 'québec', 'canada'],\n",
       " ['dépistage', 'du', 'cancer', 'du', 'col'],\n",
       " ['génétique', 'humaine'],\n",
       " ['reprise', 'graduelle', 'des', 'activités', 'intellectuelles', 'physiques'],\n",
       " ['systèmes', 'de', 'mesure'],\n",
       " ['phase', 'chronique'],\n",
       " ['outil', 'clinique', 'interactif'],\n",
       " ['modalités', \"d'évaluation\", 'des', 'médicaments'],\n",
       " ['indication',\n",
       "  'reconnue',\n",
       "  'pour',\n",
       "  'le',\n",
       "  'traitement',\n",
       "  'de',\n",
       "  'la',\n",
       "  'sep',\n",
       "  'progressive'],\n",
       " ['fluoropyrimidines', 'meilleures', 'stratégies'],\n",
       " ['appui', 'à', 'la', 'prise', 'de', 'décision', 'dans', 'le', 'secteur'],\n",
       " ['exigence', \"d'un\", 'essai', 'préalable'],\n",
       " ['usage', 'optimal', 'guide', 'posologique'],\n",
       " ['compagnon', 'les', 'autorités'],\n",
       " ['données', 'probantes', 'et', 'sécuritaires', 'traitement'],\n",
       " ['infections', 'transmissibles', 'sexuellement'],\n",
       " ['usage', 'optimal', 'du', 'médicament'],\n",
       " ['computed', 'tomography'],\n",
       " ['antécédent', 'de', 'cancer'],\n",
       " ['mousse', 'hydrophile'],\n",
       " ['transplantation', 'des', 'îlots', 'de', 'langerhans'],\n",
       " ['usage', 'des', 'médicaments', 'spécifiques', 'au', 'tdah'],\n",
       " ['infections',\n",
       "  'bactériennes',\n",
       "  'aiguës',\n",
       "  'de',\n",
       "  'la',\n",
       "  'peau',\n",
       "  'et',\n",
       "  'des',\n",
       "  'structures',\n",
       "  'cutanées'],\n",
       " ['pertinence', 'et', 'pistes'],\n",
       " ['médicaments', 'dans', 'la', 'liste', 'de', 'médicaments'],\n",
       " ['activité', 'guide'],\n",
       " ['tomographie', 'axiale', 'à', 'faible', 'dose'],\n",
       " ['évaluation', 'kimmtrak'],\n",
       " ['standardisation', 'des', 'pratiques', 'relatives', 'aux', 'allergies'],\n",
       " ['usage', 'optimal', 'thrombose', 'veineuse'],\n",
       " ['tazobactam', 'pour', 'injection', 'pipéracilline', 'sodique'],\n",
       " ['vertu',\n",
       "  'de',\n",
       "  'la',\n",
       "  'loi',\n",
       "  'sur',\n",
       "  'la',\n",
       "  'protection',\n",
       "  'de',\n",
       "  'la',\n",
       "  'jeunesse',\n",
       "  'lpj'],\n",
       " ['pms', 'lurasidone', 'lurasidone', 'chlorhydrate', 'de', 'phmscience'],\n",
       " ['réanimation', 'cardiorespiratoire', 'rcr', 'dans', 'le', 'contexte'],\n",
       " ['demande', 'en', 'attente', \"d'évaluation\", 'bijuva', 'estradiol'],\n",
       " ['autorisations', 'sont', 'données'],\n",
       " ['fentanyl', 'pour', 'injection'],\n",
       " ['rejet', \"d'organe\"],\n",
       " ['nom', 'du', 'fabricant', 'servier', 'forme'],\n",
       " ['implantation', 'valvulaire', 'aortique', 'par', 'cathéter'],\n",
       " ['fabricants', 'inesss'],\n",
       " ['décision', 'antérieure'],\n",
       " ['cas', 'de', 'covid'],\n",
       " ['poudre', 'orale'],\n",
       " ['attente', \"d'évaluation\", 'bijuva'],\n",
       " ['développemental', 'du', 'langage'],\n",
       " ['traitement', 'du', 'syndrome', 'hémolytique'],\n",
       " ['patients', 'adultes', 'souffrant', \"d'une\", 'tumeur'],\n",
       " ['proposition', 'de', 'segmentation', 'de', 'la', 'population'],\n",
       " ['irm', 'pour', 'les', 'traitements', 'de', 'radiothérapie'],\n",
       " ['traitement', 'des', 'symptômes', 'vasomoteurs'],\n",
       " ['usage', 'optimal', 'pharyngite'],\n",
       " ['niveaux', 'de', 'soins'],\n",
       " ['regard', 'sur', 'les', 'facteurs', 'associés', 'aux', 'hospitalisations'],\n",
       " ['usage', 'optimal', \"l'usage\", 'optimal'],\n",
       " ['usage', 'optimal', 'sur', 'les', 'infections', 'transmissibles'],\n",
       " ['action', 'pour', 'une', 'utilisation'],\n",
       " ['processus', \"d'évaluation\", 'des', 'analyses', 'de', 'biologie'],\n",
       " ['inscription', 'avec', 'conditions'],\n",
       " ['citrate', 'de', 'jamp'],\n",
       " ['dépôt', \"d'une\", 'demande'],\n",
       " ['mois', 'atteignent'],\n",
       " ['individus', 'asymptomatiques'],\n",
       " ['mesure', 'du', 'glucose', 'en', 'continu', 'dexcom'],\n",
       " ['évaluation', 'hulio', 'adalimumab'],\n",
       " ['cours', \"d'évaluation\", 'jemperli', 'dostarlimab'],\n",
       " ['enfants', 'à', 'risque', 'ou', 'en', 'situation'],\n",
       " ['fonds', 'de', 'recherche', 'du', 'québec'],\n",
       " ['listes', 'de', 'médicaments', 'principales', 'références'],\n",
       " ['usage', 'approprié', 'des', 'antipsychotiques'],\n",
       " ['itss', 'mycoplasma', 'genitalium'],\n",
       " ['médicaments', 'évalués', 'nom'],\n",
       " ['chlorhydrate', 'de', 'emd', 'serono'],\n",
       " ['demande', 'en', 'cours', \"d'évaluation\", 'firdapse'],\n",
       " ['guide', 'de', 'pratique'],\n",
       " ['jeunes', 'âgés'],\n",
       " ['évolution', 'des', 'modalités'],\n",
       " ['milieu', 'de', 'vie', 'en', 'centre'],\n",
       " ['fusion', 'du', 'gène', 'ret'],\n",
       " ['mutations', 'activatrices', \"d'insertion\", 'de', \"l'exon\"],\n",
       " ['technologies', 'innovantes', 'rencontres'],\n",
       " ['donnée', 'à', 'afficher', 'pour', 'la', 'période'],\n",
       " ['pertinence',\n",
       "  'et',\n",
       "  'pistes',\n",
       "  \"d'action\",\n",
       "  'pour',\n",
       "  'une',\n",
       "  'utilisation',\n",
       "  'judicieuse'],\n",
       " ['pratiques', 'de', 'prévention'],\n",
       " ['diabetes', 'and', 'dyslipidemia'],\n",
       " ['inesss', 'estime'],\n",
       " ['évaluation', 'économique'],\n",
       " ['réévaluation', 'de', \"l'indication\"],\n",
       " ['insuline', 'chez', 'les', 'patients', 'atteints', 'du', 'diabète'],\n",
       " ['suivi', 'de', \"l'évolution\", 'de', \"l'épidémie\", 'de', 'covid'],\n",
       " ['projets', 'de', \"l'inesss\"],\n",
       " ['procédures', 'de', 'biologie', 'médicale'],\n",
       " ['ioflupane', 'datscan', 'dans', 'la', 'démarche'],\n",
       " ['finérénone', 'bayer', 'traitement'],\n",
       " ['hyperoxalurie', 'primitive', 'de', 'type'],\n",
       " ['cellules', 'métastatique'],\n",
       " ['réseau', 'québécois', 'de', 'traumatologie'],\n",
       " ['refus', \"d'inscription\"],\n",
       " ['bicarbonate', 'de', 'sodium', 'darunavir', 'jamp'],\n",
       " ['projections',\n",
       "  'des',\n",
       "  'besoins',\n",
       "  'hospitaliers',\n",
       "  'basées',\n",
       "  'sur',\n",
       "  'les',\n",
       "  'données'],\n",
       " ['outil', \"d'aide\", 'à', 'la', 'décision', 'en', 'cas'],\n",
       " ['canada', 'berotralstat', 'biocryst'],\n",
       " ['concordance',\n",
       "  'avec',\n",
       "  'la',\n",
       "  'recommandation',\n",
       "  'émise',\n",
       "  'pour',\n",
       "  'le',\n",
       "  'produit'],\n",
       " ['jamp', 'glycopyrrolate', 'jamp'],\n",
       " ['syndromes', 'parkinsoniens'],\n",
       " ['nom', 'du', 'fabricant', 'servier'],\n",
       " ['guide', \"d'usage\", 'optimal', 'fibrillation', 'auriculaire'],\n",
       " ['demande', 'en', 'attente', \"d'un\", 'dépôt', 'pour', 'évaluation'],\n",
       " ['timbre', 'cutané'],\n",
       " ['leila', 'azzi'],\n",
       " ['traitement', 'endovasculaire'],\n",
       " ['décès', 'en', 'lien', 'avec', 'la', 'covid'],\n",
       " ['évaluations', 'scientifiques'],\n",
       " ['membres', 'du', 'comité', 'consultatif'],\n",
       " ['médicament', 'réfère'],\n",
       " ['pramipexole', 'pramipexole'],\n",
       " ['consensus',\n",
       "  'des',\n",
       "  'recommandations',\n",
       "  'en',\n",
       "  'lien',\n",
       "  'avec',\n",
       "  'la',\n",
       "  'priorisation'],\n",
       " ['attente', \"d'un\", 'dépôt', 'pour', 'évaluation', 'en', 'attente'],\n",
       " ['anti', 'inflammatoire'],\n",
       " ['traitement',\n",
       "  'de',\n",
       "  'la',\n",
       "  'spondylarthrite',\n",
       "  'ankylosante',\n",
       "  'évolutive',\n",
       "  'réévaluation'],\n",
       " ['sodium', 'pour', 'injection'],\n",
       " ['attente', \"d'évaluation\", 'kimmtrak', 'tebentafusp'],\n",
       " ['évaluation', 'cosentyx'],\n",
       " ['résultats', 'cliniques', 'de', \"l'implantation\"],\n",
       " ['guo', 'zona', 'ophtalmique'],\n",
       " ['réponses', 'rapides', 'disponibles', 'services', 'sociaux'],\n",
       " ['cours', \"d'évaluation\", 'jakavi'],\n",
       " ['évaluations', 'en', 'mode', 'continu', 'autres', 'évaluations'],\n",
       " ['traitement', 'des', 'plaies', 'complexes', 'thérapie'],\n",
       " ['traitement', 'des', 'plaies'],\n",
       " ['acide', 'zolédronique'],\n",
       " ['maladie', 'pulmonaire', 'obstructive', 'chronique', 'mpoc'],\n",
       " ['res', 'en', \"l'équipe\", 'de', 'projet'],\n",
       " ['dénomination', 'commune', 'sujet', 'brentuximab', 'védotine'],\n",
       " ['usage', 'optimal', 'blépharites'],\n",
       " ['amyotrophie', 'spinale', 'recommandation'],\n",
       " ['protocole', 'médical', 'national', 'chlamydia'],\n",
       " ['sécurité', 'du', 'lieu', 'et', 'conditions', 'de', 'succès'],\n",
       " ['attente', \"d'évaluation\", 'foquest'],\n",
       " ['élévation', 'du', 'segment'],\n",
       " ['cellules', 'cancéreuses'],\n",
       " ['vagues', 'de', 'la', 'pandémie'],\n",
       " ['liste', 'des', 'produits', 'du', 'système'],\n",
       " ['arrondissement', 'des', 'doses', \"d'agents\", 'antinéoplasiques'],\n",
       " ['infection', 'urinaire'],\n",
       " ['envois', 'de', 'prélèvements'],\n",
       " ['polypes', 'nasaux', 'sévères'],\n",
       " ['follitropine', 'alpha', 'gonal'],\n",
       " ['patients', \"l'inesss\"],\n",
       " ['forme', 'timbre'],\n",
       " ['produit', 'officielle'],\n",
       " ['analyses', 'effectuées', 'par', 'séquençage'],\n",
       " ['système', 'de', 'mesure', 'du', 'glucose', 'en', 'continu', 'guardian'],\n",
       " ['mésothéliome', 'pleural', 'malin'],\n",
       " ['maladie', 'du', 'québec'],\n",
       " ['traitement', 'des', 'affections', 'musculosquelettiques', 'chroniques'],\n",
       " ['symptômes', 'vasomoteurs', 'modérés', 'ou', 'graves'],\n",
       " ['symptômes', 'de', \"l'atrophie\"],\n",
       " ['nom', 'commercial', 'à', 'venir', 'tirzepatide'],\n",
       " ['attente', \"d'évaluation\", 'nucala', 'mépolizumab', 'gsk'],\n",
       " ['cariprazine', 'abbvie', 'traitement'],\n",
       " ['mise', 'en', 'ligne'],\n",
       " ['conformité', 'de', 'santé'],\n",
       " ['ans', 'ayant', 'un', 'trouble', 'du', 'spectre'],\n",
       " ['usage', 'optimal', 'pharyngite', 'amydalite', 'version'],\n",
       " ['diagnostic', 'de', 'la', 'maladie', \"d'alzheimer\"],\n",
       " ['thromboses', 'veineuses'],\n",
       " ['cpnpc', 'avec', 'mutation'],\n",
       " ['prise', 'de', 'décision', 'dans', 'le', 'contexte', 'du', 'remplacement'],\n",
       " ['maladie', 'de', 'parkinson'],\n",
       " ['analysis', 'of', 'randomized'],\n",
       " ['embryons', 'conservés', 'à', 'la', 'suite', \"d'un\", 'processus'],\n",
       " ['évaluation', 'du', 'synvisc'],\n",
       " ['imagerie',\n",
       "  'pour',\n",
       "  'le',\n",
       "  'traitement',\n",
       "  'des',\n",
       "  'patients',\n",
       "  'présentant',\n",
       "  'une',\n",
       "  'céphalée',\n",
       "  'primaire'],\n",
       " ['polyangéite', 'ou', 'polyangéite'],\n",
       " ['tep', 'en', 'oncologie'],\n",
       " ['paiement', 'sont', 'pour', 'le', 'traitement'],\n",
       " ['cours', \"d'évaluation\", 'trikafta', 'projet'],\n",
       " ['situation', 'de', 'négligence'],\n",
       " ['sédation', 'palliative', 'continue', 'soins', 'palliatifs'],\n",
       " ['post', 'covid'],\n",
       " ['gène', 'egfr', 'dans', 'le', 'cancer'],\n",
       " ['exception', 'des', 'listes'],\n",
       " ['sandoz', 'fesoterodine', 'fumarate', 'fésotérodine', 'fumarate'],\n",
       " ['dépôt', 'pour', 'évaluation', 'tremfya', 'guselkumab'],\n",
       " ['triheptanoïne',\n",
       "  'ultragenyx',\n",
       "  'traitement',\n",
       "  'des',\n",
       "  'troubles',\n",
       "  \"d'oxydation\",\n",
       "  'des',\n",
       "  'acides'],\n",
       " ['regard', 'sur', 'la', 'fréquentation'],\n",
       " ['traitement', \"d'appoint\"],\n",
       " ['travaux', 'en', 'dépistage'],\n",
       " ['portrait', 'du', 'traitement'],\n",
       " ['sport', 'related', 'concussion'],\n",
       " ['cours', \"d'évaluation\"],\n",
       " ['dénomination', 'commune', 'nom', 'du', 'fabricant'],\n",
       " ['ministre', 'recommandant', \"l'inscription\"],\n",
       " ['soins', 'alternatifs'],\n",
       " ['cours', \"d'évaluation\", 'demande'],\n",
       " ['sidekick', 'mc', 'et', 'truetrack'],\n",
       " ['chirurgie', 'pour', 'favoriser'],\n",
       " ['injury', 'patients'],\n",
       " ['risque', 'de', 'toxicités'],\n",
       " ['nouveautés', 'du', 'mois', 'archives'],\n",
       " ['douleur', 'associée'],\n",
       " ['pertinence', 'du', 'dépistage', 'néonatal', 'de', \"l'amyotrophie\"],\n",
       " ['éléments', 'facilitant'],\n",
       " ['glucose', 'freestyle'],\n",
       " ['cancer', 'de', \"l'endomètre\"],\n",
       " ['frais', 'exigibles'],\n",
       " ['télédépistage', 'de', 'la', 'rétinopathie'],\n",
       " ['maladies', 'chroniques', 'indicateurs'],\n",
       " ['production', 'scientifique'],\n",
       " ['msss', 'au', 'lien', 'suivant', 'priorisation'],\n",
       " ['conditions', 'particulaires', 'extrait'],\n",
       " ['publication', 'de', \"l'état\", 'de', 'connaissances'],\n",
       " ['attente', \"d'évaluation\", 'demande'],\n",
       " ['évaluation', 'aux', 'fins'],\n",
       " ['formules', 'nutritives', 'monomériques'],\n",
       " ['comportement', 'meilleures', 'pratiques', 'en', 'prévention'],\n",
       " ['exception', 'pour', 'le', 'traitement'],\n",
       " ['critères', \"d'évaluation\"],\n",
       " ['amivantamab', 'janssen'],\n",
       " ['spondylarthrite',\n",
       "  'ankylosante',\n",
       "  'évolutive',\n",
       "  'réévaluation',\n",
       "  'en',\n",
       "  'cours'],\n",
       " ['traitement', 'pharmacologique', 'de', 'la', 'maladie', \"d'alzheimer\"],\n",
       " ['apo', 'eletriptan', 'élétriptan', 'bromhydrate', \"d'apotex\"],\n",
       " ['inhibiteur', 'sélectif'],\n",
       " ['impact', 'budgétaire'],\n",
       " ['exercice',\n",
       "  'de',\n",
       "  'cohérence',\n",
       "  'ou',\n",
       "  'de',\n",
       "  'concordance',\n",
       "  'avec',\n",
       "  'la',\n",
       "  'recommandation'],\n",
       " ['infections', 'bactériennes', 'aiguës'],\n",
       " ['inesss', 'a', 'évalué'],\n",
       " ['régime', 'public', \"l'inesss\"],\n",
       " ['fibrose', 'kystique', 'chez', 'les', 'patients'],\n",
       " ['algorithmes', 'en', 'cancérologie'],\n",
       " ['glucose', 'dans', 'le', 'sang'],\n",
       " ['jamp', 'teriflunomide'],\n",
       " ['paiement', 'des', 'médicaments'],\n",
       " ['dénomination', 'commune', 'sujet', 'gonadotrophines'],\n",
       " ['troubles', 'mentaux'],\n",
       " ['hospitalisation',\n",
       "  'pour',\n",
       "  'les',\n",
       "  'personnes',\n",
       "  'infectées',\n",
       "  'par',\n",
       "  'le',\n",
       "  'sras'],\n",
       " ['santé', 'mentale', 'efficacité'],\n",
       " ['ischémique', 'en', 'phase', 'hyperaiguë'],\n",
       " ['conciliation', 'du', 'milieu'],\n",
       " ['pratiques', 'cliniques'],\n",
       " ['attente', \"d'évaluation\", 'ou', 'en', 'cours', \"d'évaluation\"],\n",
       " ['compagnons', 'a', 'pour', 'objectif'],\n",
       " ['gestionnaires', 'du', 'réseau', 'de', 'la', 'santé'],\n",
       " ['visée', 'thérapeutique'],\n",
       " ['listes', 'de', 'médicaments', 'pour', 'le', 'traitement'],\n",
       " ['indication', 'reconnue', 'médicament'],\n",
       " ['guide', \"d'usage\", 'optimal', 'eampoc'],\n",
       " ['déficit', 'congénital'],\n",
       " ['neisseria', 'gonorrhoeae', 'chez', 'une', 'personne', 'asymptomatique'],\n",
       " ['jeunes', 'adultes'],\n",
       " ['regard', 'sur', 'les', 'groupes', 'de', 'médecine', 'de', 'famille'],\n",
       " ['inesss', 'annexes'],\n",
       " ['moderate', 'and', 'severe'],\n",
       " ['conditions', 'de', 'succès', 'de', \"l'accouchement\"],\n",
       " ['services', 'de', 'soins'],\n",
       " ['lien', 'avec', 'les', 'niveaux'],\n",
       " ['douleurs', 'musculosquelettiques', 'irm'],\n",
       " ['modalités', \"d'accès\", 'de', 'remboursement'],\n",
       " ['modalités', 'et', 'processus'],\n",
       " ['liste', 'des', 'médicaments', 'couverts', 'par', 'le', 'régime'],\n",
       " ['liste', 'des', 'médicaments', 'du', 'rgam'],\n",
       " ['soins', 'critiques', 'de', \"l'inesss\"],\n",
       " ['analyse', 'de', 'données'],\n",
       " ['risk', 'of', 'cardiovascular'],\n",
       " ['pertinence', 'des', 'modes'],\n",
       " ['produits', 'de', 'connaissances'],\n",
       " ['protocole', 'médical', 'problèmes'],\n",
       " ['indications', 'justifiant', 'le', 'recours', 'à', \"l'imagerie\"],\n",
       " ['précisions', 'sur', 'le', 'projet'],\n",
       " ['liste', 'des', 'principaux'],\n",
       " ['trajectoires', 'de', 'services', 'menant'],\n",
       " ['chlorhydrate', \"d'nom\"],\n",
       " ['centre', 'du', 'québec'],\n",
       " ['trouble', 'développemental'],\n",
       " ['patients', 'adultes', 'atteints', \"d'hémoglobinurie\", 'paroxystique'],\n",
       " ['solution', \"d'acétylcystéine\"],\n",
       " ['santé', 'naturels'],\n",
       " ['dégénérescence', 'maculaire'],\n",
       " ['guide', \"d'usage\", 'optimal'],\n",
       " ['arrimage', 'entre', \"l'inscription\", 'éventuelle'],\n",
       " ['micro', 'invasive'],\n",
       " ['organes', 'solides', 'volet'],\n",
       " ['normes', 'et', 'standards', 'en', 'protection', 'de', 'la', 'jeunesse'],\n",
       " ['alendronate', 'monosodique', 'nora'],\n",
       " ['usage', 'optimal', 'zona'],\n",
       " ['autosurveillance', 'glycémique', 'chez', 'les', 'adultes'],\n",
       " ['tcc', 'modéré'],\n",
       " ['sang', 'occulte'],\n",
       " ['patients', 'adultes', 'atteints', \"d'un\", 'myélome'],\n",
       " ['hémoglobinurie', 'paroxystique', 'nocturne'],\n",
       " ['utilisation', 'de', 'substances'],\n",
       " ['lénalidomide', 'pour', 'le', 'traitement'],\n",
       " ['pratiques', 'en', 'oncologie', 'cepo'],\n",
       " ['rencontres', 'avec', 'les', 'représentants', 'de', \"l'industrie\"],\n",
       " ['évaluation', 'amgevita', 'adalimumab', 'amgen'],\n",
       " ['patients', 'atteints', 'de', 'néphropathie', 'chronique'],\n",
       " ['clinico', 'administratives'],\n",
       " ['traumatismes', 'non', 'intentionnels'],\n",
       " ['interventions', 'de', 'réadaptation', 'pour', 'les', 'enfants'],\n",
       " ['consentement', 'et', 'options'],\n",
       " ['soutien',\n",
       "  'à',\n",
       "  'domicile',\n",
       "  'par',\n",
       "  'les',\n",
       "  'personnes',\n",
       "  'en',\n",
       "  'fin',\n",
       "  'de',\n",
       "  'vie'],\n",
       " ['évaluation', 'saphnelo', 'anifrolumab'],\n",
       " ['récepteurs', 'hormonaux', 'et', 'négatif'],\n",
       " ['documents', 'des', 'organismes'],\n",
       " ['évaluations', 'en', 'mode', 'continu', 'inesss', 'express'],\n",
       " ['vph', 'comme', 'test', 'de', 'dépistage', 'primaire'],\n",
       " ['insuline', 'glargine', 'bgp', 'pharma'],\n",
       " ['comptes', 'rendus'],\n",
       " ['utilisation', 'des', 'accélérateurs'],\n",
       " ['solution', 'orale'],\n",
       " ['mepolizumab', 'gsk', 'traitement'],\n",
       " ['injection', 'de', 'glycopyrrolate', 'jamp'],\n",
       " ['femmes', 'ménopausées'],\n",
       " ['lévonorgestrel', 'pour', 'la', 'contraception', 'orale', \"d'urgence\"],\n",
       " ['traitement', 'des', 'nausées'],\n",
       " ['évaluation', 'fiche'],\n",
       " ['colle', 'de', 'fibrine'],\n",
       " ['processus', \"d'évaluation\"],\n",
       " ['anticoagulants', 'oraux', 'directs', 'et', 'de', 'la', 'warfarine'],\n",
       " ['terme', 'des', 'besoins'],\n",
       " ['agents', 'biologiques'],\n",
       " ['évaluation', 'firdapse', 'amifampridine', 'kye'],\n",
       " ['liquid',\n",
       "  'inhibiteur',\n",
       "  'de',\n",
       "  \"l'proteinase\",\n",
       "  'grifols',\n",
       "  'produit',\n",
       "  'du',\n",
       "  'système'],\n",
       " ['services', 'administratifs', 'du', 'secrétariat', 'général'],\n",
       " ['réseau', 'de', 'la', 'santé'],\n",
       " ['traitement', 'de', 'la', 'leucémie', 'lymphoblastique', 'aiguë'],\n",
       " ['ors', 'édaravone'],\n",
       " ['absence', 'de', 'détérioration'],\n",
       " ['outil', 'de', 'soutien'],\n",
       " ['synthèse', 'trouble'],\n",
       " ['mild', 'traumatic', 'brain', 'injury'],\n",
       " ['myélome', 'multiple', 'carfilzomib'],\n",
       " ['mesure', 'du', 'glucose', 'en', 'continu', 'guardian'],\n",
       " ['algorithme', \"d'investigation\", 'de', 'traitement', 'et', 'de', 'suivi'],\n",
       " ['évaluation', 'cibinqo', 'projet'],\n",
       " ['autosurveillance', 'glycémique'],\n",
       " ['mutation', 'del', 'du', 'gène', 'cftr'],\n",
       " ['older', 'adults'],\n",
       " ['trauma', 'center'],\n",
       " ['pratique', 'sur', 'le', 'repérage'],\n",
       " ['expertise', 'réfère'],\n",
       " ['postsoumission', 'avec', 'les', 'fabricants'],\n",
       " ['traitement', \"d'entretien\", 'de', \"l'asthme\", 'éosinophile'],\n",
       " ['population', 'pour', 'appuyer', 'les', 'démarches'],\n",
       " ['niveau', 'de', 'preuve', 'scientifique', 'faible'],\n",
       " ['directeur', 'général'],\n",
       " ['accidents', 'vasculaires'],\n",
       " ['comités', 'scientifiques'],\n",
       " ['otsuka', 'can', 'traitement'],\n",
       " ['intervention', 'médicale'],\n",
       " ['cours', \"d'évaluation\", 'firdapse'],\n",
       " ['note', 'explicative', 'trimestre'],\n",
       " ['utilisation', 'de', \"l'imagerie\", 'par', 'résonance', 'magnétique'],\n",
       " ['troubles', 'neurocognitifs', 'majeurs'],\n",
       " ['propionate', 'de', 'phmscience'],\n",
       " ['moment', 'de', 'la', 'rencontre'],\n",
       " ['soulagement', 'des', 'dermatoses', 'sensibles', 'aux', 'corticostéroïdes'],\n",
       " ['angine', 'stable'],\n",
       " ['repérage', 'fiche'],\n",
       " ['chirurgie', 'pour', 'favoriser', \"l'hémostase\"],\n",
       " ['voies', 'respiratoires', 'version', 'française'],\n",
       " ['traitement', 'de', 'la', 'diarrhée'],\n",
       " ['trauma', 'centres'],\n",
       " ['mint', 'quetiapine'],\n",
       " ['traitement', 'des', 'symptômes', 'vasomoteurs', 'modérés'],\n",
       " ['cost', 'effectiveness'],\n",
       " ['évaluation', 'mvasi'],\n",
       " ['trajectoire', 'diagnostiques'],\n",
       " ['glycopyrrolate', 'glycopyrrolate', 'jamp'],\n",
       " ['services',\n",
       "  'administratifs',\n",
       "  'du',\n",
       "  'secrétariat',\n",
       "  'général',\n",
       "  'et',\n",
       "  'des',\n",
       "  'communications'],\n",
       " ['patients', 'atteints', 'de', 'maladies'],\n",
       " ['collaborateurs', 'institutionnels'],\n",
       " ['application', 'inesss'],\n",
       " ['forme', 'capsule'],\n",
       " ['littérature', 'consultée'],\n",
       " ['ans', 'qui', 'présentent'],\n",
       " ['fabricant', 'zeneca'],\n",
       " ['processus', 'synchronisé', \"d'évaluation\"],\n",
       " ['plasma', 'riche', 'en', 'plaquettes'],\n",
       " ['rhumatisme', 'psoriasique'],\n",
       " ['greffon', 'contre', \"l'hôte\", 'chez', 'les', 'patients'],\n",
       " ['usage', 'optimal', 'maladie', 'de', 'lyme'],\n",
       " ['agence', 'de', 'la', 'santé'],\n",
       " ['produit', 'de', 'santé'],\n",
       " ['opioïdes', 'chez', 'les', 'personnes', 'couvertes'],\n",
       " ['présoumission', 'avec', 'les', 'fabricants'],\n",
       " ['sédation', 'palliative', 'continue'],\n",
       " ['problèmes', 'de', 'santé'],\n",
       " ['évaluation', 'wakix'],\n",
       " ['génotypage', 'du', 'rhd', 'fœtal', 'par', 'test', 'prénatal'],\n",
       " ['fibrose', 'pulmonaire'],\n",
       " ['apo', 'teriflunomide'],\n",
       " ['mepolizumab', 'gsk', 'traitement', 'des', 'polypes', 'nasaux', 'sévères'],\n",
       " ['évaluation', 'mvasi', 'bévacizumab'],\n",
       " ['fabricant', 'biogen'],\n",
       " ['transfusions', 'sanguines'],\n",
       " ['analyses', 'de', 'biologie', 'médicale'],\n",
       " ['maladies', 'cardiovasculaires', 'héréditaires'],\n",
       " ['injection', 'fentanyl', 'citrate', 'de', 'jamp'],\n",
       " ['traitement', 'de', 'la', 'cellulite'],\n",
       " ['imagerie', 'par', 'résonance', 'magnétique', 'irm'],\n",
       " ['conciliation', 'du', 'milieu', 'de', 'soins'],\n",
       " ['jeunes', 'en', 'difficulté', \"d'adaptation\"],\n",
       " ['renseignements',\n",
       "  'touchant',\n",
       "  'la',\n",
       "  'gestion',\n",
       "  'des',\n",
       "  'analyses',\n",
       "  'biomédicales'],\n",
       " ['nom', 'commercial', 'à', 'venir', 'finérénone'],\n",
       " ['infarctus', 'aigu', 'du', 'myocarde', 'avec', 'élévation'],\n",
       " ['cas', 'de', 'diarrhée', 'chez', \"l'adulte\"],\n",
       " ['coups', 'et', 'projets', 'en', 'cours'],\n",
       " ['prévention', 'de', 'la', 'grossesse'],\n",
       " ['décision', 'clinique'],\n",
       " ['réponse', 'inadéquate'],\n",
       " ['exacerbation', 'aiguë'],\n",
       " ['exercice', 'du', 'collège', 'des', 'médecins'],\n",
       " ['détection', 'taan'],\n",
       " ['évaluation', 'tremfya'],\n",
       " ['mépolizumab',\n",
       "  'gsk',\n",
       "  'traitement',\n",
       "  \"d'entretien\",\n",
       "  'de',\n",
       "  \"l'asthme\",\n",
       "  'éosinophile'],\n",
       " ['résultat', 'positif'],\n",
       " ['spectre', 'de', \"l'autisme\", 'tsa'],\n",
       " ['poussée', 'clinique'],\n",
       " ['processus', 'synchronisé'],\n",
       " ['évaluation',\n",
       "  'en',\n",
       "  'attente',\n",
       "  \"d'évaluation\",\n",
       "  'ou',\n",
       "  'en',\n",
       "  'cours',\n",
       "  \"d'évaluation\"],\n",
       " ['option', 'de', 'traitement'],\n",
       " ['profil', 'évolutif', \"d'utilisation\"],\n",
       " ['arrondissement', 'des', 'doses'],\n",
       " ['corticostéroïdes', 'et', 'traitement'],\n",
       " ['trouble', 'lié', 'à', \"l'usage\"],\n",
       " ['évaluation', 'enhertu', 'projet', 'aligné'],\n",
       " ['myocarde', 'avec', 'élévation', 'du', 'segment', 'st', 'iamest'],\n",
       " ['randomized', 'controlled', 'trials'],\n",
       " ['mesures', 'de', 'précaution'],\n",
       " ['situation', 'clinique'],\n",
       " ['guselkumab',\n",
       "  'janss',\n",
       "  'inc',\n",
       "  'traitement',\n",
       "  'du',\n",
       "  'rhumatisme',\n",
       "  'psoriasique'],\n",
       " ['activité', 'affiche'],\n",
       " ['pratiques', 'portrait', 'de', \"l'utilisation\"],\n",
       " ['difficultés', 'apparentées'],\n",
       " ['services', 'en', 'santé', 'mentale'],\n",
       " ['chloral', 'hydrate', 'syrup'],\n",
       " ['glucose', 'en', 'continu', 'guardian'],\n",
       " ['oxlumo', 'lumasiran', 'alnylam'],\n",
       " ['conseil', 'du', 'médicament'],\n",
       " ['analyses', 'de', 'laboratoire', 'au', 'répertoire'],\n",
       " ['cardiologie', 'et', 'maladies'],\n",
       " ['travaux', 'en', 'dépistage', 'et', 'pratiques'],\n",
       " ['services', 'psychosociaux'],\n",
       " ['usage', 'optimal', 'infection'],\n",
       " ['travaux', 'de', 'recherche'],\n",
       " ['technologies', 'biomédicales'],\n",
       " ['autorités', 'ministérielles', 'pour', 'une', 'prise'],\n",
       " ['évaluation', 'en', 'mode', 'continu', 'par', \"l'inesss\", 'statut'],\n",
       " ['intitulé', 'les', 'ordonnances'],\n",
       " ['fabricant', 'forme', 'teneur'],\n",
       " ['principes', 'directeurs'],\n",
       " ['pipéracilline', 'et', 'tazobactam', 'pour', 'injection'],\n",
       " ['nom', 'du', 'fabricant', 'roche'],\n",
       " ['attente', \"d'évaluation\", 'xpovio', 'sélinexor'],\n",
       " ['graves', 'des', 'symptômes'],\n",
       " ['test', 'vph'],\n",
       " ['dosage', 'de', \"l'antigène\", 'prostatique', 'spécifique', 'aps'],\n",
       " ['lien', 'avec', 'la', 'priorisation', 'des', 'soins', 'en', 'contexte'],\n",
       " ['monothérapie', 'pour', 'le', 'traitement', 'adjuvant', 'des', 'patients'],\n",
       " ['postmenopausal', 'women'],\n",
       " ['pralsetinib', 'roche'],\n",
       " ['exercice', 'du', 'collège', 'des', 'médecins', 'du', 'québec'],\n",
       " ['maladie', 'du', 'québec', 'liste', 'des', 'médicaments'],\n",
       " ['salmétérol', 'xinafoate'],\n",
       " ['patients', 'souffrant'],\n",
       " ['demande', 'en', 'cours', \"d'évaluation\", 'vraylar', 'cariprazine'],\n",
       " ['évaluation', 'des', 'installations', 'de', 'soins', 'aigus'],\n",
       " ['priorisation', 'des', 'soins'],\n",
       " ['traitement', 'adjuvant'],\n",
       " ['critère', 'de', 'la', 'valeur', 'thérapeutique'],\n",
       " ['professionnels', 'de', 'la', 'santé'],\n",
       " ['qualité', 'du', 'milieu'],\n",
       " ['prévention', 'du', 'rejet'],\n",
       " ['dipropionate', 'de', 'taro'],\n",
       " ['virus', 'respiratoire'],\n",
       " ['revue', 'rapide'],\n",
       " ['trouble', 'de', 'stress', 'post'],\n",
       " ['diagnostic', 'moléculaire', 'avis', 'au', 'ministre'],\n",
       " ['analyses', 'microbiologiques', 'des', 'selles', 'en', 'cas'],\n",
       " ['traitement', 'de', \"l'hypertension\"],\n",
       " ['évaluation', 'jakavi', 'projet'],\n",
       " ['troubles', 'graves', 'du', 'comportement'],\n",
       " ['cours', \"d'évaluation\", 'saphnelo', 'anifrolumab'],\n",
       " ['head', 'injury'],\n",
       " ['heure', 'actuelle'],\n",
       " ['alzheimer', 'et', 'démence'],\n",
       " ['calcipotriol', 'bétaméthasone'],\n",
       " ['faiza', 'boughrassa'],\n",
       " ['contexte', 'québécois', 'des', 'inhibiteurs', 'de', 'la', 'tyrosine'],\n",
       " ['gestion', 'du', 'sevrage'],\n",
       " ['pertinence',\n",
       "  'et',\n",
       "  'indications',\n",
       "  'de',\n",
       "  'transmission',\n",
       "  'des',\n",
       "  'prélèvements'],\n",
       " ['exercice', 'de', 'cohérence', 'ou', 'de', 'concordance'],\n",
       " ['perte', 'vaginale', 'inhabituelles'],\n",
       " ['soutien', 'au', 'guide', \"d'usage\", 'optimal', 'pneumonie'],\n",
       " ['documents', 'institutionnels', 'emplois'],\n",
       " ['contexte', 'préventif'],\n",
       " ['rapid', 'response'],\n",
       " ['outil', 'de', 'transfert', 'de', 'connaissances'],\n",
       " ['accident', 'vasculaire', 'cérébral'],\n",
       " ['nonacog', 'bêta'],\n",
       " ['alendronate', 'monosodique'],\n",
       " ['cataplexie', 'chez', 'des', 'patients'],\n",
       " ['suivi', 'de', \"l'évolution\"],\n",
       " ['services', 'intégrés'],\n",
       " ['écoulement', 'urétral', 'version'],\n",
       " ['réévaluation', 'en', 'cours', \"d'évaluation\", 'qinlock', 'ripretinib'],\n",
       " ['pertinence', \"d'utiliser\", 'un', 'médicament'],\n",
       " ['taro', 'ticagrelor', 'ticagrélor', 'taro'],\n",
       " ['projets', 'dans', 'les', 'meilleurs'],\n",
       " ['congrès', 'et', 'colloques', 'en', 'traumatologie'],\n",
       " ['besoins', 'des', 'enfants', 'à', 'risque', 'ou', 'en', 'situation'],\n",
       " ['aide', 'médicale', 'à', 'mourir'],\n",
       " ['interventions', 'pharmacologiques'],\n",
       " ['usage', 'optimal', 'personnes', 'âgées'],\n",
       " ['calcipotriol', 'betamethasone'],\n",
       " ['maladies', 'chroniques', 'comité'],\n",
       " ['soins', 'palliatifs', 'détresse', 'soins', 'palliatifs'],\n",
       " ['médicament', 'en', 'particulier', 'médicaments'],\n",
       " ['femmes', 'atteintes'],\n",
       " ['chlamydia', 'et', 'gonorrhoeae', 'protocole', 'médical', 'national'],\n",
       " ['dose', 'quotidienne'],\n",
       " ['transition', 'à', 'la', 'vie', 'adulte'],\n",
       " ['réduction',\n",
       "  'des',\n",
       "  'événements',\n",
       "  'athérothrombotiques',\n",
       "  'en',\n",
       "  'appoint',\n",
       "  'aux',\n",
       "  'traitements'],\n",
       " ['johnson', 'produit', 'du', 'système', 'du', 'sang'],\n",
       " ['axicabtagene',\n",
       "  'ciloleucel',\n",
       "  'pour',\n",
       "  'le',\n",
       "  'traitement',\n",
       "  'des',\n",
       "  'lymphomes'],\n",
       " ['gène', 'ret'],\n",
       " ['polyangéite', 'ou', 'polyangéite', 'microscopique'],\n",
       " ['fumarate', 'de', 'apo', 'eletriptan', 'apotex'],\n",
       " ['dépression', 'bipolaire'],\n",
       " ['suivi', 'pour', 'le', 'cancer', 'du', 'rectum'],\n",
       " ['programme', 'québécois'],\n",
       " ['utilisation', 'des', 'antiviraux', 'pour', 'le', 'traitement'],\n",
       " ['suivi', 'des', 'projets', 'cliniques'],\n",
       " ['indications', 'de', \"l'irm\"],\n",
       " ['angioedème', 'héréditaire', 'aoh', 'pré'],\n",
       " ['jeunesse', 'sommaire', 'de', 'la', 'littérature'],\n",
       " ['traitement', 'de', \"l'œdème\", 'maculaire', 'diabétique', 'pré'],\n",
       " ['chlorhydrate', 'de', 'nom'],\n",
       " ['amélioration', 'continue'],\n",
       " ['unité', \"d'évaluation\", 'en', 'traumatologie', 'et', 'en', 'soins'],\n",
       " ['guides', 'de', 'pratique'],\n",
       " ['biologie', 'médicale', 'contexte'],\n",
       " ['services', 'sociaux', 'jeunes'],\n",
       " ['prise', 'en', 'charge', 'des', 'accidents', 'vasculaires', 'cérébraux'],\n",
       " ['lymphome', 'à', 'cellules', 'du', 'manteau'],\n",
       " ['pratiques', 'proposées', 'dans', 'un', 'contexte', 'préventif'],\n",
       " ['mesure', 'prometteuse'],\n",
       " ['hypertension', 'artérielle', 'pulmonaire'],\n",
       " ['liso', 'cel'],\n",
       " ['projet', 'collaboratif', 'inesss'],\n",
       " ['syndrome', 'génito', 'urinaire'],\n",
       " ['documents', 'consultés'],\n",
       " ['tests', 'moléculaires'],\n",
       " ['milieu', 'de', 'soins'],\n",
       " ['risque', 'de', 'négligence', 'ou', 'en', 'situation'],\n",
       " ['test', 'immunochimique', 'de', 'recherche', 'de', 'sang', 'occulte'],\n",
       " ['fabricant', 'biogen', 'forme', 'solution'],\n",
       " ['vph', 'comme', 'test'],\n",
       " ['traitement', 'des', 'patients', 'adultes', 'atteints', \"d'un\", 'myélome'],\n",
       " ['envois', 'de', 'prélèvements', 'en', 'pathologie'],\n",
       " ['ciusss', 'de', 'la', 'capitale'],\n",
       " ['dépistage', 'du', 'cancer', 'colorectal'],\n",
       " ['dépistage', 'du', 'cancer', 'de', 'la', 'prostate', 'au', 'québec'],\n",
       " ['évaluation', 'vraylar', 'cariprazine'],\n",
       " ['utilisation', 'des', 'médicaments'],\n",
       " ['liaison',\n",
       "  'à',\n",
       "  \"l'attention\",\n",
       "  'du',\n",
       "  'pharmacien',\n",
       "  'communautaire',\n",
       "  'modèle'],\n",
       " ['mémoire', 'trouble'],\n",
       " ['tomosynthèse', 'mammaire'],\n",
       " ['victimes', 'de', 'traumatismes'],\n",
       " ['traitement', 'de', \"l'insomnie\"],\n",
       " ['oeuvre', 'de', 'la', 'méthode', 'de', 'réponse'],\n",
       " ['cellulite', 'infectieuse'],\n",
       " ['évaluation', 'du', 'risque'],\n",
       " ['validation', 'pour', 'les', 'analyses', 'de', 'laboratoires'],\n",
       " ['pratiques', 'organisationnelles', 'en', 'réadaptation'],\n",
       " ['contexte', 'de', \"l'administration\"],\n",
       " ['prothrombine', 'dans', 'le', 'sang'],\n",
       " ['caplacizumab', 'sanofiaven', 'traitement', 'du', 'purpura'],\n",
       " ['immunoglobulines', 'en', 'hématologie'],\n",
       " ['dexaméthasone', 'pour', 'le', 'traitement'],\n",
       " ['agence', \"d'évaluation\"],\n",
       " ['conseils', 'pour', 'la', 'reprise', 'graduelle'],\n",
       " ['tumeur', 'stromale', 'gastro'],\n",
       " ['ordonnance', 'individuelle', 'préimprimée'],\n",
       " ['déficience', 'physique', 'déficience', 'intellectuelle'],\n",
       " ['patientes', 'ménopausées'],\n",
       " ['évaluations', 'en', 'appui'],\n",
       " ['résultats', 'de', 'plusieurs', 'méta'],\n",
       " ['mucosite', 'oropharyngée', 'naloxone', 'pertes', 'vaginales'],\n",
       " ['services', 'pour', 'les', 'enfants', 'à', 'risque'],\n",
       " ['selles', 'en', 'cas'],\n",
       " ['psoriasis', 'en', 'plaques'],\n",
       " ['traitement', 'au', 'fer', 'intraveineux'],\n",
       " ['estrogènes', 'conjugués', 'biologiques'],\n",
       " ['cancer', 'du', 'poumon', 'par', 'la', 'tomographie'],\n",
       " ['guides', \"d'usage\", 'optimal', 'résumés'],\n",
       " ['ministre', 'de', 'la', 'santé', 'et', 'des', 'services', 'sociaux'],\n",
       " ['traitement', 'de', 'la', 'thrombose'],\n",
       " ['maladies', 'cardiovasculaires', 'infectieuses'],\n",
       " ['dépôt', 'électronique', \"d'une\", 'demande'],\n",
       " ['onetouch', 'mc', 'verio'],\n",
       " ['guide', 'posologique'],\n",
       " ['test', 'immunochimique'],\n",
       " ['traitement', 'par', 'agonistes'],\n",
       " ['démarche', \"d'évaluation\"],\n",
       " ['prélèvements', 'chirurgicaux', 'au', 'laboratoire', \"d'anatomopathologie\"],\n",
       " ['déficit', 'grave', 'en', 'antitrypsine', 'chez', 'les', 'adultes'],\n",
       " ['cancer', 'du', 'poumon', 'à', 'petites', 'cellules'],\n",
       " ['usage', 'optimal', 'usage'],\n",
       " ['cours', \"d'évaluation\", 'wakix'],\n",
       " ['sep', 'progressive', 'secondaire', 'pour', 'avonex'],\n",
       " ['normes', 'et', 'standards', 'de', 'qualité'],\n",
       " ['infections', 'urinaires'],\n",
       " ['naloxone', 'par', 'voie', 'nasale'],\n",
       " ['répertoire', 'québécois'],\n",
       " ['traitement', 'de', 'la', 'maladie'],\n",
       " ['bandelettes', 'de', 'glycémie'],\n",
       " ['patients', 'en', 'attente', \"d'une\", 'coloscopie'],\n",
       " ['évaluation', 'nucala', 'mépolizumab', 'gsk'],\n",
       " ['protoxyde', \"d'azote\"],\n",
       " ['soutien', 'au', 'guide', \"d'usage\", 'optimal', 'eampoc'],\n",
       " ['nourrissons', 'ou', 'enfants'],\n",
       " ['emergency', 'care'],\n",
       " ['projets', 'cliniques', 'et', 'de', 'recherche'],\n",
       " ['recommandations', 'en', 'lien', 'avec', 'la', 'priorisation'],\n",
       " ['évaluation', 'et', 'gestion'],\n",
       " ['association', 'avec', 'une', 'endocrinothérapie'],\n",
       " ['anesthésie',\n",
       "  'générale',\n",
       "  'pour',\n",
       "  'les',\n",
       "  'soins',\n",
       "  'dentaires',\n",
       "  'en',\n",
       "  'pédiatrie'],\n",
       " ['monohydrate', 'de', 'sanis'],\n",
       " ['standards', 'en', 'protection', 'de', 'la', 'jeunesse'],\n",
       " ['fer', 'intraveineux', 'chez', \"l'adulte\", 'trouble', 'dépressif'],\n",
       " ['maladies', 'chroniques', 'indicateurs', 'de', 'qualité', 'prise'],\n",
       " ['mépolizumab', 'gsk'],\n",
       " ['population', 'pour', 'appuyer', 'les', 'démarches', \"d'amélioration\"],\n",
       " ['critères', 'prévus'],\n",
       " ['annexes', 'complémentaires'],\n",
       " ['mucosite', 'oropharyngée', 'naloxone', 'pertes'],\n",
       " ['déficience', 'intellectuelle', 'trouble'],\n",
       " ['lyme', 'ppe', 'mucosite', 'oropharyngée', 'naloxone'],\n",
       " ['usage', 'optimal', 'herpès', 'génital', 'version', 'française'],\n",
       " ['victimes', 'de', 'brûlures'],\n",
       " ['cours', \"d'évaluation\", 'cibinqo', 'projet'],\n",
       " ['cas', 'de', 'cancer', 'du', 'sein', 'invasif'],\n",
       " ['transmission',\n",
       "  'des',\n",
       "  'prélèvements',\n",
       "  'chirurgicaux',\n",
       "  'au',\n",
       "  'laboratoire',\n",
       "  \"d'anatomopathologie\"],\n",
       " ['inhibiteurs', 'de', 'la', 'protéase'],\n",
       " ['médicaments', 'biosimilaires'],\n",
       " ['infection', 'par', 'le', 'sras'],\n",
       " ['conseil', 'déplore'],\n",
       " ['recension', 'sommaire', 'des', 'principales', 'lignes', 'directrices'],\n",
       " ['zeneca', 'forme'],\n",
       " ['aide', 'à', 'la', 'décision', 'céphalée', 'adulte', 'irm'],\n",
       " ['inesss', \"d'élaborer\"],\n",
       " ['pandémie', 'de', 'la', 'covid'],\n",
       " ['centre', 'de', 'réadaptation', 'pour', 'jeunes'],\n",
       " ['coût', 'unitaire'],\n",
       " ['échelle', 'nationale'],\n",
       " ['cancer', 'du', 'poumon', 'par', 'la', 'tomographie', 'axiale'],\n",
       " ['réadaptation', 'pour', 'jeunes', 'en', 'difficulté', \"d'adaptation\"],\n",
       " ['niacine', 'à', 'libération', 'prolongée'],\n",
       " ['déficiences', 'physiques', 'intellectuelles', 'et', 'tsa'],\n",
       " ['segmentation', 'de', 'la', 'population'],\n",
       " ['ordonnances', 'associées', 'aide'],\n",
       " ['segmentation', 'de', 'la', 'population', 'pour', 'appuyer'],\n",
       " ['réduction', 'de', 'la', 'pression'],\n",
       " ['sandoz', 'fesoterodine'],\n",
       " ['cours', \"d'évaluation\", 'mvasi', 'bévacizumab', 'amgen'],\n",
       " ['modéré', 'grave'],\n",
       " ['tézépélumab', 'azc', 'traitement', \"d'entretien\"],\n",
       " ['modalités', \"d'évaluation\"],\n",
       " ['exercice', 'du', 'collège'],\n",
       " ['ménopayse', 'chez', 'la', 'femme', 'ménopausée'],\n",
       " ['statut', 'de', 'la', 'demande', 'en', 'attente', \"d'un\", 'dépôt'],\n",
       " ['maribavir', 'takeda', 'traitement'],\n",
       " ['tests', 'sérologiques'],\n",
       " ['processus', 'et', 'critères', \"d'évaluation\"],\n",
       " ['lignes', 'directrices'],\n",
       " ['cancer', 'du', 'sein', 'métastatique'],\n",
       " ['mode', 'continu', 'par', \"l'inesss\"],\n",
       " ['sandoz', 'lurasidone', 'lurasidone'],\n",
       " ['adaptation', 'au', 'québec'],\n",
       " ['gestion', 'du', 'risque', 'de', 'complications', 'neurologiques', 'graves'],\n",
       " ['attente', \"d'un\", 'avis', 'de', 'conformité'],\n",
       " ['antécédent', 'de', 'cancer', 'infectées'],\n",
       " ['chlorhydrate', 'de', 'nom', 'du', 'fabricant'],\n",
       " ['institut', 'national', 'de', 'santé'],\n",
       " ['besoins', 'des', 'familles', 'suivies', 'dans', 'les', 'services'],\n",
       " ['cours', 'des', 'prochaines'],\n",
       " ['effets', 'des', 'chiens'],\n",
       " ['sotorasib', 'amgen', 'pour', 'le', 'traitement'],\n",
       " ['système', 'de', 'mesure', 'du', 'glucose', 'en', 'continu'],\n",
       " ['arrimage', 'entre', \"l'inscription\"],\n",
       " ['msss', 'pour', 'alimenter', 'les', 'discussions'],\n",
       " ['mois', 'et', 'version', 'française'],\n",
       " ['travaux', 'en', 'cardiologie'],\n",
       " ['produits', 'de', 'santé'],\n",
       " ['pertinence',\n",
       "  'de',\n",
       "  \"l'exigence\",\n",
       "  \"d'un\",\n",
       "  'essai',\n",
       "  'préalable',\n",
       "  'avec',\n",
       "  'un',\n",
       "  'immunosuppresseur'],\n",
       " ['semaines', 'avant', 'le', 'dépôt', 'annoncé'],\n",
       " ['cours', \"d'évaluation\", 'ngenla'],\n",
       " ['jamp', 'glycopyrrolate'],\n",
       " ['secteur', 'des', 'services', 'sociaux'],\n",
       " ['imagerie', 'par', 'résonance'],\n",
       " ['usage', 'judicieux', 'répertoire', 'des', 'procédures'],\n",
       " ['médicament', 'innovateur'],\n",
       " ['prévention', 'en', 'évaluation', 'et', 'en', 'intervention'],\n",
       " ['demande', 'en', 'cours', \"d'évaluation\", 'verzenio', 'abémaciclib'],\n",
       " ['réadaptation', 'pour', 'jeunes', 'en', 'difficulté'],\n",
       " ['transmission', 'des', 'prélèvements', 'chirurgicaux'],\n",
       " ['médicament', 'générique'],\n",
       " ['liste', 'des', 'médicaments'],\n",
       " ['immunoglobulines', 'humaines', 'non', 'spécifiques'],\n",
       " ['revues', 'systématiques'],\n",
       " ['calcium', 'polystyrene', 'sulfonate'],\n",
       " ['dexcom', 'mc', 'dexcom'],\n",
       " ['industrie', 'des', 'technologies'],\n",
       " ['adultes', 'atteints', 'de', 'diabète'],\n",
       " ['tests', 'diagnostiques'],\n",
       " ['vph', 'comme', 'test', 'de', 'dépistage'],\n",
       " ['outil', \"d'aide\"],\n",
       " ['intervention', 'en', 'matière'],\n",
       " ['fractures', 'vertébrales'],\n",
       " ['nodules', 'thyroïdiens', 'à', 'cytologie', 'indéterminée'],\n",
       " ['efficacité', 'du', 'traitement'],\n",
       " ['imagerie', 'pour', 'le', 'traitement', 'des', 'patients'],\n",
       " ['analyses',\n",
       "  'microbiologiques',\n",
       "  'des',\n",
       "  'selles',\n",
       "  'en',\n",
       "  'cas',\n",
       "  'de',\n",
       "  'diarrhée'],\n",
       " ['ordonnance', 'individuelle', \"d'ajustement\", 'de', 'la', 'warfarine'],\n",
       " ['comité', \"d'experts\", 'sur', 'la', 'pertinence'],\n",
       " ['articles', 'scientifiques'],\n",
       " ['pembrolizumab', 'merck', 'traitement', 'du', 'cancer'],\n",
       " ['résultats', 'préliminaires'],\n",
       " ['outil', \"d'aide\", 'à', 'la', 'décision', 'calculatrice', 'prévention'],\n",
       " ['attente', \"d'évaluation\", 'cablivi'],\n",
       " ['infarctus', 'aigu', 'du', 'myocarde'],\n",
       " ['pression', 'intraoculaire'],\n",
       " ['principes', 'et', 'fondements'],\n",
       " ['indication', 'reconnue', 'à', 'la', 'liste'],\n",
       " ['urgence', 'sanitaire'],\n",
       " ['projets', 'présentés'],\n",
       " ['patients', 'adultes', 'atteints', \"d'un\", 'lymphome'],\n",
       " ['industrie', 'des', 'technologies', 'biomédicales'],\n",
       " ['review', 'and', 'meta', 'analysis'],\n",
       " ['évaluation', \"d'une\", 'demande', \"d'exemption\", 'de', 'la', 'méthode'],\n",
       " ['usage', 'des', 'anticoagulants'],\n",
       " ['accès', 'aux', 'documents'],\n",
       " ['autonomie', 'des', 'jeunes'],\n",
       " ['réévaluation', 'en', 'cours', \"d'évaluation\", 'tepmetko'],\n",
       " ['tests', 'moléculaires', 'pour', 'préciser'],\n",
       " ['severe', 'traumatic', 'brain', 'injury'],\n",
       " ['note', 'des', 'références', 'publiées'],\n",
       " ['allergies', 'aux', 'bêta', 'lactamines'],\n",
       " ['attente', \"d'évaluation\", 'gavreto'],\n",
       " ['arrimage', 'entre', \"l'inscription\", 'éventuelle', \"d'un\", 'médicament'],\n",
       " ['usage', 'judicieux', 'répertoire'],\n",
       " ['sep', 'de', 'forme', 'rémittente'],\n",
       " ['salbutamol', 'en', 'aérosol'],\n",
       " ['taan', 'multiplex'],\n",
       " ['prise', 'en', 'charge', 'de', \"l'arthrose\", 'du', 'genou'],\n",
       " ['vie', 'adulte', 'des', 'jeunes'],\n",
       " ['fabricant', 'en', 'attente'],\n",
       " ['risque', \"d'insuffisance\", 'cardiaque', 'congestive'],\n",
       " ['lumière', 'des', 'résultats'],\n",
       " ['argent', 'coloplast'],\n",
       " ['covid', 'pour', 'la', 'semaine'],\n",
       " ['critical', 'care'],\n",
       " ['traitement', 'de', 'la', 'dégénérescence', 'maculaire'],\n",
       " ['récepteur', 'de', 'la', 'tyrosine'],\n",
       " ['plaies', 'complexes'],\n",
       " ['présidente', 'directrice', 'générale'],\n",
       " ['procédure', 'de', 'biologie', 'médicale', 'au', 'répertoire'],\n",
       " ['recours', 'à', \"l'imagerie\", 'pour', 'le', 'traitement', 'des', 'patients'],\n",
       " ['gène', 'egfr', 'dans', 'le', 'cancer', 'du', 'poumon'],\n",
       " ['traitement', \"d'une\", 'mycose', 'fongoïde'],\n",
       " ['cariprazine', 'abbvie', 'traitement', 'de', 'la', 'schizophrénie'],\n",
       " ['aérosol', 'pour', 'inhalation'],\n",
       " ['conseil', 'juge'],\n",
       " ['regard', 'sur', 'les', 'groupes', 'de', 'médecine'],\n",
       " ['gène', 'cftr', 'pré'],\n",
       " ['recommandation', 'de', \"l'inesss\", 'décision', 'du', 'ministre'],\n",
       " ['soins', 'aigus', 'désignées', 'en', 'traumatologie'],\n",
       " ['réseau', 'québécois'],\n",
       " ['ciusss', 'de', 'la', 'mauricie', 'et', 'du', 'centre'],\n",
       " ['pss', 'en', 'attente', \"d'un\", 'avis', 'de', 'conformité'],\n",
       " ['orlando', 'floride'],\n",
       " ['accès', 'équitable'],\n",
       " ['furoate', 'monohydraté', 'de', 'sanis'],\n",
       " ['aide', 'à', 'la', 'décision', 'en', 'cas'],\n",
       " ['naloxone',\n",
       "  'pour',\n",
       "  'surdose',\n",
       "  'aux',\n",
       "  'opioïdes',\n",
       "  'dans',\n",
       "  'la',\n",
       "  'communauté'],\n",
       " ['usage', 'optimal', 'fibrillation'],\n",
       " ['nat', 'teriflunomide', 'tériflunomide'],\n",
       " ['pertinence', 'du', 'dépistage', 'néonatal', 'du', 'déficit', 'immunitaire'],\n",
       " ['fumarate', 'de', 'nom', 'du', 'fabricant'],\n",
       " ['lits', 'réguliers'],\n",
       " ['traitements', 'utilisés'],\n",
       " ['lévonorgestrel', 'pour', 'la', 'contraception'],\n",
       " ['analyses', 'déjà', 'inscrites'],\n",
       " ['technologies', 'biomédicales', 'directions'],\n",
       " ['length', 'of', 'stay'],\n",
       " ['adultes', 'atteints', 'de', 'néphropathie'],\n",
       " ['traitement', \"d'une\", 'réaction'],\n",
       " ['portrait', 'des', 'fugueurs', 'et', 'des', 'pratiques', 'actuelles'],\n",
       " ['qualité', 'des', 'services'],\n",
       " ['unité', \"d'évaluation\", 'en', 'traumatologie'],\n",
       " ['diagnostic', 'de', 'la', 'maladie'],\n",
       " ['changement', 'apporté'],\n",
       " ['liaison', 'à', \"l'attention\", 'du', 'pharmacien'],\n",
       " ['évaluation', 'des', 'médicaments', 'aux', 'fins', \"d'inscription\"],\n",
       " ['dispensation', 'des', 'services', 'aux', 'enfants', 'âgés'],\n",
       " ['diagnostic', 'confirmé', 'de', 'covid'],\n",
       " ['évaluation', 'amgevita'],\n",
       " ['fibrine', 'humaine', 'johnson'],\n",
       " ['laboratoires', 'regroupés'],\n",
       " ['traitement',\n",
       "  'des',\n",
       "  'patients',\n",
       "  'adultes',\n",
       "  'atteints',\n",
       "  'du',\n",
       "  'syndrome',\n",
       "  'myasthénique'],\n",
       " ['stade', 'avancé'],\n",
       " ['soins', 'intensifs', 'ventilation', 'assistée'],\n",
       " ['gestion', 'des', 'pénuries'],\n",
       " ['remplacement', 'du', 'générateur', \"d'un\", 'défibrillateur'],\n",
       " ['rcr', 'en', 'contexte', 'hors', 'hospitalier'],\n",
       " ['documents', 'inhérents'],\n",
       " ['aide', \"d'une\", 'solution', \"d'intelligence\", 'artificielle'],\n",
       " ['coups', 'et', 'projets'],\n",
       " ['services', 'en', 'traumatologie'],\n",
       " ['refus', 'de', \"l'inscription\"],\n",
       " ['plan', 'triennal'],\n",
       " ['prolothérapie', 'dans', 'le', 'traitement', 'des', 'affections'],\n",
       " ['profil', \"d'effets\", 'indésirables'],\n",
       " ['hypernéphrome', 'avancé'],\n",
       " ['jeunes', 'en', 'difficulté'],\n",
       " ['carfilzomib', 'amgen'],\n",
       " ['résultats', 'cliniques', 'en', 'contexte', 'réel'],\n",
       " ['leucémie', 'aiguë'],\n",
       " ['normes',\n",
       "  'et',\n",
       "  'standards',\n",
       "  'en',\n",
       "  'protection',\n",
       "  'de',\n",
       "  'la',\n",
       "  'jeunesse',\n",
       "  'sommaire'],\n",
       " ['traitements', 'alternatifs', 'aux', 'immunoglobulines'],\n",
       " ['oxygénation', 'extracorporelle'],\n",
       " ['usage', 'optimal', 'cellulite'],\n",
       " ['jamp', 'bicalutamide', 'bicalutamide', 'sanis', 'cephalexin'],\n",
       " ['traitement', 'de', 'la', 'schizophrénie'],\n",
       " ['consensus', 'des', 'recommandations'],\n",
       " ['test', 'de', 'détection', 'des', 'virus', 'du', 'papillome', 'humain'],\n",
       " ['soins', 'propres'],\n",
       " ['troubles', \"d'oxydation\", 'des', 'acides', 'gras'],\n",
       " ['description', 'du', 'médicament'],\n",
       " ['déficiences', 'physiques', 'intellectuelles', 'et', 'tsa', 'jeunes'],\n",
       " ['groupe', 'traité'],\n",
       " ['formations', 'et', 'capsules'],\n",
       " ['chlamydia', 'et', 'gonorrhoeae', 'davc'],\n",
       " ['répertoire', 'signifie'],\n",
       " ['traitement', 'pharmacologique', 'de', 'la', 'mucosite', 'oropharyngée'],\n",
       " ['infection', 'par', 'le', 'sars', 'cov'],\n",
       " ['prévention',\n",
       "  'des',\n",
       "  'maladies',\n",
       "  'cardiovasculaires',\n",
       "  'version',\n",
       "  'française'],\n",
       " ['angita', 'quétiapine', 'fumarate', 'de', 'apo', 'eletriptan'],\n",
       " ['chlorhydrate', 'de', 'phmscience'],\n",
       " ['évaluation', 'bryhali', 'halobétasol', 'bauschhealth', 'soulagement'],\n",
       " ['chlamydia', 'trachomatis', 'neisseria', 'gonorrhoeae'],\n",
       " ['amélioration', 'de', 'la', 'qualité'],\n",
       " ['pharma', 'pour', 'le', 'traitement', 'de', 'la', 'sclérose'],\n",
       " ['intention', 'de', 'la', 'candidose', 'buccale', 'chez', \"l'adulte\"],\n",
       " ['carcinome', 'différencié', 'de', 'la', 'thyroïde', 'cdt'],\n",
       " ['facteur', 'de', 'croissance', 'épidermique', 'egfr'],\n",
       " ['naloxone', 'par', 'voie', 'nasale', 'version'],\n",
       " ['usage', \"d'alcool\"],\n",
       " ['lymphomes', 'à', 'grandes', 'cellules'],\n",
       " ['ioflupane', 'datscan'],\n",
       " ['entérococcus', 'résistant'],\n",
       " ['traumatic', 'spinal'],\n",
       " ['cardiopathies', 'congénitales'],\n",
       " ['jeunesse', 'lpj'],\n",
       " ['pembrolizumab', 'merck', 'traitement', 'du', 'cancer', 'du', 'col'],\n",
       " ['inactivation', 'des', 'pathogènes'],\n",
       " ['utérus', 'au', 'québec'],\n",
       " ['microchirurgies', 'pour', 'la', 'prévention', 'et', 'le', 'traitement'],\n",
       " ['patients', 'atteints', 'du', 'diabète', 'de', 'type'],\n",
       " ['pansement', 'absorbant', 'bordé'],\n",
       " ['dénomination', 'commune', 'nom'],\n",
       " ['attente', \"d'évaluation\", 'ultomiris', 'ravulizumab'],\n",
       " ['résultat', 'sur', \"l'échelle\", 'edss'],\n",
       " ['recommandations', 'pour', \"l'implantation\"],\n",
       " ['recherche', 'clinique'],\n",
       " ['médicaments', 'du', 'québec'],\n",
       " ['réaction', \"d'allergie\"],\n",
       " ['inscription', \"d'un\", 'médicament', 'associé', 'à', 'un', 'test'],\n",
       " ['demande', \"d'ajout\"],\n",
       " ['base', 'des', 'données'],\n",
       " ['recommandations', 'sur', \"l'usage\"],\n",
       " ['bromhydrate', \"d'bicarbonate\"],\n",
       " ['facteur', 'de', 'croissance'],\n",
       " ['santé', 'mentale'],\n",
       " ['apotex', 'élétriptan'],\n",
       " ['trichomonas', 'vaginalis'],\n",
       " ['bilan', 'sanguin'],\n",
       " ['utilisation', \"d'endopredict\"],\n",
       " ['traitements', 'pharmacologiques', 'pour', 'les', 'enfants'],\n",
       " ['attente', \"d'une\", 'évaluation'],\n",
       " ['tavneos', 'avacopan', 'otsuka'],\n",
       " ['dispositifs', 'médicaux', 'évaluation'],\n",
       " ['incyte',\n",
       "  'en',\n",
       "  'association',\n",
       "  'avec',\n",
       "  'la',\n",
       "  'lénalidomide',\n",
       "  'pour',\n",
       "  'le',\n",
       "  'traitement'],\n",
       " ['infection', 'à', 'clostridium', 'difficile', 'réévaluation'],\n",
       " ['institut', 'de', 'recherche'],\n",
       " ['options', 'de', 'disposition', 'des', 'embryons', 'conservés'],\n",
       " ['tumeur', 'stromale', 'gastro', 'intestinale'],\n",
       " ['pompes', 'intrathécales'],\n",
       " ['services', 'de', 'réadaptation', 'présentant'],\n",
       " ['réponses', 'rapides'],\n",
       " ['surveillance', 'du', 'glucose'],\n",
       " ['nombre', 'de', 'nouveaux', 'cas', 'covid', 'hospitaliers'],\n",
       " ['amygdalite', 'infections'],\n",
       " ['projet', 'sujet', 'début', 'des', 'travaux'],\n",
       " ['présentations', 'cliniques'],\n",
       " ['demande', 'en', 'attente', \"d'évaluation\"],\n",
       " ['affections', 'post', 'covid'],\n",
       " ['soulagement', 'du', 'prurit'],\n",
       " ['population', 'du', 'québec'],\n",
       " ['dénomination', 'commune', 'sujet', 'nusinersen'],\n",
       " ['critères', 'économique', 'et', 'pharmacoéconomique', 'conclusion'],\n",
       " ['réévaluation', 'en', 'attente', \"d'évaluation\"],\n",
       " ['prophylaxie', 'de', \"l'influenza\"],\n",
       " ['nodules', 'thyroïdiens', 'à', 'cytologie'],\n",
       " ['indication', 'reconnue', 'aux', 'listes', 'des', 'médicaments'],\n",
       " ['covid', 'puis', 'déclarée'],\n",
       " ['dose', 'chez', 'les', 'patients'],\n",
       " ['plaques', 'de', 'forme'],\n",
       " ['excellence', 'en', 'santé', 'et', 'services'],\n",
       " ['soulagement', 'du', 'prurit', 'patients'],\n",
       " ['guide', \"d'usage\", 'optimal', 'fibrillation'],\n",
       " ['création', 'et', 'caractérisation', \"d'une\", 'cohorte'],\n",
       " ['évaluation', 'aux', 'fins', \"d'inscription\"],\n",
       " ['hyperkaliémie', 'chez', 'les', 'patients', 'atteints'],\n",
       " ['cours', \"d'évaluation\", 'vraylar', 'cariprazine', 'abbvie'],\n",
       " ['trouble', 'dépressif'],\n",
       " ['note', 'des', 'références'],\n",
       " ['usage', 'optimal', 'guide', \"d'usage\"],\n",
       " ['conditions', 'de', 'succès'],\n",
       " ['influenza', 'chez', \"l'enfant\", 'et', \"l'adulte\"],\n",
       " ['fabricant', 'forme', 'solution'],\n",
       " ['évaluation', 'tavneos'],\n",
       " ['sevrage', \"d'alcool\"],\n",
       " ['marcan', 'mometasone', 'mométasone', 'furoate', 'monohydraté'],\n",
       " ['données', 'contextuelles'],\n",
       " ['analyses', 'de', 'laboratoires', 'regroupés'],\n",
       " ['portrait', 'de', \"l'utilisation\", 'des', 'soins'],\n",
       " ['sotorasib', 'amgen'],\n",
       " ['nom', 'commercial', 'à', 'venir', 'tézépélumab'],\n",
       " ['qualité', 'du', 'milieu', 'de', 'vie', 'en', 'centre', \"d'hébergement\"],\n",
       " ['traitement', 'de', \"l'angioedème\"],\n",
       " ['étude', 'randomisée'],\n",
       " ['évaluation', 'des', 'installations'],\n",
       " ['ordonnances', 'individuelles'],\n",
       " ['iste', 'des', 'médicaments'],\n",
       " ['évaluation', 'de', 'afstyla', 'mc', 'rfviii'],\n",
       " ...]"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokenized_queries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>diagnostic confirmé</th>\n",
       "      <th>trauma patients</th>\n",
       "      <th>régime public</th>\n",
       "      <th>solution d'intelligence artificielle</th>\n",
       "      <th>cancer infectées par le sras cov</th>\n",
       "      <th>dispositifs d'accès vasculaire</th>\n",
       "      <th>conseil en traumatologie</th>\n",
       "      <th>rétention urinaire</th>\n",
       "      <th>herpès génital</th>\n",
       "      <th>cardiologie et maladies neurovasculaires</th>\n",
       "      <th>...</th>\n",
       "      <th>sonde urinaire chez un adulte</th>\n",
       "      <th>incyte en association avec la lénalidomide</th>\n",
       "      <th>comportement meilleures</th>\n",
       "      <th>critical care medicine</th>\n",
       "      <th>analyses de laboratoire au répertoire québécois</th>\n",
       "      <th>arrondissement des doses d'agents</th>\n",
       "      <th>fabricant novartis</th>\n",
       "      <th>alcool troubles neurocognitifs document complémentaire</th>\n",
       "      <th>durée de vie</th>\n",
       "      <th>évaluation ultomiris</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.232356</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8.109969</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>6.543854</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.289166</td>\n",
       "      <td>...</td>\n",
       "      <td>2.511007</td>\n",
       "      <td>2.511007</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.425369</td>\n",
       "      <td>3.067883</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.425369</td>\n",
       "      <td>1.302201</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.232356</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8.109969</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>6.543854</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.289166</td>\n",
       "      <td>...</td>\n",
       "      <td>2.511007</td>\n",
       "      <td>2.511007</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.425369</td>\n",
       "      <td>3.067883</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.425369</td>\n",
       "      <td>1.302201</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.232356</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>8.109969</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>6.543854</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.289166</td>\n",
       "      <td>...</td>\n",
       "      <td>2.511007</td>\n",
       "      <td>2.511007</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.425369</td>\n",
       "      <td>3.067883</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.425369</td>\n",
       "      <td>1.302201</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1.585282</td>\n",
       "      <td>3.776687</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.535006</td>\n",
       "      <td>2.077158</td>\n",
       "      <td>8.756992</td>\n",
       "      <td>4.038318</td>\n",
       "      <td>0.0</td>\n",
       "      <td>11.545511</td>\n",
       "      <td>...</td>\n",
       "      <td>6.612289</td>\n",
       "      <td>6.160739</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>10.352865</td>\n",
       "      <td>3.327449</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>9.392838</td>\n",
       "      <td>3.390084</td>\n",
       "      <td>1.596599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.413158</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.706826</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.005098</td>\n",
       "      <td>...</td>\n",
       "      <td>1.809041</td>\n",
       "      <td>5.838985</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.263093</td>\n",
       "      <td>3.154049</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.377245</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1221</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.807276</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.545371</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.545371</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.869992</td>\n",
       "      <td>1.968600</td>\n",
       "      <td>0.408552</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.324622</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>686</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.570779</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.999615</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.945713</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.414895</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.374934</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1223</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.568807</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>2.998272</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5.943174</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.414401</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.374367</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>857</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.120735</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>6.034552</td>\n",
       "      <td>2.669159</td>\n",
       "      <td>0.440126</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.365394</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>860</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2.201622</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>...</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>3.362812</td>\n",
       "      <td>2.201622</td>\n",
       "      <td>0.456913</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.362812</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1226 rows × 6670 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      diagnostic confirmé  trauma patients  régime public  \\\n",
       "0                0.000000         1.232356       0.000000   \n",
       "0                0.000000         1.232356       0.000000   \n",
       "0                0.000000         1.232356       0.000000   \n",
       "3                1.585282         3.776687       0.000000   \n",
       "4                0.000000         0.000000       0.000000   \n",
       "...                   ...              ...            ...   \n",
       "1221             0.000000         0.000000       2.807276   \n",
       "686              0.000000         0.000000       0.000000   \n",
       "1223             0.000000         0.000000       0.000000   \n",
       "857              0.000000         0.000000       0.000000   \n",
       "860              0.000000         0.000000       0.000000   \n",
       "\n",
       "      solution d'intelligence artificielle  cancer infectées par le sras cov  \\\n",
       "0                                      0.0                          8.109969   \n",
       "0                                      0.0                          8.109969   \n",
       "0                                      0.0                          8.109969   \n",
       "3                                      0.0                          3.535006   \n",
       "4                                      0.0                          5.413158   \n",
       "...                                    ...                               ...   \n",
       "1221                                   0.0                          2.545371   \n",
       "686                                    0.0                          2.570779   \n",
       "1223                                   0.0                          2.568807   \n",
       "857                                    0.0                          2.120735   \n",
       "860                                    0.0                          2.201622   \n",
       "\n",
       "      dispositifs d'accès vasculaire  conseil en traumatologie  \\\n",
       "0                           0.000000                  6.543854   \n",
       "0                           0.000000                  6.543854   \n",
       "0                           0.000000                  6.543854   \n",
       "3                           2.077158                  8.756992   \n",
       "4                           0.000000                  2.706826   \n",
       "...                              ...                       ...   \n",
       "1221                        0.000000                  0.000000   \n",
       "686                         0.000000                  0.000000   \n",
       "1223                        0.000000                  0.000000   \n",
       "857                         0.000000                  0.000000   \n",
       "860                         0.000000                  0.000000   \n",
       "\n",
       "      rétention urinaire  herpès génital  \\\n",
       "0               0.000000             0.0   \n",
       "0               0.000000             0.0   \n",
       "0               0.000000             0.0   \n",
       "3               4.038318             0.0   \n",
       "4               0.000000             0.0   \n",
       "...                  ...             ...   \n",
       "1221            0.000000             0.0   \n",
       "686             0.000000             0.0   \n",
       "1223            0.000000             0.0   \n",
       "857             0.000000             0.0   \n",
       "860             0.000000             0.0   \n",
       "\n",
       "      cardiologie et maladies neurovasculaires  ...  \\\n",
       "0                                     6.289166  ...   \n",
       "0                                     6.289166  ...   \n",
       "0                                     6.289166  ...   \n",
       "3                                    11.545511  ...   \n",
       "4                                     3.005098  ...   \n",
       "...                                        ...  ...   \n",
       "1221                                  0.000000  ...   \n",
       "686                                   0.000000  ...   \n",
       "1223                                  0.000000  ...   \n",
       "857                                   0.000000  ...   \n",
       "860                                   0.000000  ...   \n",
       "\n",
       "      sonde urinaire chez un adulte  \\\n",
       "0                          2.511007   \n",
       "0                          2.511007   \n",
       "0                          2.511007   \n",
       "3                          6.612289   \n",
       "4                          1.809041   \n",
       "...                             ...   \n",
       "1221                       0.000000   \n",
       "686                        0.000000   \n",
       "1223                       0.000000   \n",
       "857                        0.000000   \n",
       "860                        0.000000   \n",
       "\n",
       "      incyte en association avec la lénalidomide  comportement meilleures  \\\n",
       "0                                       2.511007                      0.0   \n",
       "0                                       2.511007                      0.0   \n",
       "0                                       2.511007                      0.0   \n",
       "3                                       6.160739                      0.0   \n",
       "4                                       5.838985                      0.0   \n",
       "...                                          ...                      ...   \n",
       "1221                                    2.545371                      0.0   \n",
       "686                                     2.999615                      0.0   \n",
       "1223                                    2.998272                      0.0   \n",
       "857                                     0.000000                      0.0   \n",
       "860                                     0.000000                      0.0   \n",
       "\n",
       "      critical care medicine  analyses de laboratoire au répertoire québécois  \\\n",
       "0                        0.0                                         3.425369   \n",
       "0                        0.0                                         3.425369   \n",
       "0                        0.0                                         3.425369   \n",
       "3                        0.0                                        10.352865   \n",
       "4                        0.0                                         6.263093   \n",
       "...                      ...                                              ...   \n",
       "1221                     0.0                                         5.869992   \n",
       "686                      0.0                                         5.945713   \n",
       "1223                     0.0                                         5.943174   \n",
       "857                      0.0                                         6.034552   \n",
       "860                      0.0                                         3.362812   \n",
       "\n",
       "      arrondissement des doses d'agents  fabricant novartis  \\\n",
       "0                              3.067883            0.000000   \n",
       "0                              3.067883            0.000000   \n",
       "0                              3.067883            0.000000   \n",
       "3                              3.327449            0.000000   \n",
       "4                              3.154049            0.000000   \n",
       "...                                 ...                 ...   \n",
       "1221                           1.968600            0.408552   \n",
       "686                            0.000000            0.414895   \n",
       "1223                           0.000000            0.414401   \n",
       "857                            2.669159            0.440126   \n",
       "860                            2.201622            0.456913   \n",
       "\n",
       "      alcool troubles neurocognitifs document complémentaire  durée de vie  \\\n",
       "0                                              0.000000           3.425369   \n",
       "0                                              0.000000           3.425369   \n",
       "0                                              0.000000           3.425369   \n",
       "3                                              9.392838           3.390084   \n",
       "4                                              0.000000           3.377245   \n",
       "...                                                 ...                ...   \n",
       "1221                                           0.000000           3.324622   \n",
       "686                                            0.000000           3.374934   \n",
       "1223                                           0.000000           3.374367   \n",
       "857                                            0.000000           3.365394   \n",
       "860                                            0.000000           3.362812   \n",
       "\n",
       "      évaluation ultomiris  \n",
       "0                 1.302201  \n",
       "0                 1.302201  \n",
       "0                 1.302201  \n",
       "3                 1.596599  \n",
       "4                 0.000000  \n",
       "...                    ...  \n",
       "1221              0.000000  \n",
       "686               0.000000  \n",
       "1223              0.000000  \n",
       "857               0.000000  \n",
       "860               0.000000  \n",
       "\n",
       "[1226 rows x 6670 columns]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df.to_csv(base_path + titre + '_matrice-OkapiBM25.csv') # Si on veut avoir la matrice (mais le fichier peut être très volumineux)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "terms_okapi = {term: df[term].max() for term in df}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'diagnostic confirmé': 10.953869653208749,\n",
       " 'trauma patients': 9.510870872554289,\n",
       " 'régime public': 9.461682222679254,\n",
       " \"solution d'intelligence artificielle\": 14.13648897755764,\n",
       " 'cancer infectées par le sras cov': 34.56908602070112,\n",
       " \"dispositifs d'accès vasculaire\": 10.54573923365426,\n",
       " 'conseil en traumatologie': 13.127230284192766,\n",
       " 'rétention urinaire': 12.466973350047947,\n",
       " 'herpès génital': 13.83570112169787,\n",
       " 'cardiologie et maladies neurovasculaires': 23.993398941487513,\n",
       " \"publication de l'état des pratiques\": 14.082523130654216,\n",
       " 'évaluation foquest méthylphénidate chlorhydrate': 5.709888502219647,\n",
       " 'formule nutritive': 13.636504985388681,\n",
       " \"traitement de l'oedème\": 6.7777936973800355,\n",
       " 'blessures médullaires': 12.401140916174867,\n",
       " 'validation analytique de tests': 20.808310752496595,\n",
       " 'instituts de recherche en santé': 19.88202668384567,\n",
       " 'réactif quantitatif du temps': 16.030637546965117,\n",
       " 'cardio ou neuro vasculaires': 22.937198541908227,\n",
       " 'nom du fabricant novartis': 8.679826576999414,\n",
       " 'présence de douleurs': 14.015136027645447,\n",
       " \"rinçage pour les dispositifs d'accès\": 17.806631308998828,\n",
       " \"prise en charge de l'infarctus\": 14.126783635671103,\n",
       " \"comité d'experts\": 6.108517787438919,\n",
       " 'réanimation cardiorespiratoire naloxone': 18.14185194811513,\n",
       " 'milieu ambulatoire': 13.090259699111797,\n",
       " 'investigation diagnostique du cancer': 16.523365721077447,\n",
       " 'nom du fabricant roche forme': 9.584399124268073,\n",
       " 'patients usagers proches': 15.632201341997394,\n",
       " 'lyme aux stades localisé': 27.63553115970367,\n",
       " 'itss mycoplasma': 12.273891128516539,\n",
       " 'santé de la population': 11.60498457845511,\n",
       " 'forme grave de la granulomatose': 11.668365054283557,\n",
       " \"publication de l'avis au ministre\": 12.440825331956484,\n",
       " 'système nerveux': 7.24785647222305,\n",
       " 'association avec le bortézomib et la dexaméthasone': 15.089424127980047,\n",
       " 'génito urinaire': 8.127894718325429,\n",
       " 'demande ultérieure': 8.24503333448979,\n",
       " 'outil clinique céphalée': 18.94448712860521,\n",
       " 'cas échéant': 9.595014649020934,\n",
       " 'jeunes et familles': 16.17618927022792,\n",
       " 'antipsychotiques atypiques': 18.687694885558667,\n",
       " 'projet aligné inesss acmts': 16.409718418034462,\n",
       " 'étude de cohorte': 13.121773612866706,\n",
       " 'transplantation cardiaque et pulmonaire au québec': 26.402706917227608,\n",
       " 'modifications des indications': 11.17377878173269,\n",
       " \"usage d'alcool troubles\": 6.753515793317932,\n",
       " 'selpercatinib lilly pour le traitement': 14.103554541264598,\n",
       " 'bunod bausch réduction de la pression': 14.067260410600754,\n",
       " 'prise de décision partagée formations': 20.89021706437149,\n",
       " 'troubles graves du comportement meilleures': 26.86144605726271,\n",
       " 'québec québec canada': 4.785473101408627,\n",
       " 'dépistage du cancer du col': 22.79575283452761,\n",
       " 'génétique humaine': 11.134356321443494,\n",
       " 'reprise graduelle des activités intellectuelles physiques': 24.987191907940765,\n",
       " 'systèmes de mesure': 12.257370452149035,\n",
       " 'phase chronique': 10.327550724341556,\n",
       " 'outil clinique interactif': 14.396480531014813,\n",
       " \"modalités d'évaluation des médicaments\": 11.182988744812182,\n",
       " 'indication reconnue pour le traitement de la sep progressive': 32.57413281863616,\n",
       " 'fluoropyrimidines meilleures stratégies': 16.435829248865407,\n",
       " 'appui à la prise de décision dans le secteur': 33.947468192484656,\n",
       " \"exigence d'un essai préalable\": 24.43476815775579,\n",
       " 'usage optimal guide posologique': 19.24340829380818,\n",
       " 'compagnon les autorités': 17.50205377008509,\n",
       " 'données probantes et sécuritaires traitement': 27.908273656025802,\n",
       " 'infections transmissibles sexuellement': 15.381287413545472,\n",
       " 'usage optimal du médicament': 11.514505683812734,\n",
       " 'computed tomography': 6.101690752427583,\n",
       " 'antécédent de cancer': 15.983011608177252,\n",
       " 'mousse hydrophile': 14.09891644950356,\n",
       " 'transplantation des îlots de langerhans': 35.20026780575054,\n",
       " 'usage des médicaments spécifiques au tdah': 25.357298334718312,\n",
       " 'infections bactériennes aiguës de la peau et des structures cutanées': 23.599238545977276,\n",
       " 'pertinence et pistes': 12.109254185444879,\n",
       " 'médicaments dans la liste de médicaments': 18.104813171488665,\n",
       " 'activité guide': 10.569496386826406,\n",
       " 'tomographie axiale à faible dose': 32.56018977880774,\n",
       " 'évaluation kimmtrak': 2.6884838948204637,\n",
       " 'standardisation des pratiques relatives aux allergies': 27.049325496773083,\n",
       " 'usage optimal thrombose veineuse': 15.175846633940605,\n",
       " 'tazobactam pour injection pipéracilline sodique': 12.623561025649485,\n",
       " 'vertu de la loi sur la protection de la jeunesse lpj': 55.85022099041874,\n",
       " 'pms lurasidone lurasidone chlorhydrate de phmscience': 13.418884587402381,\n",
       " 'réanimation cardiorespiratoire rcr dans le contexte': 31.06537220623442,\n",
       " \"demande en attente d'évaluation bijuva estradiol\": 16.047654107622506,\n",
       " 'autorisations sont données': 10.049829486393014,\n",
       " 'fentanyl pour injection': 9.844886417805967,\n",
       " \"rejet d'organe\": 9.769126561358688,\n",
       " 'nom du fabricant servier forme': 10.52130917501067,\n",
       " 'implantation valvulaire aortique par cathéter': 30.277310005107665,\n",
       " 'fabricants inesss': 8.643955495111955,\n",
       " 'décision antérieure': 4.994998831271946,\n",
       " 'cas de covid': 10.785823541150025,\n",
       " 'poudre orale': 10.362694486619821,\n",
       " \"attente d'évaluation bijuva\": 6.829116334735193,\n",
       " 'développemental du langage': 14.600853029033356,\n",
       " 'traitement du syndrome hémolytique': 10.22897674101529,\n",
       " \"patients adultes souffrant d'une tumeur\": 7.761152305050482,\n",
       " 'proposition de segmentation de la population': 25.601229589695713,\n",
       " 'irm pour les traitements de radiothérapie': 26.129465525985953,\n",
       " 'traitement des symptômes vasomoteurs': 12.763506295730028,\n",
       " 'usage optimal pharyngite': 13.877069831842755,\n",
       " 'niveaux de soins': 13.019174959509414,\n",
       " 'regard sur les facteurs associés aux hospitalisations': 25.09026695691315,\n",
       " \"usage optimal l'usage optimal\": 13.241037343875874,\n",
       " 'usage optimal sur les infections transmissibles': 22.45461929256589,\n",
       " 'action pour une utilisation': 12.72778876683764,\n",
       " \"processus d'évaluation des analyses de biologie\": 22.98821617022007,\n",
       " 'inscription avec conditions': 5.860912349776589,\n",
       " 'citrate de jamp': 5.103692688135404,\n",
       " \"dépôt d'une demande\": 11.003915201034351,\n",
       " 'mois atteignent': 10.10731116962045,\n",
       " 'individus asymptomatiques': 16.753850655156555,\n",
       " 'mesure du glucose en continu dexcom': 26.644108469640948,\n",
       " 'évaluation hulio adalimumab': 9.134290674832581,\n",
       " \"cours d'évaluation jemperli dostarlimab\": 4.525564957517798,\n",
       " 'enfants à risque ou en situation': 21.329519677749907,\n",
       " 'fonds de recherche du québec': 19.521572225634852,\n",
       " 'listes de médicaments principales références': 12.94934925549999,\n",
       " 'usage approprié des antipsychotiques': 23.159505974278055,\n",
       " 'itss mycoplasma genitalium': 18.909410302124563,\n",
       " 'médicaments évalués nom': 7.60974584022088,\n",
       " 'chlorhydrate de emd serono': 9.600448560280121,\n",
       " \"demande en cours d'évaluation firdapse\": 11.31333945596677,\n",
       " 'guide de pratique': 12.573487190225183,\n",
       " 'jeunes âgés': 10.372905297187295,\n",
       " 'évolution des modalités': 11.823111798043637,\n",
       " 'milieu de vie en centre': 22.766663684576617,\n",
       " 'fusion du gène ret': 11.383770799625234,\n",
       " \"mutations activatrices d'insertion de l'exon\": 8.07550187761401,\n",
       " 'technologies innovantes rencontres': 22.274737387216483,\n",
       " 'donnée à afficher pour la période': 36.40953562752181,\n",
       " \"pertinence et pistes d'action pour une utilisation judicieuse\": 25.763057690355915,\n",
       " 'pratiques de prévention': 10.2455228611434,\n",
       " 'diabetes and dyslipidemia': 19.103031502864685,\n",
       " 'inesss estime': 7.675218185137956,\n",
       " 'évaluation économique': 4.911971473546038,\n",
       " \"réévaluation de l'indication\": 8.837823289053379,\n",
       " 'insuline chez les patients atteints du diabète': 25.127208347719552,\n",
       " \"suivi de l'évolution de l'épidémie de covid\": 18.67946167554012,\n",
       " \"projets de l'inesss\": 8.3473731079379,\n",
       " 'procédures de biologie médicale': 18.451707358268862,\n",
       " 'ioflupane datscan dans la démarche': 23.55641907190604,\n",
       " 'finérénone bayer traitement': 7.511937566200867,\n",
       " 'hyperoxalurie primitive de type': 11.049827627748428,\n",
       " 'cellules métastatique': 8.883180455858536,\n",
       " 'réseau québécois de traumatologie': 19.906609918165643,\n",
       " \"refus d'inscription\": 3.4404394231755067,\n",
       " 'bicarbonate de sodium darunavir jamp': 6.569384054130202,\n",
       " 'projections des besoins hospitaliers basées sur les données': 24.990134728063833,\n",
       " \"outil d'aide à la décision en cas\": 17.43645961924045,\n",
       " 'canada berotralstat biocryst': 4.949018252493856,\n",
       " 'concordance avec la recommandation émise pour le produit': 26.227783232751744,\n",
       " 'jamp glycopyrrolate jamp': 2.566611308345862,\n",
       " 'syndromes parkinsoniens': 15.059312732484443,\n",
       " 'nom du fabricant servier': 10.177313782216922,\n",
       " \"guide d'usage optimal fibrillation auriculaire\": 22.315187582856286,\n",
       " \"demande en attente d'un dépôt pour évaluation\": 23.797413271300417,\n",
       " 'timbre cutané': 14.721961271352159,\n",
       " 'leila azzi': 14.668205884533549,\n",
       " 'traitement endovasculaire': 7.13447997217337,\n",
       " 'décès en lien avec la covid': 20.28934625665218,\n",
       " 'évaluations scientifiques': 5.44885554916389,\n",
       " 'membres du comité consultatif': 19.315423224024023,\n",
       " 'médicament réfère': 4.73997415422341,\n",
       " 'pramipexole pramipexole': 6.575106463990531,\n",
       " 'consensus des recommandations en lien avec la priorisation': 28.165387434548766,\n",
       " \"attente d'un dépôt pour évaluation en attente\": 25.33904327223408,\n",
       " 'anti inflammatoire': 16.493717789100238,\n",
       " 'traitement de la spondylarthrite ankylosante évolutive réévaluation': 18.008554788422348,\n",
       " 'sodium pour injection': 4.467934499280369,\n",
       " \"attente d'évaluation kimmtrak tebentafusp\": 7.775530146257776,\n",
       " 'évaluation cosentyx': 8.401602076941098,\n",
       " \"résultats cliniques de l'implantation\": 8.1089870360214,\n",
       " 'guo zona ophtalmique': 27.79569584015244,\n",
       " 'réponses rapides disponibles services sociaux': 14.561508078633063,\n",
       " \"cours d'évaluation jakavi\": 4.324412258698878,\n",
       " 'évaluations en mode continu autres évaluations': 14.602610096449181,\n",
       " 'traitement des plaies complexes thérapie': 26.834371753145895,\n",
       " 'traitement des plaies': 12.852738818971044,\n",
       " 'acide zolédronique': 20.371466005959107,\n",
       " 'maladie pulmonaire obstructive chronique mpoc': 24.19394782439136,\n",
       " \"res en l'équipe de projet\": 16.118658758821265,\n",
       " 'dénomination commune sujet brentuximab védotine': 19.24837562525117,\n",
       " 'usage optimal blépharites': 17.724894230841954,\n",
       " 'amyotrophie spinale recommandation': 18.482118224019267,\n",
       " 'protocole médical national chlamydia': 21.12029541724196,\n",
       " 'sécurité du lieu et conditions de succès': 27.619766090880653,\n",
       " \"attente d'évaluation foquest\": 7.60945058804373,\n",
       " 'élévation du segment': 17.719893108551517,\n",
       " 'cellules cancéreuses': 11.071552594275218,\n",
       " 'vagues de la pandémie': 17.287259645399168,\n",
       " 'liste des produits du système': 15.573513833756156,\n",
       " \"arrondissement des doses d'agents antinéoplasiques\": 23.09864925372204,\n",
       " 'infection urinaire': 10.489371075945527,\n",
       " 'envois de prélèvements': 23.25389921094735,\n",
       " 'polypes nasaux sévères': 4.889127064589522,\n",
       " 'follitropine alpha gonal': 24.517979378161666,\n",
       " \"patients l'inesss\": 2.1101650239358727,\n",
       " 'forme timbre': 9.136898051416022,\n",
       " 'produit officielle': 11.176801816075569,\n",
       " 'analyses effectuées par séquençage': 21.310258684755677,\n",
       " 'système de mesure du glucose en continu guardian': 41.874201773378324,\n",
       " 'mésothéliome pleural malin': 33.70888745563167,\n",
       " 'maladie du québec': 6.464956722369863,\n",
       " 'traitement des affections musculosquelettiques chroniques': 23.510526056823405,\n",
       " 'symptômes vasomoteurs modérés ou graves': 13.153276297840076,\n",
       " \"symptômes de l'atrophie\": 7.931716130364925,\n",
       " 'nom commercial à venir tirzepatide': 12.352966747639325,\n",
       " \"attente d'évaluation nucala mépolizumab gsk\": 18.057452480548342,\n",
       " 'cariprazine abbvie traitement': 7.870652393895362,\n",
       " 'mise en ligne': 6.608026392835049,\n",
       " 'conformité de santé': 9.446649646683886,\n",
       " 'ans ayant un trouble du spectre': 21.837491466775777,\n",
       " 'usage optimal pharyngite amydalite version': 26.119180670465187,\n",
       " \"diagnostic de la maladie d'alzheimer\": 13.941586502659074,\n",
       " 'thromboses veineuses': 20.334654423887095,\n",
       " 'cpnpc avec mutation': 12.22223898364475,\n",
       " 'prise de décision dans le contexte du remplacement': 24.518979506583353,\n",
       " 'maladie de parkinson': 15.454434084732288,\n",
       " 'analysis of randomized': 13.385297422786067,\n",
       " \"embryons conservés à la suite d'un processus\": 29.12830542952564,\n",
       " 'évaluation du synvisc': 17.37413155414994,\n",
       " 'imagerie pour le traitement des patients présentant une céphalée primaire': 38.69821807149617,\n",
       " 'polyangéite ou polyangéite': 10.828429727345284,\n",
       " 'tep en oncologie': 15.231724475554522,\n",
       " 'paiement sont pour le traitement': 15.028884141407799,\n",
       " \"cours d'évaluation trikafta projet\": 6.648649362617398,\n",
       " 'situation de négligence': 17.005370392847787,\n",
       " 'sédation palliative continue soins palliatifs': 24.98004079368224,\n",
       " 'post covid': 7.854515508196067,\n",
       " 'gène egfr dans le cancer': 20.23646384204895,\n",
       " 'exception des listes': 7.261653795377294,\n",
       " 'sandoz fesoterodine fumarate fésotérodine fumarate': 11.031609566226713,\n",
       " 'dépôt pour évaluation tremfya guselkumab': 12.07335006116142,\n",
       " \"triheptanoïne ultragenyx traitement des troubles d'oxydation des acides\": 15.686606833097777,\n",
       " 'regard sur la fréquentation': 17.670881221535367,\n",
       " \"traitement d'appoint\": 3.3505741998352705,\n",
       " 'travaux en dépistage': 11.01931804640843,\n",
       " 'portrait du traitement': 10.414350467844066,\n",
       " 'sport related concussion': 13.630146665825027,\n",
       " \"cours d'évaluation\": 2.632737334472632,\n",
       " 'dénomination commune nom du fabricant': 5.044166162289372,\n",
       " \"ministre recommandant l'inscription\": 4.933912167930519,\n",
       " 'soins alternatifs': 10.382610895810872,\n",
       " \"cours d'évaluation demande\": 6.9738098567515845,\n",
       " 'sidekick mc et truetrack': 31.709422754215467,\n",
       " 'chirurgie pour favoriser': 8.78309216043602,\n",
       " 'injury patients': 11.228507415738852,\n",
       " 'risque de toxicités': 13.454308891208548,\n",
       " 'nouveautés du mois archives': 20.30544993344469,\n",
       " 'douleur associée': 11.83334847174727,\n",
       " \"pertinence du dépistage néonatal de l'amyotrophie\": 23.566296560683465,\n",
       " 'éléments facilitant': 10.836165819322769,\n",
       " 'glucose freestyle': 16.152577169910863,\n",
       " \"cancer de l'endomètre\": 7.1515090177504295,\n",
       " 'frais exigibles': 19.767839363425416,\n",
       " 'télédépistage de la rétinopathie': 24.058536788377708,\n",
       " 'maladies chroniques indicateurs': 18.8715028687797,\n",
       " 'production scientifique': 7.393220631299933,\n",
       " 'msss au lien suivant priorisation': 20.883005958998854,\n",
       " 'conditions particulaires extrait': 10.349643112084461,\n",
       " \"publication de l'état de connaissances\": 13.947546435904668,\n",
       " \"attente d'évaluation demande\": 10.223775045491564,\n",
       " 'évaluation aux fins': 9.249113413436067,\n",
       " 'formules nutritives monomériques': 37.241166991212665,\n",
       " 'comportement meilleures pratiques en prévention': 24.493289175318992,\n",
       " 'exception pour le traitement': 11.575828784410076,\n",
       " \"critères d'évaluation\": 4.158834897023278,\n",
       " 'amivantamab janssen': 2.6045547756607883,\n",
       " 'spondylarthrite ankylosante évolutive réévaluation en cours': 12.772846068762766,\n",
       " \"traitement pharmacologique de la maladie d'alzheimer\": 18.19945130825347,\n",
       " \"apo eletriptan élétriptan bromhydrate d'apotex\": 2.4941426324155196,\n",
       " 'inhibiteur sélectif': 7.8424169331834115,\n",
       " 'impact budgétaire': 10.211663903987985,\n",
       " 'exercice de cohérence ou de concordance avec la recommandation': 30.81011603442674,\n",
       " 'infections bactériennes aiguës': 10.10292870807482,\n",
       " 'inesss a évalué': 8.361598125767099,\n",
       " \"régime public l'inesss\": 9.461682222679254,\n",
       " 'fibrose kystique chez les patients': 16.629081370610383,\n",
       " 'algorithmes en cancérologie': 14.193003730946582,\n",
       " 'glucose dans le sang': 14.069642265883441,\n",
       " 'jamp teriflunomide': 5.660406052154579,\n",
       " 'paiement des médicaments': 12.299062256214832,\n",
       " 'dénomination commune sujet gonadotrophines': 10.066810869967336,\n",
       " 'troubles mentaux': 14.410644686092303,\n",
       " 'hospitalisation pour les personnes infectées par le sras': 34.07171767621095,\n",
       " 'santé mentale efficacité': 9.492461552685395,\n",
       " 'ischémique en phase hyperaiguë': 22.867372869552835,\n",
       " 'conciliation du milieu': 20.806480331192382,\n",
       " 'pratiques cliniques': 5.500362237726815,\n",
       " \"attente d'évaluation ou en cours d'évaluation\": 14.82138130197197,\n",
       " 'compagnons a pour objectif': 14.768770674886403,\n",
       " 'gestionnaires du réseau de la santé': 18.19991898101411,\n",
       " 'visée thérapeutique': 8.458929634804202,\n",
       " 'listes de médicaments pour le traitement': 17.85531910013527,\n",
       " 'indication reconnue médicament': 4.381643912002459,\n",
       " \"guide d'usage optimal eampoc\": 13.750407691665849,\n",
       " 'déficit congénital': 9.304076932332649,\n",
       " 'neisseria gonorrhoeae chez une personne asymptomatique': 33.325023753638135,\n",
       " 'jeunes adultes': 9.366282531078491,\n",
       " 'regard sur les groupes de médecine de famille': 32.891599591529115,\n",
       " 'inesss annexes': 9.011501615179135,\n",
       " 'moderate and severe': 15.31018727482413,\n",
       " \"conditions de succès de l'accouchement\": 15.63887128808243,\n",
       " 'services de soins': 6.035406439578054,\n",
       " 'lien avec les niveaux': 14.929175886356624,\n",
       " 'douleurs musculosquelettiques irm': 18.949158159818644,\n",
       " \"modalités d'accès de remboursement\": 13.584161594209679,\n",
       " 'modalités et processus': 10.2363220231834,\n",
       " 'liste des médicaments couverts par le régime': 19.38215284020992,\n",
       " 'liste des médicaments du rgam': 16.94634668561657,\n",
       " \"soins critiques de l'inesss\": 13.686091378967447,\n",
       " 'analyse de données': 10.07947382110743,\n",
       " 'risk of cardiovascular': 17.65877152223635,\n",
       " 'pertinence des modes': 12.042742311700781,\n",
       " 'produits de connaissances': 7.444342475157536,\n",
       " 'protocole médical problèmes': 15.03500839058442,\n",
       " \"indications justifiant le recours à l'imagerie\": 25.953859859148523,\n",
       " 'précisions sur le projet': 10.653133804841536,\n",
       " 'liste des principaux': 8.012089802766393,\n",
       " 'trajectoires de services menant': 17.203960891406332,\n",
       " \"chlorhydrate d'nom\": 0.7122912624613087,\n",
       " 'centre du québec': 9.260538251885542,\n",
       " 'trouble développemental': 10.249866667202566,\n",
       " \"patients adultes atteints d'hémoglobinurie paroxystique\": 10.516222463455353,\n",
       " \"solution d'acétylcystéine\": 5.14247593932203,\n",
       " 'santé naturels': 7.416755864957322,\n",
       " 'dégénérescence maculaire': 11.956439577914425,\n",
       " \"guide d'usage optimal\": 10.579488187644905,\n",
       " \"arrimage entre l'inscription éventuelle\": 10.38565737104473,\n",
       " 'micro invasive': 17.88863913232243,\n",
       " 'organes solides volet': 19.332745644190865,\n",
       " 'normes et standards en protection de la jeunesse': 37.585674765978204,\n",
       " 'alendronate monosodique nora': 7.878154321305195,\n",
       " 'usage optimal zona': 17.81604043184393,\n",
       " 'autosurveillance glycémique chez les adultes': 22.896901181199716,\n",
       " 'tcc modéré': 12.81825098352503,\n",
       " 'sang occulte': 12.05249446265323,\n",
       " \"patients adultes atteints d'un myélome\": 11.078874764368432,\n",
       " 'hémoglobinurie paroxystique nocturne': 11.08891513630715,\n",
       " 'utilisation de substances': 12.850396952422726,\n",
       " 'lénalidomide pour le traitement': 12.667416332843587,\n",
       " 'pratiques en oncologie cepo': 18.91700212197314,\n",
       " \"rencontres avec les représentants de l'industrie\": 25.641582763172636,\n",
       " 'évaluation amgevita adalimumab amgen': 12.72629796505555,\n",
       " 'patients atteints de néphropathie chronique': 12.210343641281376,\n",
       " 'clinico administratives': 12.900101831065818,\n",
       " 'traumatismes non intentionnels': 7.781777192306112,\n",
       " 'interventions de réadaptation pour les enfants': 24.873649474145246,\n",
       " 'consentement et options': 15.426293803928075,\n",
       " 'soutien à domicile par les personnes en fin de vie': 38.2650207739566,\n",
       " 'évaluation saphnelo anifrolumab': 3.6348977063430468,\n",
       " 'récepteurs hormonaux et négatif': 16.28417077844172,\n",
       " 'documents des organismes': 12.073486328786393,\n",
       " 'évaluations en mode continu inesss express': 24.124789243981997,\n",
       " 'vph comme test de dépistage primaire': 33.165858235336515,\n",
       " 'insuline glargine bgp pharma': 9.85020739332721,\n",
       " 'comptes rendus': 23.85897684653781,\n",
       " 'utilisation des accélérateurs': 12.736017087316316,\n",
       " 'solution orale': 10.081520968023145,\n",
       " 'mepolizumab gsk traitement': 6.8153837234881705,\n",
       " 'injection de glycopyrrolate jamp': 5.784792472778876,\n",
       " 'femmes ménopausées': 11.498044244493595,\n",
       " \"lévonorgestrel pour la contraception orale d'urgence\": 24.658594090743613,\n",
       " 'traitement des nausées': 11.321918231471429,\n",
       " 'évaluation fiche': 7.164277595139311,\n",
       " 'colle de fibrine': 12.869703366596912,\n",
       " \"processus d'évaluation\": 3.7530796658573657,\n",
       " 'anticoagulants oraux directs et de la warfarine': 41.811898704334894,\n",
       " 'terme des besoins': 10.813246573990538,\n",
       " 'agents biologiques': 14.94291264563677,\n",
       " 'évaluation firdapse amifampridine kye': 5.792507702541135,\n",
       " \"liquid inhibiteur de l'proteinase grifols produit du système\": 15.262783577331891,\n",
       " 'services administratifs du secrétariat général': 24.091787226378358,\n",
       " 'réseau de la santé': 12.254156438485628,\n",
       " 'traitement de la leucémie lymphoblastique aiguë': 28.592798622632948,\n",
       " 'ors édaravone': 1.9991027876013137,\n",
       " 'absence de détérioration': 12.999216781432683,\n",
       " 'outil de soutien': 11.66827681570065,\n",
       " 'synthèse trouble': 9.479897550114131,\n",
       " 'mild traumatic brain injury': 33.41791041488702,\n",
       " 'myélome multiple carfilzomib': 21.462020842897097,\n",
       " 'mesure du glucose en continu guardian': 35.207270903966965,\n",
       " \"algorithme d'investigation de traitement et de suivi\": 24.841780927747166,\n",
       " 'évaluation cibinqo projet': 4.977647858134111,\n",
       " 'autosurveillance glycémique': 15.261819670396223,\n",
       " 'mutation del du gène cftr': 14.486405855083731,\n",
       " 'older adults': 7.150914767792845,\n",
       " 'trauma center': 14.429425470875973,\n",
       " 'pratique sur le repérage': 15.172172920528384,\n",
       " 'expertise réfère': 6.156546674982746,\n",
       " 'postsoumission avec les fabricants': 14.386817654340511,\n",
       " \"traitement d'entretien de l'asthme éosinophile\": 10.914175339513669,\n",
       " 'population pour appuyer les démarches': 20.603719478756364,\n",
       " 'niveau de preuve scientifique faible': 22.0506314644271,\n",
       " 'directeur général': 8.897195979130977,\n",
       " 'accidents vasculaires': 14.396151210315942,\n",
       " 'comités scientifiques': 12.12975500992353,\n",
       " 'otsuka can traitement': 7.731612565543501,\n",
       " 'intervention médicale': 7.714465481533475,\n",
       " \"cours d'évaluation firdapse\": 3.579151145995215,\n",
       " 'note explicative trimestre': 28.911301688406446,\n",
       " \"utilisation de l'imagerie par résonance magnétique\": 24.103296887439676,\n",
       " 'troubles neurocognitifs majeurs': 18.414131483303095,\n",
       " 'propionate de phmscience': 9.50995400061695,\n",
       " 'moment de la rencontre': 16.490990550549668,\n",
       " 'soulagement des dermatoses sensibles aux corticostéroïdes': 12.71210134224826,\n",
       " 'angine stable': 20.216976849892987,\n",
       " 'repérage fiche': 13.539026033070211,\n",
       " \"chirurgie pour favoriser l'hémostase\": 8.78309216043602,\n",
       " 'voies respiratoires version française': 26.186455421777357,\n",
       " 'traitement de la diarrhée': 14.837683373431762,\n",
       " 'trauma centres': 10.790198280701564,\n",
       " 'mint quetiapine': 4.050638145305194,\n",
       " 'traitement des symptômes vasomoteurs modérés': 13.263107910269346,\n",
       " 'cost effectiveness': 9.769199366092955,\n",
       " 'évaluation mvasi': 2.6884838948204637,\n",
       " 'trajectoire diagnostiques': 9.469313593402312,\n",
       " 'glycopyrrolate glycopyrrolate jamp': 2.4640762567258205,\n",
       " 'services administratifs du secrétariat général et des communications': 38.96658300619967,\n",
       " 'patients atteints de maladies': 12.507348674729174,\n",
       " 'collaborateurs institutionnels': 11.822575557848914,\n",
       " 'application inesss': 8.662140913201728,\n",
       " 'forme capsule': 6.554583005868988,\n",
       " 'littérature consultée': 11.164612030260532,\n",
       " 'ans qui présentent': 8.050117935712441,\n",
       " 'fabricant zeneca': 9.041816461882568,\n",
       " \"processus synchronisé d'évaluation\": 11.292711768579048,\n",
       " 'plasma riche en plaquettes': 28.588261967824153,\n",
       " 'rhumatisme psoriasique': 9.693832164875658,\n",
       " \"greffon contre l'hôte chez les patients\": 11.320610773798393,\n",
       " 'usage optimal maladie de lyme': 17.25232786166137,\n",
       " 'agence de la santé': 12.70634093479693,\n",
       " 'produit de santé': 8.606827067829387,\n",
       " 'opioïdes chez les personnes couvertes': 21.298823541256688,\n",
       " 'présoumission avec les fabricants': 15.336876203300882,\n",
       " 'sédation palliative continue': 18.607986876695655,\n",
       " 'problèmes de santé': 9.158632083999624,\n",
       " 'évaluation wakix': 2.6884838948204637,\n",
       " 'génotypage du rhd fœtal par test prénatal': 48.1275144414596,\n",
       " 'fibrose pulmonaire': 8.767139336845693,\n",
       " 'apo teriflunomide': 5.19213285911333,\n",
       " 'mepolizumab gsk traitement des polypes nasaux sévères': 12.609143739814925,\n",
       " 'évaluation mvasi bévacizumab': 3.6348977063430468,\n",
       " 'fabricant biogen': 5.892269111121852,\n",
       " 'transfusions sanguines': 21.344133340472787,\n",
       " 'analyses de biologie médicale': 21.46801318409342,\n",
       " 'maladies cardiovasculaires héréditaires': 18.926338602481195,\n",
       " 'injection fentanyl citrate de jamp': 11.39835401152301,\n",
       " 'traitement de la cellulite': 19.451805919660444,\n",
       " 'imagerie par résonance magnétique irm': 32.66405318804175,\n",
       " 'conciliation du milieu de soins': 26.0996615813796,\n",
       " \"jeunes en difficulté d'adaptation\": 16.21209792267004,\n",
       " 'renseignements touchant la gestion des analyses biomédicales': 26.092619213932405,\n",
       " 'nom commercial à venir finérénone': 12.352966747639325,\n",
       " 'infarctus aigu du myocarde avec élévation': 31.819311824461,\n",
       " \"cas de diarrhée chez l'adulte\": 13.703278931082647,\n",
       " 'coups et projets en cours': 15.284705844151304,\n",
       " 'prévention de la grossesse': 15.4732842523977,\n",
       " 'décision clinique': 3.2811935986796175,\n",
       " 'réponse inadéquate': 10.782903893512126,\n",
       " 'exacerbation aiguë': 9.947950662423153,\n",
       " 'exercice du collège des médecins': 25.17415331779881,\n",
       " 'détection taan': 14.204140172431945,\n",
       " 'évaluation tremfya': 2.6884838948204637,\n",
       " \"mépolizumab gsk traitement d'entretien de l'asthme éosinophile\": 13.621889017919289,\n",
       " 'résultat positif': 11.777618721372036,\n",
       " \"spectre de l'autisme tsa\": 16.615164765940428,\n",
       " 'poussée clinique': 11.589041728989681,\n",
       " 'processus synchronisé': 11.292711768579048,\n",
       " \"évaluation en attente d'évaluation ou en cours d'évaluation\": 19.945177070677843,\n",
       " 'option de traitement': 10.126158908961585,\n",
       " \"profil évolutif d'utilisation\": 13.946197473714172,\n",
       " 'arrondissement des doses': 16.06515137153461,\n",
       " 'corticostéroïdes et traitement': 12.098121022340687,\n",
       " \"trouble lié à l'usage\": 12.518587247247613,\n",
       " 'évaluation enhertu projet aligné': 10.689081856981854,\n",
       " 'myocarde avec élévation du segment st iamest': 39.5905080128491,\n",
       " 'randomized controlled trials': 11.306248655112801,\n",
       " 'mesures de précaution': 19.868851392675584,\n",
       " 'situation clinique': 5.744533848610297,\n",
       " 'guselkumab janss inc traitement du rhumatisme psoriasique': 15.681695304358135,\n",
       " 'activité affiche': 12.179846395987347,\n",
       " \"pratiques portrait de l'utilisation\": 11.324639640916377,\n",
       " 'difficultés apparentées': 11.687172522721696,\n",
       " 'services en santé mentale': 10.803070993318691,\n",
       " 'chloral hydrate syrup': 4.629068072180415,\n",
       " 'glucose en continu guardian': 27.612209913975107,\n",
       " 'oxlumo lumasiran alnylam': 3.5946406078650766,\n",
       " 'conseil du médicament': 6.260585806146949,\n",
       " 'analyses de laboratoire au répertoire': 25.63030750128769,\n",
       " 'cardiologie et maladies': 15.799386432572895,\n",
       " 'travaux en dépistage et pratiques': 17.942014138901087,\n",
       " 'services psychosociaux': 10.655360332021473,\n",
       " 'usage optimal infection': 11.486264154470652,\n",
       " 'travaux de recherche': 9.905987416451879,\n",
       " 'technologies biomédicales': 11.064830080107784,\n",
       " 'autorités ministérielles pour une prise': 19.014860842518342,\n",
       " \"évaluation en mode continu par l'inesss statut\": 15.630633382691173,\n",
       " 'intitulé les ordonnances': 13.621935527303297,\n",
       " 'fabricant forme teneur': 1.664264023574489,\n",
       " 'principes directeurs': 13.436094283815995,\n",
       " 'pipéracilline et tazobactam pour injection': 12.89470444912271,\n",
       " 'nom du fabricant roche': 9.152017403087111,\n",
       " \"attente d'évaluation xpovio sélinexor\": 7.775530146257776,\n",
       " 'graves des symptômes': 9.369362624597938,\n",
       " 'test vph': 15.58285829715326,\n",
       " \"dosage de l'antigène prostatique spécifique aps\": 37.10335434834433,\n",
       " 'lien avec la priorisation des soins en contexte': 25.72778182112544,\n",
       " 'monothérapie pour le traitement adjuvant des patients': 20.56162258524707,\n",
       " 'postmenopausal women': 18.037845693687064,\n",
       " 'pralsetinib roche': 5.259346158716538,\n",
       " 'exercice du collège des médecins du québec': 29.02612394189804,\n",
       " 'maladie du québec liste des médicaments': 13.754068798164171,\n",
       " 'salmétérol xinafoate': 13.98260066137663,\n",
       " 'patients souffrant': 6.272753663476514,\n",
       " \"demande en cours d'évaluation vraylar cariprazine\": 13.820421774106425,\n",
       " 'évaluation des installations de soins aigus': 25.91821421820255,\n",
       " 'priorisation des soins': 12.190456270068077,\n",
       " 'traitement adjuvant': 10.220959122600519,\n",
       " 'critère de la valeur thérapeutique': 16.487678632766823,\n",
       " 'professionnels de la santé': 11.301549689983487,\n",
       " 'qualité du milieu': 13.590554605042904,\n",
       " 'prévention du rejet': 16.15230260402652,\n",
       " 'dipropionate de taro': 11.172770554232425,\n",
       " 'virus respiratoire': 10.566319450281682,\n",
       " 'revue rapide': 8.912337986341184,\n",
       " 'trouble de stress post': 18.32293342174541,\n",
       " 'diagnostic moléculaire avis au ministre': 13.846012112305079,\n",
       " 'analyses microbiologiques des selles en cas': 26.497837963185876,\n",
       " \"traitement de l'hypertension\": 6.7777936973800355,\n",
       " 'évaluation jakavi projet': 5.711660966063032,\n",
       " 'troubles graves du comportement': 21.343638268846334,\n",
       " \"cours d'évaluation saphnelo anifrolumab\": 4.525564957517798,\n",
       " 'head injury': 15.310719612082465,\n",
       " 'heure actuelle': 10.423153506172822,\n",
       " 'alzheimer et démence': 16.98610268422076,\n",
       " 'calcipotriol bétaméthasone': 15.512528060618134,\n",
       " 'faiza boughrassa': 13.347509889760678,\n",
       " 'contexte québécois des inhibiteurs de la tyrosine': 27.856868142834784,\n",
       " 'gestion du sevrage': 17.045074677406063,\n",
       " 'pertinence et indications de transmission des prélèvements': 31.612505504428896,\n",
       " 'exercice de cohérence ou de concordance': 27.12267044828674,\n",
       " 'perte vaginale inhabituelles': 12.546209675598442,\n",
       " \"soutien au guide d'usage optimal pneumonie\": 24.254359573804532,\n",
       " 'documents institutionnels emplois': 16.188916513221894,\n",
       " 'contexte préventif': 10.914967861756804,\n",
       " 'rapid response': 18.855558748433918,\n",
       " 'outil de transfert de connaissances': 18.985554816075243,\n",
       " 'accident vasculaire cérébral': 17.698664450324458,\n",
       " 'nonacog bêta': 14.773829670790565,\n",
       " 'alendronate monosodique': 7.878154321305195,\n",
       " 'cataplexie chez des patients': 12.845508569120938,\n",
       " \"suivi de l'évolution\": 7.935303498774012,\n",
       " 'services intégrés': 7.813245787164493,\n",
       " 'écoulement urétral version': 18.698626474167646,\n",
       " \"réévaluation en cours d'évaluation qinlock ripretinib\": 11.913896274410178,\n",
       " \"pertinence d'utiliser un médicament\": 6.8608146414628655,\n",
       " 'taro ticagrelor ticagrélor taro': 12.778956718088136,\n",
       " 'projets dans les meilleurs': 13.145236096889347,\n",
       " 'congrès et colloques en traumatologie': 24.086466216131424,\n",
       " 'besoins des enfants à risque ou en situation': 27.189414635500036,\n",
       " 'aide médicale à mourir': 17.6773241462786,\n",
       " 'interventions pharmacologiques': 10.559047410227762,\n",
       " 'usage optimal personnes âgées': 16.21494003039041,\n",
       " 'calcipotriol betamethasone': 12.837925829432017,\n",
       " 'maladies chroniques comité': 15.76208961053569,\n",
       " 'soins palliatifs détresse soins palliatifs': 23.204382891475216,\n",
       " 'médicament en particulier médicaments': 8.861755000904871,\n",
       " 'femmes atteintes': 10.739753495779432,\n",
       " 'chlamydia et gonorrhoeae protocole médical national': 30.393317841114857,\n",
       " 'dose quotidienne': 11.169865486006568,\n",
       " 'transition à la vie adulte': 22.21042163518625,\n",
       " 'réduction des événements athérothrombotiques en appoint aux traitements': 17.587850328525192,\n",
       " 'johnson produit du système du sang': 25.27818997483169,\n",
       " 'axicabtagene ciloleucel pour le traitement des lymphomes': 36.08048005362745,\n",
       " 'gène ret': 5.664568500934969,\n",
       " 'polyangéite ou polyangéite microscopique': 13.320742155276129,\n",
       " 'fumarate de apo eletriptan apotex': 5.791571731987963,\n",
       " 'dépression bipolaire': 7.368800416337705,\n",
       " 'suivi pour le cancer du rectum': 24.415589561001433,\n",
       " 'programme québécois': 8.378857991001627,\n",
       " 'utilisation des antiviraux pour le traitement': 23.072820066917537,\n",
       " 'suivi des projets cliniques': 12.116965425654964,\n",
       " \"indications de l'irm\": 8.026607951500319,\n",
       " 'angioedème héréditaire aoh pré': 10.105624044073833,\n",
       " 'jeunesse sommaire de la littérature': 23.349946599972924,\n",
       " \"traitement de l'œdème maculaire diabétique pré\": 17.921380273721518,\n",
       " 'chlorhydrate de nom': 4.589275678567636,\n",
       " 'amélioration continue': 9.229080622022739,\n",
       " \"unité d'évaluation en traumatologie et en soins\": 22.662070917699413,\n",
       " 'guides de pratique': 12.599847899624244,\n",
       " 'biologie médicale contexte': 13.202105662305055,\n",
       " 'services sociaux jeunes': 8.48185773786295,\n",
       " 'prise en charge des accidents vasculaires cérébraux': 34.02479645647045,\n",
       " 'lymphome à cellules du manteau': 19.577656769255714,\n",
       " 'pratiques proposées dans un contexte préventif': 23.43010590254051,\n",
       " 'mesure prometteuse': 6.513237577160274,\n",
       " 'hypertension artérielle pulmonaire': 16.80506295248194,\n",
       " 'liso cel': 26.18282181602513,\n",
       " 'projet collaboratif inesss': 5.768897765717606,\n",
       " 'syndrome génito urinaire': 8.127894718325429,\n",
       " 'documents consultés': 6.146052181888488,\n",
       " 'tests moléculaires': 15.44130606907554,\n",
       " 'milieu de soins': 11.812232824433794,\n",
       " 'risque de négligence ou en situation': 26.34277532440158,\n",
       " 'test immunochimique de recherche de sang occulte': 35.33483526755739,\n",
       " 'fabricant biogen forme solution': 9.935093430522915,\n",
       " 'vph comme test': 18.1154851925016,\n",
       " \"traitement des patients adultes atteints d'un myélome\": 17.680236674420044,\n",
       " 'envois de prélèvements en pathologie': 37.144799918457096,\n",
       " 'ciusss de la capitale': 20.763136921691668,\n",
       " 'dépistage du cancer colorectal': 19.068617615589634,\n",
       " 'dépistage du cancer de la prostate au québec': 29.245337940730455,\n",
       " 'évaluation vraylar cariprazine': 5.195566212960119,\n",
       " 'utilisation des médicaments': 8.39575462683873,\n",
       " \"liaison à l'attention du pharmacien communautaire modèle\": 28.518879319478916,\n",
       " 'mémoire trouble': 9.472977562023202,\n",
       " 'tomosynthèse mammaire': 13.714093454530538,\n",
       " 'victimes de traumatismes': 16.168537534797178,\n",
       " \"traitement de l'insomnie\": 6.7777936973800355,\n",
       " 'oeuvre de la méthode de réponse': 20.394679645076728,\n",
       " 'cellulite infectieuse': 17.9228194368007,\n",
       " 'évaluation du risque': 8.51779081706058,\n",
       " 'validation pour les analyses de laboratoires': 25.299603178695,\n",
       " 'pratiques organisationnelles en réadaptation': 14.913587658586664,\n",
       " \"contexte de l'administration\": 5.878199608822575,\n",
       " 'prothrombine dans le sang': 16.609931583517575,\n",
       " 'caplacizumab sanofiaven traitement du purpura': 11.631999776318631,\n",
       " 'immunoglobulines en hématologie': 19.85281340607857,\n",
       " 'dexaméthasone pour le traitement': 13.09185290684278,\n",
       " \"agence d'évaluation\": 5.853582866608384,\n",
       " 'conseils pour la reprise graduelle': 20.086664115928105,\n",
       " 'tumeur stromale gastro': 18.822882819097025,\n",
       " 'ordonnance individuelle préimprimée': 20.530602701706933,\n",
       " 'déficience physique déficience intellectuelle': 26.141179728115112,\n",
       " 'patientes ménopausées': 9.307860430341947,\n",
       " 'évaluations en appui': 11.260376940317036,\n",
       " 'résultats de plusieurs méta': 14.145638753908086,\n",
       " 'mucosite oropharyngée naloxone pertes vaginales': 24.17125910116117,\n",
       " 'services pour les enfants à risque': 17.01679095760909,\n",
       " 'selles en cas': 12.045532207343317,\n",
       " 'psoriasis en plaques': 15.496694549689433,\n",
       " 'traitement au fer intraveineux': 19.926024602403977,\n",
       " 'estrogènes conjugués biologiques': 27.34123660817422,\n",
       " 'cancer du poumon par la tomographie': 27.66614316607444,\n",
       " \"guides d'usage optimal résumés\": 19.65855744926879,\n",
       " 'ministre de la santé et des services sociaux': 16.727874310342866,\n",
       " 'traitement de la thrombose': 13.665952888291311,\n",
       " 'maladies cardiovasculaires infectieuses': 17.859383097446266,\n",
       " \"dépôt électronique d'une demande\": 17.501208681813594,\n",
       " 'onetouch mc verio': 30.404325042264023,\n",
       " 'guide posologique': 11.162536898191078,\n",
       " 'test immunochimique': 13.113028095739821,\n",
       " 'traitement par agonistes': 11.713873532728119,\n",
       " \"démarche d'évaluation\": 4.214138052009753,\n",
       " \"prélèvements chirurgicaux au laboratoire d'anatomopathologie\": 25.63108505876011,\n",
       " 'déficit grave en antitrypsine chez les adultes': 17.178450050096504,\n",
       " 'cancer du poumon à petites cellules': 24.16790868098776,\n",
       " 'usage optimal usage': 11.455782717001519,\n",
       " \"cours d'évaluation wakix\": 3.579151145995215,\n",
       " 'sep progressive secondaire pour avonex': 31.558263910090346,\n",
       " 'normes et standards de qualité': 19.501971213257256,\n",
       " 'infections urinaires': 11.608988506822254,\n",
       " 'naloxone par voie nasale': 19.090256974802767,\n",
       " 'répertoire québécois': 11.752257004562896,\n",
       " 'traitement de la maladie': 12.041469641726955,\n",
       " 'bandelettes de glycémie': 18.929378317313024,\n",
       " \"patients en attente d'une coloscopie\": 21.45506979937677,\n",
       " 'évaluation nucala mépolizumab gsk': 18.057452480548342,\n",
       " \"protoxyde d'azote\": 12.810786933841365,\n",
       " \"soutien au guide d'usage optimal eampoc\": 19.808134206885818,\n",
       " 'nourrissons ou enfants': 13.37431137278953,\n",
       " 'emergency care': 16.023146976527265,\n",
       " 'projets cliniques et de recherche': 15.482582423590102,\n",
       " 'recommandations en lien avec la priorisation': 18.859682992212683,\n",
       " 'évaluation et gestion': 10.371138130127497,\n",
       " 'association avec une endocrinothérapie': 7.437784395486082,\n",
       " 'anesthésie générale pour les soins dentaires en pédiatrie': 47.118143913738464,\n",
       " 'monohydrate de sanis': 9.094616146193452,\n",
       " 'standards en protection de la jeunesse': 30.596786907579517,\n",
       " \"fer intraveineux chez l'adulte trouble dépressif\": 21.71313518201012,\n",
       " 'maladies chroniques indicateurs de qualité prise': 28.948777390485816,\n",
       " 'mépolizumab gsk': 10.273325405934877,\n",
       " \"population pour appuyer les démarches d'amélioration\": 20.603719478756364,\n",
       " 'critères prévus': 6.119508643717739,\n",
       " 'annexes complémentaires': 11.183404891660947,\n",
       " 'mucosite oropharyngée naloxone pertes': 20.555777653961897,\n",
       " 'déficience intellectuelle trouble': 18.044427813835622,\n",
       " 'lyme ppe mucosite oropharyngée naloxone': 24.596763985607456,\n",
       " 'usage optimal herpès génital version française': 38.31286689647567,\n",
       " 'victimes de brûlures': 16.322443696570097,\n",
       " \"cours d'évaluation cibinqo projet\": 5.868315109308862,\n",
       " 'cas de cancer du sein invasif': 21.671241932324264,\n",
       " \"transmission des prélèvements chirurgicaux au laboratoire d'anatomopathologie\": 35.39029407603723,\n",
       " 'inhibiteurs de la protéase': 21.688214732640454,\n",
       " 'médicaments biosimilaires': 9.688805567729109,\n",
       " 'infection par le sras': 14.726842082754786,\n",
       " 'conseil déplore': 7.291256614612715,\n",
       " 'recension sommaire des principales lignes directrices': 27.018422755799126,\n",
       " 'zeneca forme': 8.99470394284605,\n",
       " 'aide à la décision céphalée adulte irm': 29.487773441956367,\n",
       " \"inesss d'élaborer\": 3.4330410118640127,\n",
       " 'pandémie de la covid': 14.397526856729673,\n",
       " 'centre de réadaptation pour jeunes': 21.486920611678105,\n",
       " 'coût unitaire': 8.697979757439626,\n",
       " 'échelle nationale': 9.000907234877506,\n",
       " 'cancer du poumon par la tomographie axiale': 38.10785015022334,\n",
       " \"réadaptation pour jeunes en difficulté d'adaptation\": 24.02853427580191,\n",
       " 'niacine à libération prolongée': 29.97565212892603,\n",
       " 'déficiences physiques intellectuelles et tsa': 37.03905675720638,\n",
       " 'segmentation de la population': 16.47039782290099,\n",
       " 'ordonnances associées aide': 10.486587449672893,\n",
       " 'segmentation de la population pour appuyer': 26.422042199815866,\n",
       " 'réduction de la pression': 13.520448329688135,\n",
       " 'sandoz fesoterodine': 8.11778387106615,\n",
       " \"cours d'évaluation mvasi bévacizumab amgen\": 8.508841610084986,\n",
       " 'modéré grave': 10.990789671627121,\n",
       " \"tézépélumab azc traitement d'entretien\": 7.847231676442372,\n",
       " \"modalités d'évaluation\": 4.558927007585922,\n",
       " 'exercice du collège': 16.459821846747936,\n",
       " 'ménopayse chez la femme ménopausée': 11.38113102870429,\n",
       " \"statut de la demande en attente d'un dépôt\": 26.867438073075245,\n",
       " 'maribavir takeda traitement': 6.110359911963801,\n",
       " 'tests sérologiques': 17.55101186426493,\n",
       " \"processus et critères d'évaluation\": 10.422821048010471,\n",
       " 'lignes directrices': 11.318095235686327,\n",
       " 'cancer du sein métastatique': 16.278101742207074,\n",
       " \"mode continu par l'inesss\": 12.19693464013307,\n",
       " 'sandoz lurasidone lurasidone': 8.842092958076512,\n",
       " 'adaptation au québec': 9.302053679536423,\n",
       " 'gestion du risque de complications neurologiques graves': 34.592194671436204,\n",
       " \"attente d'un avis de conformité\": 13.36049780290612,\n",
       " 'antécédent de cancer infectées': 24.70145056949377,\n",
       " 'chlorhydrate de nom du fabricant': 8.21032787634119,\n",
       " 'institut national de santé': 12.288674512052369,\n",
       " 'besoins des familles suivies dans les services': 25.854370837601227,\n",
       " 'cours des prochaines': 12.363716120420904,\n",
       " 'effets des chiens': 18.07462249776106,\n",
       " 'sotorasib amgen pour le traitement': 14.295910233548838,\n",
       " 'système de mesure du glucose en continu': 30.05798351143772,\n",
       " \"arrimage entre l'inscription\": 6.15732734309846,\n",
       " 'msss pour alimenter les discussions': 20.175216196870345,\n",
       " 'mois et version française': 23.221325974749227,\n",
       " 'travaux en cardiologie': 12.933641550642108,\n",
       " 'produits de santé': 6.4682920428028075,\n",
       " \"pertinence de l'exigence d'un essai préalable avec un immunosuppresseur\": 35.43857546585585,\n",
       " 'semaines avant le dépôt annoncé': 13.994692312255307,\n",
       " \"cours d'évaluation ngenla\": 3.579151145995215,\n",
       " 'jamp glycopyrrolate': 1.6737854488289567,\n",
       " 'secteur des services sociaux': 11.191028795584533,\n",
       " 'imagerie par résonance': 18.82084939893295,\n",
       " 'usage judicieux répertoire des procédures': 22.004596106231343,\n",
       " 'médicament innovateur': 11.1291806697987,\n",
       " 'prévention en évaluation et en intervention': 19.220220453525542,\n",
       " \"demande en cours d'évaluation verzenio abémaciclib\": 12.259753267489351,\n",
       " 'réadaptation pour jeunes en difficulté': 24.02853427580191,\n",
       " 'transmission des prélèvements chirurgicaux': 25.8072597803149,\n",
       " 'médicament générique': 8.73689740566417,\n",
       " 'liste des médicaments': 9.015928587701032,\n",
       " 'immunoglobulines humaines non spécifiques': 17.226480945120198,\n",
       " 'revues systématiques': 18.31492618244021,\n",
       " 'calcium polystyrene sulfonate': 2.2665987753767416,\n",
       " 'dexcom mc dexcom': 18.954337805523686,\n",
       " 'industrie des technologies': 17.293919050114006,\n",
       " 'adultes atteints de diabète': 15.233378436453965,\n",
       " 'tests diagnostiques': 8.084352420723322,\n",
       " 'vph comme test de dépistage': 26.966317565109204,\n",
       " \"outil d'aide\": 5.544379985779179,\n",
       " 'intervention en matière': 12.069161572055673,\n",
       " 'fractures vertébrales': 15.583047098508324,\n",
       " 'nodules thyroïdiens à cytologie indéterminée': 35.59142079042281,\n",
       " 'efficacité du traitement': 9.168447110611417,\n",
       " 'imagerie pour le traitement des patients': 21.362947089798023,\n",
       " 'analyses microbiologiques des selles en cas de diarrhée': 36.56719787661028,\n",
       " \"ordonnance individuelle d'ajustement de la warfarine\": 23.709663133165254,\n",
       " \"comité d'experts sur la pertinence\": 11.984884083895384,\n",
       " 'articles scientifiques': 7.462241036651326,\n",
       " 'pembrolizumab merck traitement du cancer': 18.58364875760645,\n",
       " 'résultats préliminaires': 8.235532473211885,\n",
       " \"outil d'aide à la décision calculatrice prévention\": 23.785751591270703,\n",
       " \"attente d'évaluation cablivi\": 6.829116334735193,\n",
       " 'infarctus aigu du myocarde': 24.4698731500458,\n",
       " 'pression intraoculaire': 9.803773076870344,\n",
       " 'principes et fondements': 19.359803505621393,\n",
       " 'indication reconnue à la liste': 11.643787603208805,\n",
       " 'urgence sanitaire': 9.02183233060122,\n",
       " 'projets présentés': 6.210556955987733,\n",
       " \"patients adultes atteints d'un lymphome\": 13.579420250430847,\n",
       " 'industrie des technologies biomédicales': 22.557713736148898,\n",
       " 'review and meta analysis': 19.03692480794456,\n",
       " \"évaluation d'une demande d'exemption de la méthode\": 16.527979717801294,\n",
       " 'usage des anticoagulants': 14.970531497697452,\n",
       " 'accès aux documents': 10.266473372584036,\n",
       " 'autonomie des jeunes': 14.540969249411742,\n",
       " \"réévaluation en cours d'évaluation tepmetko\": 10.967482462887595,\n",
       " 'tests moléculaires pour préciser': 24.506369673890894,\n",
       " 'severe traumatic brain injury': 33.39939007147191,\n",
       " 'note des références publiées': 9.385307844549653,\n",
       " 'allergies aux bêta lactamines': 26.351378571619186,\n",
       " \"attente d'évaluation gavreto\": 6.829116334735193,\n",
       " \"arrimage entre l'inscription éventuelle d'un médicament\": 10.71303846573292,\n",
       " 'usage judicieux répertoire': 15.766087049549254,\n",
       " 'sep de forme rémittente': 21.083858037802422,\n",
       " 'salbutamol en aérosol': 26.81243857535488,\n",
       " 'taan multiplex': 14.756832201394207,\n",
       " \"prise en charge de l'arthrose du genou\": 25.698943348584677,\n",
       " 'vie adulte des jeunes': 17.32087910814092,\n",
       " 'fabricant en attente': 9.498898708817531,\n",
       " \"risque d'insuffisance cardiaque congestive\": 10.700838990008549,\n",
       " 'lumière des résultats': 9.790055120940355,\n",
       " 'argent coloplast': 6.2899149030697314,\n",
       " 'covid pour la semaine': 16.98492230525835,\n",
       " 'critical care': 15.73114545681662,\n",
       " 'traitement de la dégénérescence maculaire': 21.760625709893034,\n",
       " 'récepteur de la tyrosine': 17.94255594648736,\n",
       " 'plaies complexes': 15.406419774921496,\n",
       " 'présidente directrice générale': 24.002674482440778,\n",
       " 'procédure de biologie médicale au répertoire': 31.78245691258026,\n",
       " \"recours à l'imagerie pour le traitement des patients\": 20.707489920090442,\n",
       " 'gène egfr dans le cancer du poumon': 29.521714531961763,\n",
       " \"traitement d'une mycose fongoïde\": 9.129086405399221,\n",
       " 'cariprazine abbvie traitement de la schizophrénie': 17.355240008370693,\n",
       " 'aérosol pour inhalation': 22.637807491167763,\n",
       " 'conseil juge': 6.8300885048278275,\n",
       " 'regard sur les groupes de médecine': 23.6359453417353,\n",
       " 'gène cftr pré': 12.107693992896717,\n",
       " \"recommandation de l'inesss décision du ministre\": 7.516105606750603,\n",
       " 'soins aigus désignées en traumatologie': 24.901144319196202,\n",
       " 'réseau québécois': 9.670859056500976,\n",
       " 'ciusss de la mauricie et du centre': 33.46774259022632,\n",
       " \"pss en attente d'un avis de conformité\": 24.262733394016383,\n",
       " 'orlando floride': 20.462707998497592,\n",
       " 'accès équitable': 10.89198128496162,\n",
       " 'furoate monohydraté de sanis': 10.244570525831449,\n",
       " 'aide à la décision en cas': 15.645660573901024,\n",
       " 'naloxone pour surdose aux opioïdes dans la communauté': 35.371242047912844,\n",
       " 'usage optimal fibrillation': 14.89325521836389,\n",
       " 'nat teriflunomide tériflunomide': 11.358798508371038,\n",
       " 'pertinence du dépistage néonatal du déficit immunitaire': 39.25657452368517,\n",
       " 'fumarate de nom du fabricant': 8.053795970882527,\n",
       " 'lits réguliers': 14.559769947146147,\n",
       " 'traitements utilisés': 6.194895800167496,\n",
       " 'lévonorgestrel pour la contraception': 20.93519170828003,\n",
       " 'analyses déjà inscrites': 12.311867537841959,\n",
       " 'technologies biomédicales directions': 15.970981895409489,\n",
       " 'length of stay': 8.375878779045246,\n",
       " 'adultes atteints de néphropathie': 12.989101771796717,\n",
       " \"traitement d'une réaction\": 7.010975513300146,\n",
       " 'portrait des fugueurs et des pratiques actuelles': 30.29948431275719,\n",
       " 'qualité des services': 7.858052084680447,\n",
       " \"unité d'évaluation en traumatologie\": 15.19575502186392,\n",
       " 'diagnostic de la maladie': 13.941586502659074,\n",
       " 'changement apporté': 13.719994686401078,\n",
       " \"liaison à l'attention du pharmacien\": 17.590111222816873,\n",
       " \"évaluation des médicaments aux fins d'inscription\": 15.998988098068338,\n",
       " 'dispensation des services aux enfants âgés': 20.52059475862788,\n",
       " 'diagnostic confirmé de covid': 17.820979099403207,\n",
       " 'évaluation amgevita': 4.123262736057372,\n",
       " 'fibrine humaine johnson': 14.435122695833332,\n",
       " 'laboratoires regroupés': 14.67462338344166,\n",
       " 'traitement des patients adultes atteints du syndrome myasthénique': 22.650855971716172,\n",
       " 'stade avancé': 9.989568094456569,\n",
       " 'soins intensifs ventilation assistée': 12.213965208966812,\n",
       " 'gestion des pénuries': 15.90934480495572,\n",
       " \"remplacement du générateur d'un défibrillateur\": 29.26039138112501,\n",
       " 'rcr en contexte hors hospitalier': 23.979427911937194,\n",
       " 'documents inhérents': 9.676117307398684,\n",
       " \"aide d'une solution d'intelligence artificielle\": 17.690901003440445,\n",
       " 'coups et projets': 10.33415592169742,\n",
       " 'services en traumatologie': 11.160259338045476,\n",
       " \"refus de l'inscription\": 6.791065373303339,\n",
       " 'plan triennal': 14.02659016484347,\n",
       " 'prolothérapie dans le traitement des affections': 23.015478915831647,\n",
       " \"profil d'effets indésirables\": 10.092173416638822,\n",
       " 'hypernéphrome avancé': 5.8198837869986235,\n",
       " 'jeunes en difficulté': 16.21209792267004,\n",
       " 'carfilzomib amgen': 12.027567101887172,\n",
       " 'résultats cliniques en contexte réel': 15.12364013630306,\n",
       " 'leucémie aiguë': 12.828505174946399,\n",
       " 'normes et standards en protection de la jeunesse sommaire': 42.7271795681572,\n",
       " 'traitements alternatifs aux immunoglobulines': 20.58383217190404,\n",
       " 'oxygénation extracorporelle': 19.28719542063679,\n",
       " 'usage optimal cellulite': 17.40041623048642,\n",
       " 'jamp bicalutamide bicalutamide sanis cephalexin': 9.955313047145765,\n",
       " 'traitement de la schizophrénie': 17.355240008370693,\n",
       " 'consensus des recommandations': 9.667842125162709,\n",
       " 'test de détection des virus du papillome humain': 40.47732928850811,\n",
       " 'soins propres': 6.864524565535748,\n",
       " \"troubles d'oxydation des acides gras\": 12.338816932659421,\n",
       " 'description du médicament': 5.7013922018008305,\n",
       " 'déficiences physiques intellectuelles et tsa jeunes': 40.821328079079095,\n",
       " 'groupe traité': 11.134552912730946,\n",
       " 'formations et capsules': 19.838649634678834,\n",
       " 'chlamydia et gonorrhoeae davc': 19.09161500688949,\n",
       " 'répertoire signifie': 12.476763691209138,\n",
       " 'traitement pharmacologique de la mucosite oropharyngée': 31.55439836301991,\n",
       " 'infection par le sars cov': 26.405607472418264,\n",
       " 'prévention des maladies cardiovasculaires version française': 27.404525311055547,\n",
       " 'angita quétiapine fumarate de apo eletriptan': 6.565143763567681,\n",
       " 'chlorhydrate de phmscience': 9.451536417700288,\n",
       " 'évaluation bryhali halobétasol bauschhealth soulagement': 6.227401509951741,\n",
       " 'chlamydia trachomatis neisseria gonorrhoeae': 30.644430691535597,\n",
       " 'amélioration de la qualité': 15.440463351819224,\n",
       " 'pharma pour le traitement de la sclérose': 21.736163227214202,\n",
       " \"intention de la candidose buccale chez l'adulte\": 27.71090771117878,\n",
       " 'carcinome différencié de la thyroïde cdt': 12.772358091114148,\n",
       " 'facteur de croissance épidermique egfr': 25.737494371122995,\n",
       " 'naloxone par voie nasale version': 19.090256974802767,\n",
       " \"usage d'alcool\": 3.223509363375721,\n",
       " 'lymphomes à grandes cellules': 22.985634963570426,\n",
       " 'ioflupane datscan': 15.677639068539328,\n",
       " 'entérococcus résistant': 14.88568071607411,\n",
       " 'traumatic spinal': 15.971035377228866,\n",
       " 'cardiopathies congénitales': 20.09862728288761,\n",
       " 'jeunesse lpj': 17.568552609746433,\n",
       " 'pembrolizumab merck traitement du cancer du col': 22.583030824158048,\n",
       " 'inactivation des pathogènes': 14.515450783426466,\n",
       " 'utérus au québec': 10.62261254431652,\n",
       " 'microchirurgies pour la prévention et le traitement': 29.825719681389856,\n",
       " 'patients atteints du diabète de type': 21.38864586319782,\n",
       " 'pansement absorbant bordé': 27.15523714544856,\n",
       " 'dénomination commune nom': 1.7359481516195139,\n",
       " \"attente d'évaluation ultomiris ravulizumab\": 9.336198652874849,\n",
       " \"résultat sur l'échelle edss\": 15.865119242626985,\n",
       " \"recommandations pour l'implantation\": 3.5784253228375986,\n",
       " 'recherche clinique': 6.488056907331249,\n",
       " 'médicaments du québec': 7.0406254204177205,\n",
       " \"réaction d'allergie\": 6.936375343181206,\n",
       " \"inscription d'un médicament associé à un test\": 19.58881839850897,\n",
       " \"demande d'ajout\": 4.617587521101031,\n",
       " 'base des données': 10.843211903884766,\n",
       " \"recommandations sur l'usage\": 3.562338333653997,\n",
       " \"bromhydrate d'bicarbonate\": 0.6314120038596447,\n",
       " 'facteur de croissance': 13.560997376537422,\n",
       " 'santé mentale': 6.944155827134884,\n",
       " 'apotex élétriptan': 1.236537479708307,\n",
       " 'trichomonas vaginalis': 17.729439521893894,\n",
       " 'bilan sanguin': 18.145261509127494,\n",
       " \"utilisation d'endopredict\": 2.461418480930669,\n",
       " 'traitements pharmacologiques pour les enfants': 18.32383941525916,\n",
       " \"attente d'une évaluation\": 7.624772606510491,\n",
       " 'tavneos avacopan otsuka': 3.813861126791193,\n",
       " 'dispositifs médicaux évaluation': 13.460875277715381,\n",
       " 'incyte en association avec la lénalidomide pour le traitement': 22.97078066538708,\n",
       " 'infection à clostridium difficile réévaluation': 15.549946135637239,\n",
       " 'institut de recherche': 12.120895360151284,\n",
       " 'options de disposition des embryons conservés': 37.12483149816062,\n",
       " 'tumeur stromale gastro intestinale': 25.960831396273928,\n",
       " 'pompes intrathécales': 14.321805999499606,\n",
       " 'services de réadaptation présentant': 14.455418518887356,\n",
       " 'réponses rapides': 9.641898277485828,\n",
       " 'surveillance du glucose': 16.121691079232544,\n",
       " 'nombre de nouveaux cas covid hospitaliers': 22.305988723579464,\n",
       " 'amygdalite infections': 5.507571604402781,\n",
       " 'projet sujet début des travaux': 10.831170524409863,\n",
       " 'présentations cliniques': 4.651532013584195,\n",
       " \"demande en attente d'évaluation\": 13.616890833184165,\n",
       " 'affections post covid': 12.196272435222015,\n",
       " 'soulagement du prurit': 7.90781501830012,\n",
       " 'population du québec': 6.925479498773783,\n",
       " 'dénomination commune sujet nusinersen': 8.340095230282417,\n",
       " 'critères économique et pharmacoéconomique conclusion': 18.126029992688345,\n",
       " \"réévaluation en attente d'évaluation\": 13.27103384010499,\n",
       " \"prophylaxie de l'influenza\": 7.266156670516958,\n",
       " 'nodules thyroïdiens à cytologie': 27.216841060597343,\n",
       " 'indication reconnue aux listes des médicaments': 14.06839138005501,\n",
       " 'covid puis déclarée': 14.059933407732704,\n",
       " 'dose chez les patients': 11.620537379684077,\n",
       " 'plaques de forme': 9.707733626793937,\n",
       " 'excellence en santé et services': 13.877609308858691,\n",
       " 'soulagement du prurit patients': 9.61002444369486,\n",
       " \"guide d'usage optimal fibrillation\": 16.109481325886524,\n",
       " \"création et caractérisation d'une cohorte\": 27.207770158565893,\n",
       " \"évaluation aux fins d'inscription\": 9.249113413436067,\n",
       " 'hyperkaliémie chez les patients atteints': 10.02306598838238,\n",
       " \"cours d'évaluation vraylar cariprazine abbvie\": 8.864929955298397,\n",
       " 'trouble dépressif': 9.447088359551312,\n",
       " 'note des références': 8.772082873223406,\n",
       " \"usage optimal guide d'usage\": 13.802997551020626,\n",
       " 'conditions de succès': 12.300325218312182,\n",
       " \"influenza chez l'enfant et l'adulte\": 12.91354279980065,\n",
       " 'fabricant forme solution': 5.830314562274101,\n",
       " 'évaluation tavneos': 2.6884838948204637,\n",
       " \"sevrage d'alcool\": 9.019630423752735,\n",
       " 'marcan mometasone mométasone furoate monohydraté': 7.895597776260118,\n",
       " 'données contextuelles': 8.636877134402482,\n",
       " 'analyses de laboratoires regroupés': 22.082113448793145,\n",
       " \"portrait de l'utilisation des soins\": 13.395801010792946,\n",
       " 'sotorasib amgen': 5.566421479365978,\n",
       " 'nom commercial à venir tézépélumab': 12.352966747639325,\n",
       " \"qualité du milieu de vie en centre d'hébergement\": 28.0788232544769,\n",
       " \"traitement de l'angioedème\": 6.7777936973800355,\n",
       " 'étude randomisée': 8.999804341850156,\n",
       " 'évaluation des installations': 13.319868256661408,\n",
       " 'ordonnances individuelles': 10.47835331999584,\n",
       " 'iste des médicaments': 7.314075842205272,\n",
       " 'évaluation de afstyla mc rfviii': 28.23501144655354,\n",
       " ...}"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "terms_okapi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Collocation</th>\n",
       "      <th>OkapiBM25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>diagnostic confirmé</td>\n",
       "      <td>10.953870</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>trauma patients</td>\n",
       "      <td>9.510871</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>régime public</td>\n",
       "      <td>9.461682</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>solution d'intelligence artificielle</td>\n",
       "      <td>14.136489</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>cancer infectées par le sras cov</td>\n",
       "      <td>34.569086</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6665</th>\n",
       "      <td>arrondissement des doses d'agents</td>\n",
       "      <td>16.065151</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6666</th>\n",
       "      <td>fabricant novartis</td>\n",
       "      <td>5.588819</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6667</th>\n",
       "      <td>alcool troubles neurocognitifs document complé...</td>\n",
       "      <td>20.569432</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6668</th>\n",
       "      <td>durée de vie</td>\n",
       "      <td>11.555622</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6669</th>\n",
       "      <td>évaluation ultomiris</td>\n",
       "      <td>3.468818</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6670 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Collocation  OkapiBM25\n",
       "0                                   diagnostic confirmé  10.953870\n",
       "1                                       trauma patients   9.510871\n",
       "2                                         régime public   9.461682\n",
       "3                  solution d'intelligence artificielle  14.136489\n",
       "4                      cancer infectées par le sras cov  34.569086\n",
       "...                                                 ...        ...\n",
       "6665                  arrondissement des doses d'agents  16.065151\n",
       "6666                                 fabricant novartis   5.588819\n",
       "6667  alcool troubles neurocognitifs document complé...  20.569432\n",
       "6668                                       durée de vie  11.555622\n",
       "6669                               évaluation ultomiris   3.468818\n",
       "\n",
       "[6670 rows x 2 columns]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tab = DataFrame(terms_okapi.items(), columns=['Collocation', 'OkapiBM25'])\n",
    "tab"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Collocation</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence</th>\n",
       "      <th>TF-IDF</th>\n",
       "      <th>OkapiBM25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4255</th>\n",
       "      <td>seringues bd saline sp nacl</td>\n",
       "      <td>NOM ADJ ADJ NOM ADJ</td>\n",
       "      <td>7</td>\n",
       "      <td>0.590901</td>\n",
       "      <td>64.530807</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3937</th>\n",
       "      <td>vertu de la loi sur la protection de la jeunes...</td>\n",
       "      <td>NOM PRP DET:ART NOM PRP DET:ART NOM PRP DET:AR...</td>\n",
       "      <td>8</td>\n",
       "      <td>0.159432</td>\n",
       "      <td>55.850221</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4831</th>\n",
       "      <td>système de mesure du glucose en continu guardi...</td>\n",
       "      <td>NOM PRP NOM PRP:det NOM PRP NOM ADJ ADJ</td>\n",
       "      <td>6</td>\n",
       "      <td>0.156902</td>\n",
       "      <td>53.401714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2331</th>\n",
       "      <td>services en vertu de la loi sur la protection ...</td>\n",
       "      <td>NOM PRP NOM PRP DET:ART NOM PRP DET:ART NOM PR...</td>\n",
       "      <td>17</td>\n",
       "      <td>0.203912</td>\n",
       "      <td>50.589724</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4750</th>\n",
       "      <td>pertinence des envois de prélèvements en patho...</td>\n",
       "      <td>NOM PRP:det NOM PRP NOM PRP NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "      <td>0.272956</td>\n",
       "      <td>50.390892</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>apotex élétriptan</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>474</td>\n",
       "      <td>0.133841</td>\n",
       "      <td>1.236537</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>apo eletriptan</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>489</td>\n",
       "      <td>0.131846</td>\n",
       "      <td>1.220759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>dénomination commune</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>564</td>\n",
       "      <td>0.129499</td>\n",
       "      <td>1.203497</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>évaluations récemment</td>\n",
       "      <td>NOM ADV</td>\n",
       "      <td>474</td>\n",
       "      <td>0.133841</td>\n",
       "      <td>1.158830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>fabricant forme</td>\n",
       "      <td>NOM VER:pres</td>\n",
       "      <td>30</td>\n",
       "      <td>0.210755</td>\n",
       "      <td>1.017784</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5256 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Collocation  \\\n",
       "4255                        seringues bd saline sp nacl   \n",
       "3937  vertu de la loi sur la protection de la jeunes...   \n",
       "4831  système de mesure du glucose en continu guardi...   \n",
       "2331  services en vertu de la loi sur la protection ...   \n",
       "4750  pertinence des envois de prélèvements en patho...   \n",
       "...                                                 ...   \n",
       "57                                    apotex élétriptan   \n",
       "23                                       apo eletriptan   \n",
       "12                                 dénomination commune   \n",
       "38                                évaluations récemment   \n",
       "805                                     fabricant forme   \n",
       "\n",
       "                                   Structure syntaxique  Fréquence    TF-IDF  \\\n",
       "4255                                NOM ADJ ADJ NOM ADJ          7  0.590901   \n",
       "3937  NOM PRP DET:ART NOM PRP DET:ART NOM PRP DET:AR...          8  0.159432   \n",
       "4831            NOM PRP NOM PRP:det NOM PRP NOM ADJ ADJ          6  0.156902   \n",
       "2331  NOM PRP NOM PRP DET:ART NOM PRP DET:ART NOM PR...         17  0.203912   \n",
       "4750            NOM PRP:det NOM PRP NOM PRP NOM PRP NOM          6  0.272956   \n",
       "...                                                 ...        ...       ...   \n",
       "57                                              NOM ADJ        474  0.133841   \n",
       "23                                              NOM ADJ        489  0.131846   \n",
       "12                                              NOM ADJ        564  0.129499   \n",
       "38                                              NOM ADV        474  0.133841   \n",
       "805                                        NOM VER:pres         30  0.210755   \n",
       "\n",
       "      OkapiBM25  \n",
       "4255  64.530807  \n",
       "3937  55.850221  \n",
       "4831  53.401714  \n",
       "2331  50.589724  \n",
       "4750  50.390892  \n",
       "...         ...  \n",
       "57     1.236537  \n",
       "23     1.220759  \n",
       "12     1.203497  \n",
       "38     1.158830  \n",
       "805    1.017784  \n",
       "\n",
       "[5256 rows x 5 columns]"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tab.sort_values([\"OkapiBM25\"], \n",
    "                    axis=0,\n",
    "                    ascending=[False], \n",
    "                    inplace=True)\n",
    "\n",
    "tab = pd.merge(terms_weighted, tab, on=\"Collocation\")\n",
    "tab.sort_values([\"OkapiBM25\"], \n",
    "                    axis=0,\n",
    "                    ascending=[False], \n",
    "                    inplace=True)\n",
    "\n",
    "tab"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "base_path = '../05-transformation/'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "if tag:\n",
    "    file_path = base_path + acteur + '_' + tag + '_weighting_OKapiBM25.csv'\n",
    "\n",
    "else: \n",
    "    file_path = base_path + acteur  + '_weighting_OKapiBM25.csv'\n",
    "tab.to_csv(file_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Collocation</th>\n",
       "      <th>Structure syntaxique</th>\n",
       "      <th>Fréquence</th>\n",
       "      <th>TF-IDF</th>\n",
       "      <th>OkapiBM25</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4255</th>\n",
       "      <td>seringues bd saline sp nacl</td>\n",
       "      <td>NOM ADJ ADJ NOM ADJ</td>\n",
       "      <td>7</td>\n",
       "      <td>0.590901</td>\n",
       "      <td>64.530807</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3937</th>\n",
       "      <td>vertu de la loi sur la protection de la jeunes...</td>\n",
       "      <td>NOM PRP DET:ART NOM PRP DET:ART NOM PRP DET:AR...</td>\n",
       "      <td>8</td>\n",
       "      <td>0.159432</td>\n",
       "      <td>55.850221</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4831</th>\n",
       "      <td>système de mesure du glucose en continu guardi...</td>\n",
       "      <td>NOM PRP NOM PRP:det NOM PRP NOM ADJ ADJ</td>\n",
       "      <td>6</td>\n",
       "      <td>0.156902</td>\n",
       "      <td>53.401714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2331</th>\n",
       "      <td>services en vertu de la loi sur la protection ...</td>\n",
       "      <td>NOM PRP NOM PRP DET:ART NOM PRP DET:ART NOM PR...</td>\n",
       "      <td>17</td>\n",
       "      <td>0.203912</td>\n",
       "      <td>50.589724</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4750</th>\n",
       "      <td>pertinence des envois de prélèvements en patho...</td>\n",
       "      <td>NOM PRP:det NOM PRP NOM PRP NOM PRP NOM</td>\n",
       "      <td>6</td>\n",
       "      <td>0.272956</td>\n",
       "      <td>50.390892</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>apotex élétriptan</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>474</td>\n",
       "      <td>0.133841</td>\n",
       "      <td>1.236537</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>apo eletriptan</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>489</td>\n",
       "      <td>0.131846</td>\n",
       "      <td>1.220759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>dénomination commune</td>\n",
       "      <td>NOM ADJ</td>\n",
       "      <td>564</td>\n",
       "      <td>0.129499</td>\n",
       "      <td>1.203497</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>évaluations récemment</td>\n",
       "      <td>NOM ADV</td>\n",
       "      <td>474</td>\n",
       "      <td>0.133841</td>\n",
       "      <td>1.158830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>fabricant forme</td>\n",
       "      <td>NOM VER:pres</td>\n",
       "      <td>30</td>\n",
       "      <td>0.210755</td>\n",
       "      <td>1.017784</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5256 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            Collocation  \\\n",
       "4255                        seringues bd saline sp nacl   \n",
       "3937  vertu de la loi sur la protection de la jeunes...   \n",
       "4831  système de mesure du glucose en continu guardi...   \n",
       "2331  services en vertu de la loi sur la protection ...   \n",
       "4750  pertinence des envois de prélèvements en patho...   \n",
       "...                                                 ...   \n",
       "57                                    apotex élétriptan   \n",
       "23                                       apo eletriptan   \n",
       "12                                 dénomination commune   \n",
       "38                                évaluations récemment   \n",
       "805                                     fabricant forme   \n",
       "\n",
       "                                   Structure syntaxique  Fréquence    TF-IDF  \\\n",
       "4255                                NOM ADJ ADJ NOM ADJ          7  0.590901   \n",
       "3937  NOM PRP DET:ART NOM PRP DET:ART NOM PRP DET:AR...          8  0.159432   \n",
       "4831            NOM PRP NOM PRP:det NOM PRP NOM ADJ ADJ          6  0.156902   \n",
       "2331  NOM PRP NOM PRP DET:ART NOM PRP DET:ART NOM PR...         17  0.203912   \n",
       "4750            NOM PRP:det NOM PRP NOM PRP NOM PRP NOM          6  0.272956   \n",
       "...                                                 ...        ...       ...   \n",
       "57                                              NOM ADJ        474  0.133841   \n",
       "23                                              NOM ADJ        489  0.131846   \n",
       "12                                              NOM ADJ        564  0.129499   \n",
       "38                                              NOM ADV        474  0.133841   \n",
       "805                                        NOM VER:pres         30  0.210755   \n",
       "\n",
       "      OkapiBM25  \n",
       "4255  64.530807  \n",
       "3937  55.850221  \n",
       "4831  53.401714  \n",
       "2331  50.589724  \n",
       "4750  50.390892  \n",
       "...         ...  \n",
       "57     1.236537  \n",
       "23     1.220759  \n",
       "12     1.203497  \n",
       "38     1.158830  \n",
       "805    1.017784  \n",
       "\n",
       "[5256 rows x 5 columns]"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tab"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.9.12 ('base')",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "a33210152f7d2bd255fb16656f372b633dbf298ed202bbbac20290b0375cadb7"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
